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Abstract 
 
Paediatric burn injuries are a traumatic event causing significant pain, anxiety and distress 
at the time of injury and throughout the resulting wound care procedures.   Pain and 
anxiety management not only play a significant role in determining how the child will cope 
with wound care procedures, but may influence long term pain hypersensitivities and the 
development of psychological conditions (e.g. acute stress symptoms and post-traumatic 
stress disorder).  Mounting evidence supports links between pain/anxiety/stress and the 
negative effects these experiences have on wound healing, however no study has delved 
into investigating these possible links or causal relationships in the area of burns.  The aim 
of this study was to determine if reducing the pain, anxiety and stress of a child during 
repeated burn wound care procedures (using the multi-modal procedural preparation and 
distraction Ditto™ intervention), reduced the number of days for burns to re-epithelialise.  
 
A pilot study was carried out to understand the profiles of salivary alpha-amylase and 
salivary cortisol during burn wound care procedures, to inform the larger study on ideal 
collection time points to measure these biological markers of stress.  Salivary alpha-
amylase levels peaked at zero minutes post dressing removal/wound debridement, and 
salivary cortisol levels peaked a further ten minutes later.   
 
A prospective randomised controlled trial (RCT) was undertaken with children 4-12 years 
who presented with an acute burn injury for their first dressing change.  Participants were 
randomly assigned to either the (1) Control group (standard preparation and distraction) or 
(2) Ditto™ intervention group (receiving Ditto™ procedural preparation and Ditto™ 
distraction).  Repeated measures of pain intensity, anxiety, stress and re-epithelialisation 
were taken at every dressing change until complete re-epithelialisation.   
 
Seventy-seven children (4-12 years) participated in the RCT; 41 in the control group and 
36 in the Ditto™ intervention group.  Ditto™ procedural preparation and distraction were 
found to reduce re-epithelialisation by two days (p=0.046) when adjusted for burn depth.  
An economic evaluation was performed which concluded the Ditto™ intervention to be 
highly effective against standard practice at a minimal cost for the significant benefits 
gained.  The estimated cost-effectiveness ratio showed a median cost of $64 (interquartile 
range = $10 - $106) for every one day reduction in days to re-epithelialise when children 
had access to Ditto™ intervention, over standard practice.  The positive gains support the 
implementation of Ditto™ procedural preparation and distraction intervention during burn 
wound care. 
 
Factors that contributed towards delaying re-epithelialisation were identified as: burn depth 
(by laser Doppler imaging), days taken to present to the burn centre, pain levels of children 
who did not receive the Ditto™ intervention, ethnic origin, flame as the mechanism of 
injury and total body surface area of the burn.  These factors accounted for 69% of 
variance in the model.  Surprisingly, burn injuries on participants from ethnicities of darker 
skin complexion re-epithelialised 25% faster than participants with a lighter skin 
complexion (p=0.001).  Despite adjustment for burn depth, flame as the mechanism of 
burn injury was found to delay re-epithelialisation by 39% compared to all other 
mechanisms (p=0.003).   
 
Salivary alpha-amylase was found to be a better biological measure of stress than salivary 
cortisol during morning burn clinics.  Higher salivary alpha-amylase levels were 
significantly associated with higher pain scores (p=0.021), receiving no medication 
(p=0.047), and higher Child Trauma Screening Questionnaire scores (p=0.008) at three 
months post re-epithelialisation.  
 
Burden of injury encompasses a multitude of psychological and physiological factors for 
the patient and significant costs to the health care system.  Use of the Ditto™ non-
pharmacological intervention as an adjunct to standard practice is a worthwhile 
intervention minimising days to re-epithelialise at a minimal cost to the health care system.    
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1.1 Background 
Burn injuries are a traumatic event and remain one of the leading causes of paediatric 
morbidity and mortality globally [1].  Burns and their resultant wound care procedures 
cause undeniably high levels of pain and distress.  The complexities surrounding 
procedural pain, together with the challenges of assessing and treating paediatric pain, 
highlight why pain continues to be an adverse outcome of burn wound care [2, 3]. 
 
‘Pain treatment,’ (treating pain before its onset), rather than ‘pain management’ (treating 
pain when it occurs), is required to achieve optimal care, minimising pain experiences and 
preventing conditioned anxiety responses to stimuli associated with painful burn wound 
care procedures [4].  Medication alone often falls short of treating and alleviating 
procedural burn pain.  Anticipatory anxiety reduces pain tolerance and amplifies pain 
experiences, particularly in young children [5].  Managing pain derived from escalations in 
anxiety held by the child, is more challenging than treating the pain itself [4].  A growing 
body of burn research supports a two-stage approach, combining medication with non-
pharmacological intervention to achieve optimal patient care and outcomes.  
Advancements in technology have given rise to the development of non-pharmacological 
modalities including virtual reality and customised computerised devices.  Reduction in 
pain intensity, distress, unpleasantness, the time spent thinking about pain and procedural 
time have been reported in these studies during burn wound care procedures, using these 
customised computer technologies as an adjunct to pharmacological analgesia [6-14].  
Beyond the scope of reducing pain, anxiety and distress, the potential impact these non-
pharmacological computerised interventions may have on the rate of re-epithelialisation 
has not been explored. 
 
Minimising days to re-epithelialise is of prime importance in burn injuries.  Re-
epithelialisation is the cellular process that occurs to rapidly restore the epidermal layer of 
the skin.  Integrity of this outer layer of the skin is important as a protective barrier to 
external pathogens and to maintain internal homeostasis [15].  The risk of hypertrophic 
scar formation is known to increase in wounds in which re-epithelialisation extends beyond 
Chapter 1. Introduction 
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14 days [16, 17].  Burn depth measured by laser Doppler imaging is the only known 
predictor of healing potential [18].  Other factors that may impede burn re-epithelialisation 
have not been comprehensively investigated.  Beyond the obvious physical appearance of 
scarring, functional impairments can result from scar formation in young children.  
Hypertrophic scars do not grow with the child, which can be problematic when scarring 
occurs across joints, impeding range of motion and resulting in the need for re-constructive 
surgeries. 
 
Burn injuries and hypertrophic scar formation have significant psychological impacts.  The 
incidence of acute stress symptoms occurring in children following a burn injury is as high 
as 33% [19-21].  The delineation between pain, anxiety and stress using rating scales in 
children are challenging, particularly as pain cannot be experienced without an emotive 
component [136].  The response of the hyper-pituitary adrenal axis is widely accepted 
biomarker of stress [22], however use of salivary cortisol has not been investigated well in 
burn injury [238], neither has its relationship to pain and anxiety measures.  In addition to 
stress reactions, the permanent physical disfigurement of scarring, adds even greater 
psychosocial challenges resulting in significant long-term effects on quality of life [23].  
Improving the rate of re-epithelialisation to minimise adverse physical, functional and 
psychological outcomes for burn patients is of great importance. 
 
On a structural level, increasing numbers of children with burn injuries are being treated as 
outpatients [24], due to advancements in technology of dressings and burn diagnostics.  
Freeing up hospital beds, in favour of outpatient management for partial thickness burn 
injuries has seen a strain on resources with busy clinics servicing high outpatient numbers.  
Exploration of the demographic, clinical and wound characteristics that collectively delay 
re-epithelialisation in paediatric outpatient burn injuries would provide novel and valuable 
information allowing for the prioritisation of resource allocation and identification of optimal 
patient care pathways to improve outcomes. 
 
Innovative technology comes at a cost and is a common barrier to the implementation of 
new interventions within a budget-constrained healthcare system.  Burden of injury 
encompasses a multitude of psychological and physiological factors for the patient and 
significant costs to the patient and healthcare system.  Very few economic evaluations 
have been carried out in the area of burns, with no comprehensive economic evaluation 
performed for paediatric burn outpatients.  The real cost of burns is largely unknown.  
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There is great need for cost-effectiveness analyses to be performed to justify 
implementation and clinical utility of new interventions. 
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1.2 Thesis Aims 
This thesis aimed to investigate whether procedural preparation and distraction 
intervention using the Ditto™ device (Diversionary Therapy Technologies, Brisbane, 
Australia), had an effect on reducing the number of days for burns to re-epithelialise 
compared to standard practice, in paediatric patients.  This was achieved through 
conducting a randomised controlled trial (RCT) where the primary outcome was re-
epithelialisation and secondary outcomes included measures of pain, anxiety and stress.  
Participants were children aged three to twelve years who presented with an acute burn 
injury to the Stuart Pegg Paediatric Burn Centre at the Royal Children’s Hospital, Brisbane, 
Australia.   
  
The extensive data collected from the RCT led to the development of several other 
studies.  To assess the Ditto™ in monetary terms an economic evaluation was carried out 
comparing the Ditto™ intervention against standard care throughout burn wound re-
epithelialisation and scar management.   
 
Biological measures of stress were collected in the RCT which enabled the stress 
response during burn wound care procedures to be investigated.  Additionally, factors 
associated with higher stress responses were examined.  As burn re-epithelialisation was 
the primary outcome measure, this allowed for an additional study to be undertaken, 
identifying the factors which could predict delayed burn wound re-epithelialisation in 
children with superficial to deep partial thickness burn injuries. 
 
 
1.3 Thesis Overview  
Some background information on burn injuries and the importance of hastening re-
epithelialisation is established in the beginning of this thesis (Chapter 2).  This is followed 
by a review of the literature on the pain, anxiety and stress often associated with burn 
wound care procedures and the effects these experiences have on burn re-
epithelialisation.  Chapter 3 details a pilot study which established the required saliva 
collection time points required for the randomised controlled trial (RCT), which this thesis 
is based upon.  The methodology of the RCT is detailed in Chapter 4 and has been 
published.  Chapter 5 reports on the results of the biological markers of stress collected 
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during wound care procedures (accepted for publication).  The results of the RCT which 
investigated the effect of a non-pharmacological Ditto™ intervention on the rate of burn re-
epithelialisation, in comparison to standard care, are presented in a published paper, 
(Chapter 6).  This is followed by an investigation into the factors which delay burn re-
epithelialisation, based on data collected in the RCT (Chapter 7) which is also published.  
The cost-effectiveness of the Ditto™ intervention is presented in Chapter 8, providing an 
economic evaluation of the intervention being tested in this thesis.  Chapter 9 concludes 
this thesis with a synthesis of the main findings, conceptualising these results within the 
context of clinical implications, study limitations and directions for future research. 
  
5
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This chapter includes an overview of burn injuries, providing a background level of 
understanding in regard to burn severity, classification and burn re-epithelialisation.  Current 
literature on burn pain, anxiety and stress has been reviewed and possible links with delayed 
healing have been presented.  Finally, non-pharmacological intervention targeting pain, stress 
and anxiety were explored. 
 
  
Chapter 2. Literature Review 
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2.1 Aetiology of Burns 
Burns are a common childhood injury, with over 500,000 children being hospitalised 
worldwide every year [25].  Within Australia and New Zealand, the incidence of paediatric 
burn injuries resulting in hospitalisation to a burn centre during July 2011 to June 2012 
was approximately 2772, of which 87% were less than 10% of total body surface area 
(TBSA) burned [26].  Changes in practice have shifted from treating superficial to deep 
partial-thickness burn injuries from an inpatient to an outpatient model.  Conservatively, 
80-90% of patients treated at the Stuart Pegg Paediatric Burn Centre, Brisbane, Australia, 
were managed as outpatients, meaning the true numbers of burn injuries are under 
counted.  The number of paediatric burns treated as outpatients at burn centres across 
Australia and New Zealand is unknown.  At the Royal Children’s Hospital, Brisbane, 
approximately 700 outpatients (unpublished data) accessed the Stuart Pegg Paediatric 
Burn Centre during 2013.   
 
Burn injuries are a significant cause of morbidity for children.  The associated 
psychological implications that commonly accompany the trauma of a burn injury make its 
exact cost unquantifiable [27].   The economic cost of hospitalised burn injuries (inpatients) 
to the Australian health system was estimated by the Australian Institute of Health and 
Welfare (2004) to be between $38.7 million to $40.2 million per year [28].  Similarly, data 
collected by the Bi-National Burns Registry of Australia and New Zealand represents only 
a fraction of all paediatric burn injuries treated in burn centres, as data is only recorded 
when patients are admitted for longer than 24 hours [26].  Outpatient burn data are 
challenging to collect, therefore, the burden of burn injuries to the health system and 
patients is undeniably significant, but largely unrepresented.  Arguably, burn injuries are 
one of the highest financial costs in paediatric healthcare, yet limited health economic 
research has been invested in this area. 
 
2.1.1   Classification of Burns 
Skin is the body’s largest organ and is comprised of the epidermal and dermal layers 
(Figure 2-1).  The thickness of the epidermis varies (0.05 mm to 1 mm) depending on body 
part [29, 30].  Burns result from a number of causes including: scald, solar, contact, flame, 
chemical and electrical mechanisms of injury.  Scald injuries are most commonly reported 
in the area of paediatrics [1, 26], and often result in mixed depth superficial to deep partial 
thickness burns.  Burn depth is dependent on the heat source of the burn, duration of 
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exposure/contact, mass of the heat source, skin thickness and blood flow enabling heat 
dissipation, thermal conductivity and heat convection [29, 31].   
Burn depth is categorised as follows: 
 
Superficial burn:   Erythema only, involving only the epidermis and does 
not form blisters.  Commonly seen in sunburn and typically subsides within 3-4 days [30]. 
 
Superficial dermal burn:  Commonly referred to as superficial partial thickness 
burns, extend down to the papillary dermis and commonly blister [30].  The wound is pink, 
wet and shiny in appearance, hypersensitive when left uncovered and open to air currents 
and painful when touched [29].  Re-epithelialisation typically occurs within 2-3 weeks 
without resultant scarring. 
 
Deep dermal burn:   Often referred to as a deep partial thickness burn, 
presents with a mottled pink and white appearance, it extends into the reticular dermis.  
These burns may also blister and will typically take at least three weeks to re-epithelialise, 
and may require grafting.  Patients often report feelings of discomfort and pressure [30]. 
 
Full thickness burn:  The burn involves the entire dermis and extends down to 
the subcutaneous tissue and may appear depressed compared to surrounding tissue [30].  
The appearance may be mottled, charred, waxy, leathery, dry, white, firm and insensate 
[30, 32].  On occasions they can be red in appearance, however lack of blanching with 
pressure confirms full thickness in depth [30].  Full thickness burns should be excised and 
grafted. 
 
A burn injury will usually consist of areas of different depth (e.g. predominately deep 
dermal with a small area of full thickness).  The amount of tissue damage that results from 
a burn can be divided into three zones which radiate outward from the deepest or worst 
damaged area (coagulation/necrosis, stasis and hyperaemia), and was first outlined by 
Jackson [33].  Transition between these zones is dependent on wound management, in 
particular the middle most influential zone of stasis comprises of viable and non-viable 
cells [30].  Zawacki [34] identified the ability to reverse capillary stasis with proper wound 
hydration (dressings) to prevent the transition into necrosis.  The varying zones of a burn, 
and ability for changes to occur, present a challenge in wound assessment, to accurately 
classify the heterogeneity of burns.  
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Figure 2-1 Burn depth [35] 
 
 
2.1.2   Measures to Classify Burns 
2.1.2.1 Burn Size 
Burn size is expressed as a percentage of the total body surface area burned, and is most 
commonly measured in clinical practice by surface area estimation [36] using the Lund-
Browder Chart [37], or the Rule of Nines [38].  Computer-based evaluation methods are 
emerging in the area of burn research and proving most accurate in quantifying burn size 
[39, 40] compared to subjective estimations where even experienced burn clinicians tend 
to over-estimate size.  Despite these reports of over-estimation, variance among burn 
physicians and nurses in the assessment of burn size appears minimal.  Miller et.al. [36] 
examined inter-rater variability in burn size estimation through surveying burn physicians 
and nurses and yielded consistent results across the 46 North American burn centres 
surveyed, and consistent estimates between burn physicians and nurses.  Burn size 
estimations performed by highly experienced burn clinicians within tertiary burn centres 
can therefore be considered adequate, and are favoured in clinical practice due to the high 
clinical utility of immediate bedside assessment. 
  
2.1.2.2 Burn Depth 
Accurate assessment of burn depth is critical and largely dictates wound management 
decisions and determines clinical outcomes.  The histological ‘gold standard’ assessment 
of burn depth has been a punch biopsy examination [29].  Punch biopsy is rarely used 
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today as a measure of depth due to: the invasive nature of this technique; only providing a 
snapshot of the burn depth, which is a major limitation in determining mixed depth burns 
(as adjacent areas to the biopsy are likely to differ in depth); resultant scarring from the 
biopsy; sampling error; and the need for highly trained pathologists to interpret results [18, 
29].  Advancements in technology have led to an accurate non-invasive assessment of 
burn depth with the use of laser Doppler imaging (LDI) [41-47].  A highly vascularised 
wound implies that sweat ducts, sebaceous glands and hair follicles are intact.  These 
structures are the source of newly generated epithelial cells.  Assessing blood supply to a 
wound with the use of LDI can therefore be used to estimate re-epithelialisation and is 
used to assess healing potential [47].  LDI combines the Doppler flowmetry principles [48-
50] with a scanning technique to obtain flux values of the whole wound area (rather than 
the former, measured by a probe in contact with the skin).  The flux values are expressed 
in perfusion units derived from the laser light frequency shift, which is proportional to the 
movement of red blood cells detected against the static skin tissue (Figure 2-2).  The 
perfusion units are extrapolated onto a two dimensional flux colour scale whereby the 
scanned image is pictorially graded by colour. An accompanying grey-scale photographic 
image is also produced alongside the scan which anatomically assists in mapping regions 
of interest with the Moor computer software (moorBDA v2.4), to define the borders of the 
wound.  
 
Clinical evaluation of a burn is a subjective measure based on the wound appearance, 
capillary refill, sensitivity to touch and pin prick [51].  Several studies corroborate the 
accuracy of LDI over the clinical judgement of burn specialists in the assessment of burn 
depth.  LDI has been reported to be 90% – 100% accurate, whereas burn depth and 
healing potential measured by clinical judgement has been reported as only 53% - 80% 
accurate [18, 42, 43, 52-54].  Additionally, LDI is the only burn specific measure that has 
been approved by the American Federal Drug Administration [18].  With the definitive 
evidence of LDI sensitivity, specificity, and predictive value in the assessment of burn 
depth, it can now be regarded as ‘gold standard’ in the assessment of burn depth rather 
than punch biopsy. 
 
2.1.2.2.1 Interpretation of Burn Depth by LDI 
Recent developments of the LDI flux colour scale have seen a change in scale from 16 to 
six colours [46].  Additionally, flux boundaries of each colour have been aligned with 
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clinically relevant healing potential timeframes to improve interpretability of LDI [46].  
These laser Doppler colour codes have been validated [47] and are as follows: 
 
Red   - Expected to re-epithelialise within 14 days post-injury 
Pink   - Re-epithelialisation expected around 14 days, shorter if  
associated with red and longer if associated with yellow  
Yellow   - Expected to re-epithelialise between 14 – 21 days post-injury 
Green   - Re-epithelialisation expected around 21 days, shorter if  
associated with yellow and longer if associated with blues  
Light/dark Blue - Not expected to re-epithelialise before 21 days post-injury 
 
 
 
Figure 2-2 LDI flux image colour palette [55] 
 
 
2.2 Re-epithelialisation and Hypertrophic Scar Development 
The speed of re-epithelialisation is of high importance in burn wound management.  Burn 
depth and the number of days taken for burns to re-epithelialise are the only known 
predictors of wound outcome [18, 56].  Deitch et.al. [16] studied a population of superficial 
to deep partial thickness burn injuries and was the first to identify the importance of 
wounds re-epithelialising before or within the 10-14 day window to avoid the development 
of hypertrophic scarring.  Burns re-epithelialising 14-21 days post injury became 
hypertrophic in 33% of patients and in those that re-epithelialised beyond 21 days 78% of 
patients developed hypertrophic scarring.  Cubison et.al. [17] retrospectively studied 
paediatric scald injuries and reported similar incidence rates, with hypertrophic scarring 
occurring in 20% of patients whose burns re-epithelialised within 15-21 days and in 80% of 
patients whose burns re-epithelialised in over 21 days. 
 
Beyond burn depth, no study has comprehensively investigated what other factors 
influence re-epithelialisation; however, several studies have identified the factors 
associated with hypertrophic scar formation.  The association of ethnicity with the 
likelihood of hypertrophic scar formation is well-known and reported in several studies.  
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Partial thickness burns on children and adults with darker skin complexion were reported 
to develop hypertrophic scarring in 31% of cases, compared to 16% of people with lighter 
skin complexion [16].  A retrospective study by Bombaro et.al. [57] reported the presence 
of hypertrophic scarring in 80% of people with darker skin complexion compared to 64% of 
people with lighter skin complexion.  However, that study did not account for burn depth or 
severity.  A study by Thompson et.al. [58] examined sub-populations of patient ethnicities 
and identified American Indian and Alaskan Native races had an odds ratio of 11.97 (p = 
0.02), in comparison to Caucasian race.  The development of hypertrophic scarring  on the 
site of grafted burns has also shown differences in ethnicity with 64% developing scarring 
in people with darker skin complexion compared to 22% of people with lighter skin 
complexion [59].  Anatomical burn site, mechanism of injury, burn size >20% TBSA, 
gender, age, number and type of surgical procedures have also been reported to show 
associations with the likelihood of hypertrophic scar formation [16, 58-61].   
 
Psychological implications of scarring are not determined by the size or extent of the 
physical disfigurement [62].  The psychological trauma experienced by children following a 
burn injury continues to perpetuate long after the wound has healed.  Maskell et.al. [23] 
found children and adolescents with permanent scarring resulting from a burn injury 
reported higher emotional and behavioural problems, difficulties with perceived physical 
appearance and lower health-related quality of life in comparison to healthy norms.  
Hastening re-epithelialisation may reduce the likelihood of hypertrophic scarring and have 
significant psychological and psychosocial gains for individuals.  
 
2.2.1  Measures of Re-epithelialisation 
Burn re-epithelialisation can be measured by a number of methods designed to calculate 
wound area including: the ruler method; acetate tracing with manual square counting or 
mechanical planimetry; and computerised planimetry with photography.  These methods 
have been detailed by Keast et.al. [63] in a clinical review paper which proposed a 
framework for developing best practice in the assessment of wounds.  Electronic or 
computerised planimetry methods were determined to be more accurate than manual 
methods [63].   
 
A recent development in electronic devices measuring wound area is the Visitrak™ (Smith 
& Nephew) which has been used across a number of clinical areas and research practices 
[64-66].  Wound length, width and area are accurately measured (to 0.1 cm²) by the 
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Visitrak™ tablet after tracing the wound on the transparent sterile grid [63].  No gold 
standard assessment has been established in the measurement of re-epithelialisation, 
however a number of studies have reported high validity, intra- and inter-rater reliability 
and high clinical utility of the Visitrak™ in comparison to computerised planimetry methods 
[67-69].  The Visitrak™ was chosen for use in this study to accurately measure re-
epithelialisation.  For the purpose of this thesis, burns were considered to be re-
epithelialised when wounds reached ≥95% closure of the wound area.   
 
 
2.3 Pain, Anxiety & Stress of Burn Wounds 
Burn injuries are one of the most painful types of trauma a child is ever likely to 
experience.  Additionally, burn wound management procedures such as dressing changes 
and wound debridement often inflict further pain and can be more painful than the injury 
itself [70].  It is not surprising then that the entire wound healing period can provoke a high 
level of stress and anxiety, particularly in children [71-73]. 
 
2.3.1  Anxiety and Distress 
Anxiety, which commonly coexists with pain, impedes our coping mechanisms and ability 
to tolerate pain.  Anxiety is a future-orientated emotion of apprehension, nervousness, 
tension, fear and worry, accompanying physical sensations and influencing subjective 
perception [74-76].   Highly anxious burn patients are therefore more susceptible to lower 
pain tolerance [77, 78].  Several studies refer to the reciprocal relationship between pain 
and anxiety [79-82].   In addition to anxiety, burn injuries, which are a type of trauma, may 
induce psychological disorders including acute stress symptoms [21] and post-traumatic 
stress disorder (PTSD) [20, 83, 84].  
 
2.3.2   Pain 
Pain is multidimensional and highly complex involving the orchestration of sensation and 
perception. Pain can be defined as “an unpleasant sensory and emotional experience 
associated with actual or potential tissue damage, or described in terms of such damage” 
[85].  The very nature of this definition highlights the multitude and complexity of 
assessing, managing and treating pain.  
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Emotions, individual attributes and cognitive factors greatly contribute to the experience of 
pain.  Understanding feelings of pain, past experiences of pain, memory, age, expectation, 
context, previous environmental cue conditioning, religious and cultural conditioning, focus 
of attention, anxiety, fear, level of control over the situation, personality, and pain threshold 
play a significant role in diminishing or magnifying the perception of pain [86-89].  
Ultimately, pain comes down to what the patient describes and says it is [90, 91].  This 
presents a significant challenge in the assessment of pain in young children.  
 
2.3.3  Paediatric Pain Management 
Pain management in children is greatly inadequate across varying injuries and conditions, 
compared to adult pain management.  Historical misconceptions that babies and young 
children do not feel pain due to immature neurological systems, the belief that children 
have no memory for pain, or the fear of drug addiction, have resulted in pain being 
commonly ignored and undertreated [92-100].  Attitudes and practices in paediatric pain 
have shifted in the last decade; however, under-treatment of children’s pain is still 
apparent. 
 
The inability of infants and toddlers to verbally express their pain experience places them 
in a more vulnerable position in terms of under-treatment of pain.  Young children’s 
understanding, conceptualisation and ability to cope with pain are largely shaped by social 
learning, early experiences of pain and their developmental level.  Toddlers engage in 
comfort seeking behaviours during painful experiences, whereas young school-age 
children can begin to utilise cognitive-based coping skills [101].  Exposure to repeatedly 
noxious stimuli as an infant can lead to permanent changes on the neuronal architecture of 
the developing brain, resulting in greater sensitivity to pain in adolescence [101].   
 
2.3.4  Burn Wound Pain 
Burn pain commonly does not correlate to the burn classification of thickness or total body 
surface area (TBSA) injured [2, 32, 82].  Superficial and partial thickness burns devoid of 
epidermis, with exposed peripheral nerve endings cause extreme pain (particularly when 
exposed to air currents) irrespective of TBSA of the burn [102].  Deeper burns which 
damage the nerve theoretically reduce the amount of pain experienced.  Despite this, 
more severe burns will take longer to heal, thus patients will be subjected to many more 
painful procedures than an acute burn of a much smaller surface area.  Burns are however 
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rarely completely full thickness and pain will fluctuate as nerve endings regenerate [32, 
103, 104].  On any given day, analgesia requirements may be the same irrespective of 
burn severity.  The extent of the burn injury and the severity of the burn injury therefore do 
not necessarily predict burn pain [104-106].   
 
The change in burn wounds throughout the healing process leads to fluctuating degrees of 
pain and types of pain experienced e.g. background and procedural pain, and possibly 
breakthrough and post-operative pain [2].  In addition to tissue damage, following a burn 
injury, a period of hyperalgesia occurs whereby the area around the wound is extremely 
sensitive to pain.  Repeated burn wound care procedures further aggravate the already 
highly sensitive nociceptors in the wound and surrounding areas [32, 107].   
 
Procedural pain is the most intense pain and the most common type of burn pain to be 
undertreated.  Patients describe an intense burning and stinging pain that may be 
accompanied by sharp pain lasting for minutes to hours after burn wound care procedures 
[108].  Burn wound pain at large remains insufficiently treated, regardless of considerable 
advances in burn wound management [2].  The complexity, individual and subjective 
experience of pain, together with: lack of specific education on pain medication; personal 
bias towards choice of analgesia due to a lack of well-established evidence-based 
protocols of burn pain management; inaccurate fears of addiction; infrequent pain 
assessment and poor correlations between pain perception assessed by nurses compared 
to patients, all contribute to the occurrence of under medication [2, 103, 109-112]. 
 
Challenges in predicting pain levels throughout the burn wound healing process highlight 
the need for frequent and ongoing review and monitoring of analgesia for each individual 
[103].  Lack of recognition in viewing pain as a problem creates barriers to effective pain 
management [113].  Only when pain can be reframed and viewed as an adverse event, 
will it be effectively assessed, managed and monitored.  Suboptimal analgesia received by 
burn patients has been highlighted in a number of studies from first presentation to 
emergency departments [109, 110, 114], right through to their inpatient admission and 
burn wound care procedures [104, 108, 113, 115-119].    
 
Inadequately managed acute burn pain has been linked to long-term psychological 
conditions.  In a study comparing morphine dose receipt in a paediatric burn population, a 
significant association between acute pain and long-term indicators of PTSD was reported 
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by Saxe et.al. [83].  Incidence of psychological disorders developing within the first six 
months after a burn injury is as high as one third of all children [19-21].  Common post-
traumatic reactions of children reported to develop following a burn injury include: Acute 
Stress Disorder, Post-Traumatic Stress Disorder, Separation Anxiety Disorder and 
Oppositional Defiant Disorder [19, 20, 84, 120-123].  In the adult burn population, pain was 
found to be a stronger predictor of psychosocial adjustment than burn TBSA or length of 
hospital stay at one month post discharge [124] and up to two years post discharge [125].  
Cromes et.al. [126] found pain levels were strongly associated with level of emotional 
distress, and together these factors were significant predictors of quality of life at two 
months post discharge in a sample of 110 adult burn patients.  Long-term outcomes 
showed level of emotional distress as the most significant predictor of quality of life at two 
months, six months and twelve months after burn injury [126].  Commonly reported 
psychological outcomes in adult burn injury include depression, post-traumatic stress 
symptoms and suicidal ideation [127-130].  A reciprocal relationship between pain and 
emotional distress is evident following a burn injury, and long-term psychosocial 
maladjustments commonly persist, impacting on quality of life.      
 
2.3.5  Measures of Pain and Anxiety 
2.3.5.1 Measures of Pain 
Pain intensity is primarily measured by self-report, observable/behavioural and 
physiological measures.  Pain is an individualised and highly subjective experience, 
therefore self-report measures are considered the gold standard in the assessment of pain 
intensity in both adults and children [131-134].  The Paediatric Initiative on Methods, 
Measurement, and Pain Assessment in Clinical Trials (PediIMMPACT), undertook two 
systematic reviews on self-report [135] and observational measures [136] in children and 
adolescents 3-18 years, to critically evaluate pain measures and develop 
recommendations for research and clinical practice in the assessment of pain.  Another 
review was commissioned by the Society of Paediatric Psychology (SPP) Assessment 
Task Force to put forward evidence-based assessments used by paediatric psychologists 
to assess pain [137].   
 
2.3.5.1.1 Self-Report Measures of Pain 
The Faces Pain Scale-Revised (FPS-R) [138] was the chosen self-report measure of pain 
for this study.  Collectively, PediIMMPACT and SPP reported the FPS-R as a well-
17
established, psychometrically sound, feasible and optimal measure of self-reported pain.  
The FPS-R depicts gender-neutral faces from ‘no pain’ represented by a neutral face, 
changing at equal intervals across a horizontal scale (zero to 10) to an expression of ‘most 
pain possible’ (Figure 2-3).  There have been strong correlations made between the FPS-
R and the well-established and widely validated visual analogue scale (r = 0.84 - 0.92) 
[138, 139] and other widely used measures including the Colour Analogue Scale and the 
Wong-Baker FACES Scale (r = 0.64-0.96) [140-142].  The scale is interpreted with ratings 
of 3 or more indicating significant pain in children [135].   
 
 
 
Figure 2-3 Faces Pain Scale – Revised [143] 
 
 
The Wong-Baker FACES Pain Scale [144] has been reported as a preferred self-report 
pain scale by children and parents due to the ‘happy’ and ‘cartoon-like’ design depicted in 
this scale [131].  However, across scales, comparison of pain ratings confirmed that scales 
with smiling faces rather than neutral faces used to depict ‘no pain’ do not bear equivalent 
values [131, 145].  Furthermore, the anchor effect of the Wong-Baker FACES Pain Scale 
(with a smiling face depicted at one end of the scale and a crying face at the other end), is 
argued to be a more accurate reflection of pain affect (emotional facet of pain) rather than 
pain intensity [131, 135].  The differentiation between pain intensity and pain affect is of 
high importance in this study.  These criticisms of the Wong-Baker FACES Pain Scale, 
together with recommendations [137, 146] that the FPS-R is the superior measure for pain 
intensity in children 4-12 years, led to the FPS-R being chosen over the Wong-Baker 
FACES scale for this study.  The need for further improvements in paediatric faces pain 
scales has been highlighted and will likely evolve with future research [147, 148]. 
 
2.3.5.1.2 Behavioural/Observational Measures of Pain 
The Face, Legs, Arms, Cry, Consolability (FLACC) [149] was the chosen 
behavioural/observational measure of pain for this study.  Behavioural measures are an 
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important tool for use as an adjunct to self-report scales, particularly if it appears a child’s 
self-report is exaggerated, diminished or altered due to cognitive, emotional or 
environmental and situational factors [136].  The FLACC scale is a behavioural scale 
recommended by the PedIMMPACT review for use in assessing procedural pain of 
children one year and above [136].   
 
The FLACC scale (Figure 2-4) has high clinical and research utility as it is quick and easy 
to administer, with little training.  Incorporation of an acronym assists in recall of the 
categories, and the FLACC uses readily understood metrics obtaining a pain intensity 
score out of 10 [133].  The FLACC is a well-established and psychometrically sound 
measure [136].  It has been proven to have good construct validity and inter-rater reliability 
through several studies of post-operative procedures or in intensive care or oncology units 
[133, 149-153], plus good intra-rater reliability [152].  Concurrent validity has been 
established against well validated measures including the Visual Analog Scale [151], the 
Objective Pain Scale [149] and the Faces Pain Scale (5 years and over; [133]).  The 
FLACC appears repeatedly in the literature as an outcome measure used in clinical trials 
when measuring procedural pain in young children.  Validity and inter-rater reliability of the 
FLACC was confirmed in an acute procedural setting with 80 children (5-16 years), 
scheduled for perivenous cannulation or percutaneous puncture of a venous port [153].   
 
Since the FLACC is a well-established behavioural measure and nursing staff within the 
Stuart Pegg Paediatric Burn Centre (SPPBC) at the Royal Children’s Hospital, Brisbane 
are familiar with and use the FLACC as a standard practice measure of pain intensity, 
together with the advantage of its easily interpretable and comparable scale, the FLACC 
was chosen for this study. 
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Figure 2-4 The FLACC Scale [154] 
 
 
2.3.5.1.3 Physiological Measures 
Heart rate, blood pressure and oxygen saturation are common measures taken within the 
clinical setting to monitor a patient’s level of pain and distress.  Physiological measures 
have proven unreliable in the assessment of pain intensity as they cannot specifically 
discriminate between pain, and stress occurring from other parts of the body.  
Furthermore, the assessment of physiological measures over short time periods is not 
conducive to measuring chronic pain or acute pain lasting over several days or weeks 
[155].   Physiological measures may however give some indication of stress.  There 
appear to be inconsistent findings within the literature on correlations of physiological 
measures of pain and stress.  However, several studies report elevated heart rate during 
the acute phase of injury/trauma as a possible predictor of post-traumatic stress in adults 
[21, 156, 157].  Several paediatric studies have also confirmed that elevated heart rate in 
the acute phases of trauma correlated with the development of PTSD symptoms [158, 
159].  Elevated heart rate can therefore be used to aid in identifying children at risk of 
developing symptoms of PTSD following a physical injury.  Heart rate and oxygen 
saturation levels will therefore be included in the proposed trial to determine if any 
correlations exist between physiological measures and other measures of pain, stress and 
anxiety.  
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2.3.5.2 Measures of Anxiety 
Anxiety and pain are both biopsychosocial concepts, involving complex interactions 
between the biological, psychological and social components [160].  The subjective 
experiences of pain and anxiety present a challenge in their assessment and 
management.  It is generally assumed that distress and anxiety coexist with pain, thus the 
terms pain and distress are often used inter-changeably.  Pain cannot be experienced 
without a sensory aspect and an affective, emotive aspect [137].  Pain can therefore not 
be completely distinguished from anxiety. 
 
Commonly, behavioural scales of pain intensity include items that could be viewed as 
measures of pain intensity or indicators of distress, anxiety or fear.  For example; crying, 
whimpering, rigidity, restlessness and clinging are all behaviours that could be observed 
as pain, distress or anxiety [75, 136].    With the FLACC behavioural pain measure already 
being included in this trial (which encompasses many of these behavioural measures of 
pain affect), the consideration for a secondary pain affect measure is restricted to a single-
item scale; anything else is beyond the capacity of this project.  The Visual Analogue 
Scale-Anxiety (VAS-A) was the chosen measure of anxiety for this study.  Although more 
evidence is warranted to recommend a visual analog scale to be used as a measure of 
negative affect [146], the VAS-A appears to be the best available single-item scale to 
gauge secondary pain affect of fear and anxiety in children undergoing burn wound care 
procedures.  Furthermore, children under 8 or 9 years who use self-report scales have 
difficulty differentiating between the sensory experience of pain (pain intensity) and the 
affective response (distress, anxiety, fear) to pain [161].  Therefore the inclusion of 
younger children will not be advantageous in determining pain affect, and the VAS-A 
measure will be used with children eight years and over. 
 
The VAS-A has been reported as an accurate self-report and proxy measure of anxiety.  
Several studies in adults have validated the VAS-A against the gold standard State-Trait 
Anxiety Inventory, and shown a significant correlation between the two measures (r = 0.50 
– 0.78) for the critically ill [162]; surgical procedures [163, 164]; women attending a breast 
clinic for screening and diagnostic testing [165] and for people with burn injuries [82].  The 
VAS-A has also been reported as a valid tool in comparison to the State-Trait Anxiety 
Inventory and more sensitive to change over time in the paediatric setting [75, 166].  In 
addition to the VAS-A scale, anxiety was scientifically measured in this study though 
biological markers of stress (salivary alpha-amylase and salivary cortisol analysis).   
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2.3.5.2.1 Long-Term Anxiety and Stress 
The experience of a traumatic event can cause post-traumatic stress symptoms (PSS) or 
post-traumatic stress disorder (PTSD), [20, 21, 167].  Psychological and physiological 
dysfunction post-discharge is reported to be strongly linked to the level of pain 
experienced during hospitalisation [124].  The Diagnostic and Statistical Manual of Mental 
Disorders Fourth Edition (DSM-IV) criteria for PTSD has predominately been defined and 
psychometrically tested on adults [168].  Although two items have been added to the DSM-
IV on re-experiencing symptoms, detection of PTSD in young children remains 
challenging.  Almost half of the items under the DSM-IV criterions for PTSD require young 
children to verbally articulate emotions and details of experiences for specific criteria to be 
met [21, 169].  A study which conducted a literature search of traumatised young children 
and infants reported none of the 20 cases of infants who had experienced severe trauma 
met the criteria under the DSM-IV for a PTSD diagnosis [21].  Alternate assessment and 
screening tools are needed which account for the developmental and cognitive levels of 
young children [21, 170].  Currently, clinical interview is the recommended form of 
assessment when establishing PSS and PTSD [170]; however, due to clinical utility and for 
the time constraints of the setting, screening tools were the only feasible measure for this 
study.   
 
The Child Trauma Screening Questionnaire (CTSQ) was chosen to measure post-
traumatic stress symptoms to determine if children who received the Ditto™ intervention 
had fewer PSS at three months post-re-epithelialisation compared to the first week post-
injury.  The CTSQ [171] is a self-report screener for children and adolescents 6-16 years, 
modified from the Trauma Screening Questionnaire for adults [172], into child-friendly 
questions.  The CTSQ screens for hyper-arousal symptoms and for re-experiencing 
symptoms following the traumatic event [170].  Previously, the CTSQ has been compared 
to the Children’s Impact of Events Scale (CIES) and the DSM-IV, Child Version, to assess 
PTSD symptoms at 1 and 6 months after an accident [171].  In comparison to the CIES, 
the CTSQ has good convergent validity and the CTSQ was more accurate than the CIES 
in predicting PTSD at 1 month and 6 months after injury [171].  Additionally, March et.al. 
[170] found the CTSQ a more accurate predictor for the development of full and sub-
syndromal PTSD diagnosis at 1 and 6 months following accidental injury, in comparison to 
inadequate identification from the CIES.  The CTSQ was therefore chosen for this clinical 
trial due to its promising psychometrics, its predictive performance and excellent clinical 
utility, so as to be easily implemented within the busy outpatient burns unit. 
22
2.4 Effect of Pain, Anxiety and Stress on Wound Healing 
2.4.1  The Body’s Stress Mediators 
Through the sensory modalities of vision, hearing, smell, taste, touch, vestibular 
(movement and balance), temperature and pain, physical and emotional threats alert the 
hypothalamus to stress and potential hazards.  The amygdala (the seat of emotion in the 
brain) also sends distress signals to the hypothalamus [173].  The integrative centre of the 
hypothalamus controls the stress response by activating the central hypothalamic-pituitary-
adrenal (HPA) axis and our peripheral locus ceruleus- noradrenaline (LC-NA) stress 
systems.   
 
The HPA axis includes the parvocellular corticotrophin-releasing hormone (CRH) and 
arginine-vasopressin neurons of the paraventricular nuclei of the hypothalamus.  The LC-
NA system is located in the brainstem within the sympathetic nervous system (SNS) 
(Figure 2-5), [174].  The CRH/arginine vasopressin and LC-NA systems form a positive 
feedback loop, whereby they reciprocally innervate and activate each other [174, 175].   
                                    
Figure 2-5 The Stress System [174] 
 
 
The hypothalamus controls the secretion of anterior pituitary corticotrophin (ACTH) which 
in turn stimulates the adrenal cortex to release glucocorticoid hormones, primarily cortisol 
in humans [174].  The LC-NA system stimulates the adrenal medulla to release adrenaline 
(A; epinephrine) and noradrenaline (NA; norepinephrine) into the bloodstream.  The 
degree of activation is proportional to the stress.  The secretion of glucocorticoids, 
adrenaline and noradrenaline in response to stress may evoke significant immunological 
and inflammatory reactions [176].   
HPA 
 
LC-NA 
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In addition, studies have reported that the central HPA axis has a peripheral equivalent, 
whereby the skin produces CRH and related peptides, functioning as a cutaneous HPA 
axis in response to stress. The CRH receptor is present in the epidermis and dermis and 
this may act to further modulate cell differentiation, proliferation and immune responses 
[177-181].  This cutaneous HPA axis is believed to mediate the manifestation of stress-
related skin conditions, such as acne, atopic dermatitis and psoriasis [182-185].    
 
2.4.2   Effects of Stress on Wound Healing 
In several studies, stress has been reported to interrupt and delay the cascade of healing, 
including skin barrier recovery after tape stripping [186-188]; punch wound biopsies [189-
191]; suction induced blisters [192, 193] and pre-surgical stress [194, 195].  Additionally, 
the effect of stress in delaying wound re-epithelialisation was reversed when the stress-
induced elevation of catecholamines was blocked with administration of propranolol in a 
mice rotational-stress study [196], providing further evidence for the relationship between 
stress and delayed wound healing. 
 
An increasing number of studies highlight the initial inflammatory response as the key 
factor in dictating the progression and rate of wound re-epithelialisation [197].  It is well 
documented that elevated glucocorticoid levels, induced through stress, can suppress the 
production of proinflammatory cytokines IL-1β, IL-6 and TNF-α [174, 176, 193, 197-201].  
All of these cytokines are essential to the healing cascade, helping to protect against 
infection and preparing injured tissue for repair [193, 202, 203].  Proinflammatory cytokines 
are crucial to the recruitment of phagocytic cells (to clear away contaminating debris); 
activation and recruitment of lymphocytes and macrophages; regulation of fibroblast 
chemotaxis, proliferation, collagen synthesis, and endothelial cells involved in the 
remodelling of damaged tissue.  Dysregulation of cytokine production is likely to delay the 
inflammatory response resulting in delayed wound healing [204-206].  Additionally, a 
number of studies report that prolonged physiological stress creates a corticosterone 
resistance; whereby stress down-regulates the immune system’s sensitivity to 
glucocorticoids diminishing its ability to terminate the inflammatory stage, thus leading to 
excessive inflammation [197, 207, 208].  A bidirectional relationship between stress and 
the immune system has been proposed, whereby the pain and anxiety associated with the 
wound stresses the patient, and this stress in turn may compromise the immune system, 
delaying wound healing [209].   
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Stress can also disrupt the cellular and humoral immune processes, causing delay in 
wound healing [194].  Immune function plays a key role in the early processes of wound 
healing.  The humoral immune response results in the production of antibodies and 
complement, whereas cellular immunity involves activation of neutrophils, macrophages, 
and lymphocytes [201].  The migration and peak of immune cell populations found in the 
wound appear at specific times (Figure 2-6) and their migration reflects different and 
overlapping phases of the wound healing cascade [201]. 
 
Figure 2-6 Migration of immune cell populations correlated with the phases of wound healing 
[201] 
 
 
2.4.3   Immune Responses and Wound Healing 
Cellular immunity plays a pivotal role in wound healing.  A surge in glucocorticoids, 
adrenaline and noradrenaline causes a dysregulation of cellular function and differentiation 
of T helper (Th) cells, resulting in a shift from Th1 cellular immunity to Th2 humoral 
immunity [176, 204, 205, 210, 211], (Figure 2-7).  Th1 secretion of TNF-γ stimulates 
inducible nitric oxide synthase (iNOS) in macrophages [201], but stress induces inhibition 
of this pathway. Angiogenesis, endothelial and epithelial cell proliferation and migration are 
central to wound healing and are highly influenced by nitric oxide [206].  A recent 
hypothesis suggests temperature and pain stimuli receptors in the skin exist in 
keratinocytes.  Activation of these receptors leads to nitric oxide (NO) production by 
keratinocytes, and a second source of NO becomes available in the later stages of 
healing.  Sustained activation of these thermosensory receptors by pain could lead to 
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excessive NO synthesis, resulting in impaired collagen synthesis and ultimately leading to 
impaired wound healing [212].  Excessive NO production to cytotoxic levels has been 
observed in mice [196] and rat [213] models of injury where wound healing was impaired.  
 
A stress–induced shift to Th2 humoral immunity activates mast cells, which release 
histamine and result in inflammation (Figure 2-7).  The Th2 profile also up-regulates 
lymphocytes, leading to the production of antibodies (Figure 2-8), [176, 214], rather than 
contributing to wound healing processes.  This inflammatory response leaves the wound 
environment susceptible to infection [205, 211].    
 
 
         
Figure 2-7  
Subpopulations of T Lymphocyte       
Cells with Their Respective Cytokine      Stress and the Immune/Inflammatory  
Profiles and Target Activation Cells              Response [176]. 
[201]. 
 
 
The following diagram derived from the literature (Figure 2-9) illustrates the interactions 
between stress and healing. 
 
 
Glucocorticoids 
Shift 
 
Figure 2-8 
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Figure 2-9 The Impact of Stress on Wound Healing 
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2.4.4   Effect of Pain on Wound Healing 
Pain initiates and mediates a myriad of cellular events; however, the influence these cellular 
events have on re-epithelialisation and wound healing is still not well understood.  The effects 
of pain mediators such as substance P (SP), serotonin and tumor necrosis factor (TNF-α), on 
nerves and tissues during wound healing continue to be the focus of much research [212].  
Altered substance P (SP) has been associated with impaired healing in rats [215], and has 
been linked to the impaired wound healing in diabetes mellitus and in association with 
hypertrophic scar formation [216].  Serotonin is a neurotransmitter that acts to suppress 
nociception [217] and therefore plays a central role in the perception of pain [212].  
Additionally serotonin influences wound healing, prolonging inflammation and disrupting 
collagen synthesis [217-219].  The relationship between inflammatory mediators and delayed 
wound healing  has also been associated with periods of severe and prolonged pain [212].  
TNF-α plays a primary role in regulating immune cells and inducing inflammation [212].  
Elevated levels of TNF-α and other pro-inflammatory cytokines including IL-1 and IL-6, have 
been found in non-healing wounds [220] and have been associated with inflammatory 
diseases [221].  Further studies are required to unravel the cellular influences on re-
epithelialisation resulting from heightened pain perception.     
 
The relationship between pain and wound healing has been reported in several clinical trials.  
A study of paediatric surgical tonsillectomy tested the receipt of Dexpanthenol, as opposed to 
a blinded placebo.  Dexpanthenol has an anti-inflammatory effect and is not prescribed 
primarily as analgesia (but to hydrate, coat and protect the mucous membranes).  Significant 
reductions in pain were reported by the children who received Dexpanthenol compared to 
placebo.  Additionally, significantly better tonsillar wound healing outcomes were observed in 
these children [222].  A study of patients undergoing gastric by-pass surgery reported faster 
rates of wound healing in a standard wound model (punch biopsy) when patients reported 
lower post-operative pain, including acute pain (1-2 days post-surgery; p = 0.023) and 
persistent pain (4 weeks post-surgery; p = 0.023) [223].  Future research into the links 
between pain and wound healing is necessary to understand the cellular, neuroendocrine and 
inflammatory changes resulting from pain and what roles they play in wound healing. 
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2.5 Biological Measures of Stress 
Chrousos and Gold [175] defined stress as “a state of disharmony, or threatened 
homeostasis,” with adaptive responses occurring when the degree of threat goes beyond a 
certain threshold.    Catecholamines and cortisol are considered the two major biomarkers of 
stress [224].  Invasive monitoring of biomarkers would be counterproductive when measuring 
stress (e.g. via blood draw), therefore only non-invasive measures were investigated in this 
study. 
 
2.5.1  Cortisol 
The steroid hormone cortisol (also known as hydrocortisone) is the primary glucocorticoid in 
humans. Cortisol exists in protein-bound (90-93%) and free forms (7-10%), both found in 
serum, whilst the free form is only found in saliva [225-228].  Free cortisol is the biologically 
active fraction of the hormone, and so salivary cortisol is often considered a better measure of 
adrenocortical function than serum cortisol [229-231].   
 
Cortisol has a long standing history in research as a substantiated physiological measure of 
stress, anxiety and depression. Cortisol is an end-product of the hypothalamic-pituitary-
adrenal (HPA) axis, activated by a stressor; a physiological and/or psychological stimulus.  
The degree of activation of the HPA axis is proportional to the level of perceived stress [232].  
Serum cortisol has been widely used as a measure of stress in severe burn injuries [22, 233-
235].  Only one study in the field of burns has measured salivary cortisol, investigating the 
efficacy of therapeutic touch in a small sample size of 19 patients with small to medium TBSA 
burns [236].  Salivary cortisol compares well to that of both total and free cortisol levels in 
serum [228].  Several studies comparing serum and salivary cortisol have been undertaken 
with children and adolescents with correlations ranging from r=0.74 – 0.97, p<0.001 [237-
240].   
 
Cortisol enters saliva through intracellular diffusion within the salivary glands. The cortisol 
concentration in saliva maintains an equilibrium with the plasma unbound cortisol, as the 
diffusion rate is rapid [241] and occurs independently of secretion rate and saliva volume 
[228, 230, 241, 242].  Salivary cortisol levels are reported to be one third lower than unbound 
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cortisol in serum [230, 242, 243].  This may be due to the partial conversion from cortisol to 
cortisone (inactive form of cortisol) by the steroid dehydrogenase during diffusion through the 
salivary glands [230, 240, 244].  Changes in the concentration of salivary cortisol may be 
delayed up to 15-20 minutes post stressor as the HPA axis is slower to activate than the SNS 
and then once cortisol is produced it must be released into the circulation and diffused into 
saliva [245].   
 
2.5.1.1 Factors Influencing Cortisol Measurement 
There are several factors which have been shown to interfere with the measurement of 
cortisol levels: 
• Diurnal variations - Cortisol concentrations within the body undergo diurnal variations 
peaking with the cortisol awakening response, typically occurring 30-45 minutes after 
waking [246], then decreasing progressively during the day to reach low levels in the 
evening [247].  
• Blood – Even a small degree of contamination with blood may result in an artificially 
raised cortisol level, due to the contribution from plasma [243].  Tooth brushing may 
cause blood contamination as may oral lesions [247]. 
• Food - Consumption of food or drink (other than water) particularly of low pH values 
(e.g. fruit juices) should not be undertaken 30 minutes prior to saliva sample collection 
as cortisol levels may be artificially altered [228, 247, 248]. 
• Time of waking - Time of waking affects the cortisol awakening response, with early 
awakening displaying a more pronounced response in comparison to a late awakening 
[249]. 
 
2.5.1.1.1 Implications and Study Considerations 
All clinics at SPPBC take place in the morning (typically 7:30 - 10:30 am).  This presents a 
challenge in measuring any change or increase in cortisol as levels are naturally at their 
highest in the morning.  One study in 386 healthy children found a large variation in normal 
salivary cortisol when samples were collected between 8:00 and 9:00 am after a period of rest 
[250].  A meta-analysis of 208 studies encompassing 6,153 participants exposed to laboratory 
psychological stressors illustrated the difference in average effect size between studies 
carried out in the morning (0.14 (CI = 0.03, 0.25, p <0.05), compared to afternoon (0.46 (CI = 
30
0.31, 0.61, p <0.01), when levels are more stable, and studies are able to detect significantly 
greater changes.  Time of day significantly predicted effect size, accounting for 9% of 
variance between morning and afternoon studies [251].   
 
Time of waking, time of day each saliva sample is taken and food and liquid consumed within 
two hours prior sample collection were recorded (APPENDIX A) and included in statistical 
analysis.  
 
2.5.2   Catecholamines and Salivary Alpha-amylase 
2.5.2.1 Measures of Catecholamines 
Catecholamines (adrenaline and noradrenaline) are excreted from the adrenal medulla into 
blood at a ratio of approximately 3:1 [252, 253].  The assessment of sympathetic adrenal 
medullary activity via adrenaline/noradrenaline (A/NA) is measured using electrophysiological 
methods, such as skin conductance, which requires complex experimental setup; or plasma 
blood analysis of A/NA, which in addition to being an invasive measure, requires immediate 
processing following the blood draw.  The challenges of these techniques make it almost 
impossible to include these measures in clinical trials [254].   
 
The measurement of catecholamines in saliva is thought to be an easier, faster and more 
direct reflection of stress [224].  The barrier to using salivary catecholamines as a standard 
biomarker of stress, however, is the difficulty in maintaining stability of the catecholamines 
due to oxidative decay [224, 255].  Analysis immediately after saliva collection is unrealistic in 
a clinical setting.  Furthermore, salivary catecholamines are a poor index of acute sympathetic 
activity even after adding the inhibitor glutathione as a stabilizer [256].   In addition, the 
delayed appearance rate of salivary catecholamines, with peak levels occurring 60 minutes 
post stress [257], further highlight why salivary catecholamines were not a viable measure for 
this research project.  
 
Urinary catecholamines are a less invasive method of collection and were investigated for use 
in this study.  Only 1-2% of NA is found in urine, which makes catecholamine measurement 
and interpretation complex [252, 258, 259].  In addition, urinary samples need to be obtained 
at regular time intervals coinciding with the stressor, as catecholamines have a brief half-life 
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and plasma levels alter rapidly in response to stressors.  Challenges in collecting urinary 
samples at regular time intervals during burn wound care procedures, particularly in young 
children, excluded the use of this measure. 
 
2.5.2.2 Salivary Alpha-amylase 
Difficulties in measuring catecholamines led to a broader review of the literature which 
highlighted salivary alpha-amylase (sAA) as an alternate measure for reflecting SNS activity.  
sAA is one of the major proteins in saliva and accounts for 40-50% of protein produced by the 
salivary glands [260, 261].  Activation of the autonomic nervous system has a strong influence 
over the salivary glands and controls the secretion of sAA [261].   
 
Branches of the sympathetic and parasympathetic nervous system innervate salivary glands 
through the release of NA.  Sympathetic stimulation of the salivary glands increases the 
secretion of salivary proteins, with the major protein being alpha-amylase [262].  The increase 
in sAA in response to short-term periods of stress acts to increase digestion, to make energy 
available to the body so it can engage in a “flight or fight” response [261].   
 
2.5.2.2.1 Salivary Alpha-amylase as an Indicator of the Sympathetic Nervous 
System 
Growing evidence in the literature supports sAA as a surrogate marker of SNS activity, 
providing evidence that sAA is responsive to stress and reflects the fast activation pattern of 
the SNS [245, 260, 261, 263-273].   Thoma et.al. [273], in a larger study of participants, 
confirmed earlier findings by Rohleder [254], of a significant association between sAA and NA 
in response to a reliable and well validated stressor (the Trier Social Stress Test).  Chatterton 
et.al. [272] examined subjects under a different physiological stress (exercise and exposure to 
heat and cold) and also identified a significant relationship between sAA and NA/A compared 
to controls.   
 
Many studies using the standardised Trier Social Stress Test report that induced 
psychological stress causes increases in sAA [254, 263, 268, 269, 274].   Additionally, several 
other studies have reported increases in sAA due to psychological stresses such as: 
examinations [275-277]; skydiving  [278];  video games [279], a standardised stress protocol 
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[269]; a motor-vehicle driving simulator [280]; a stressful video of corneal transplant surgery  
[281];  stress reactions in medical trainees performing surgery [282]; and mothers watching 
their children being exposed to a stressful task [266].    
 
2.5.2.2.2 Factors Influencing sAA Measurement 
Saliva samples can be stored at room temperature for 24 hrs or stored at -80°C indefinitely 
without affecting the integrity and validity of sAA [245, 260].  In addition to the stability of sAA, 
diurnal variations of sAA are favourable for morning clinics.  The profile of sAA is distinctively 
different to that of salivary cortisol.  Several studies report that sAA reaches a peak rapidly at 
approximately 0-5 minutes post stressor and returns to baseline approximately 20-30 minutes 
post-stressor [245, 266, 283].  The quick response and recovery rate of sAA reflects the rapid 
SNS activation of the system it represents [175, 245, 251, 274, 283].  Furthermore sAA may 
be more sensitive in identifying mild stressors which may not be detected in cortisol levels, 
reflecting the lower responsive threshold of the SNS in comparison to the HPA axis [245].  
Strong diurnal variations in sAA have consistently been reported, with sAA levels lowest upon 
awakening, then steadily increasing to be highest late in the afternoon [284].  
 
Several factors that may interfere with the measurement of sAA include: 
• Mastication:  As alpha-amylase is one of the major proteins enriching saliva 
secretions, its presence may be influenced by factors which promote salivation.  
Mastication activates salivary production; therefore it has been suggested that studies 
involving saliva collection must keep mastication constant by instructing participants to 
either chew or not to chew on the Salivette™ (Sarstedt Australia Pty Ltd; an absorbent 
synthetic roll used to collect saliva).   
• Asthma:  A number of studies have reported asthmatic children have lower 
concentrations of sAA [285, 286].  Furthermore asthma medication and 
antihypertensive medication, containing adrenergic agonists and antagonists will also 
affect sAA levels [260].   
• Other factors:  Age, medication, food, caffeine, alcohol, smoking, medical drugs, 
exercise and somatic or psychiatric diseases can alter sAA activity [260].    
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2.5.2.2.3 Implications and Study Considerations 
• Study participants were instructed to move the Salivette™ around in a circular pattern 
in their mouth to ensure samples were taken of whole saliva (representative of all  
major glands) [260].   
• Mastication is unlikely to significantly confound results since salivary flow is not the 
primary determinant of stress-induced increases in sAA [268]. 
• Asthmatic medication and food taken prior to the saliva sample were recorded 
(APPENDIX A).  
• Children with a psychological condition or any other diagnosed condition in addition to 
their burn injury were excluded from recruitment. 
 
2.6 Analgesia & Distraction Techniques 
2.6.1   Pharmacological Management of Burn Pain 
Appropriate pain treatment during burn wound care procedures is imperative for moral, ethical 
and humane reasons which centre around the belief that nobody should suffer.  Poorly 
managed pain leads to a range of short and long-term adverse outcomes [2, 287].  The 
implication is that poorly managed burn pain risks poor compliance with treatment and 
disrupted care.  In addition, distress and anxiety can provoke the escalation of perceived pain 
[2].  Long-term ramifications include poor compliance with rehabilitation, chronic pain, anxiety 
disorders, post-traumatic stress disorder and depression [2, 288].   
 
Opioids are the foundation of pain medication in the area of burns [2, 113, 289], with 
Oxycodone™, Morphine and Fentanyl among the more commonly used analgesics [2].  
Medication used within the Stuart Pegg Paediatric Burn Centre at the Royal Children’s 
Hospital, Brisbane is shown in Table 2-1. 
. 
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Table 2-1 Pain Medication used within the SPPBC 
Category of Medication Medication 
Simple analgesics/ Non-steroidal anti-
inflammatory drugs (NSAIDs) 
Paracetamol  
Ibuprofen  
Opioids Oxycodone™ 
Morphine 
Fentanyl 
Anxiolytics Midazolam 
Lorazepam 
Anaesthetics Nitrous Oxide (Entonox™) 
 
 
Oxycodone™ is an effective substitute for morphine, and there are reports that side effects 
such as hallucinations and histamine-induced itching are reduced with this medication [2].  
Oxycodone™ remains the primary pharmacological analgesia used within the Stuart Pegg 
Paediatric Burn Centre, and is used in combination with simple analgesia or non-steroidal 
anti-inflammatory drugs (NSAIDs).  Paracetamol (acetaminophen) inhibits pain both centrally 
and peripherally.  As a single agent, paracetamol is a weak analgesic, however when 
combined with opioids, it creates a synergistic effect, producing an analgesia equivalent to a 
higher opioid dose with fewer risks or contraindications [289].  Maximal doses of paracetamol 
are therefore recommended to be regularly used with burn patients.  NSAIDs are also a 
valuable analgesic providing anti-inflammatory and anti-pyretic (reduction of fever/body 
temperature) effects.  NSAIDs are another analgesic with a synergistic effect, and can 
therefore also reduce opioid doses and side effects [2, 289].  Entonox™ is a weak 
anaesthetic agent providing relief for painful procedures without the loss of consciousness.  It 
is made up of a 50% oxygen and 50% nitrous oxide mix and has powerful analgesic 
properties.  Entonox™ has the benefit of an extremely rapid onset and offset (occurring within 
seconds), providing effective short-term pain relief such as during wound care procedures.  
Minimal side effects of Entonox™ include nausea and vomiting [2, 289].  Entonox™ is used 
with older children in the Stuart Pegg Paediatric Burn Centre when a stronger level of pain 
management is required. 
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Fear of opioid side effects and addiction have been found to be one of the primary factors 
contributing to inadequate pain relief in children with burn injuries [290].  Repeated and 
prolonged use of opioids can lead to development of tolerance, however this is very different 
to, and should not be associated with, drug addiction.  Good pain management should involve 
prescribing as much medication as required to lessen the pain, then slowly tapering the pain 
medication off as the patient recovers and experiences less pain [77]. 
 
Opioids act on three major sites within the central nervous system: the periaqueductal gray 
and rostral ventromedial medulla of the midbrain, and the dorsal horn of the spinal cord.  
Nociceptors at these sites contain opioid receptors to which the opioids bind and so block the 
release of neurotransmitters.  Pain signals are interrupted and activation of neurons at the 
dorsal horn are inhibited, thus blocking the transmission of pain [103, 291].  
 
Despite implementation of evidence-based pharmacological management during burn wound 
care procedures, studies continue to report that 52-84% of patients with burns experience 
moderate to severe pain during these procedures [98, 292, 293].   Non-pharmacological 
interventions are called upon as an adjunct to controlling burn pain [112, 289, 294]. 
 
2.6.2   The Neurology of Non-pharmacological Intervention and Pain 
Transmission 
Non-pharmacological interventions play a significant role in dampening pain perception [9, 98, 
289, 295].  Interventions are focused around interrupting pain transmission and thus 
obstructing pain messages reaching the level of consciousness, and stimulating descending 
pathways to alter the incoming pain message [296].   
 
The idea that pain transmission can be interrupted by modulating incoming nerve impulses 
before they reach transmission has been explained by Melzack’s [297] Gate Control Theory 
(Figure 2-10).  Low intensity mechanical information including light touch, pressure and 
vibration are transmitted quickly by large myelinated Aβ fibres.  Rubbing or massaging the 
affected area to stimulate mechanoreceptor activation at the dorsal horn reduces the 
activation of A delta and C fibres (carrying intense noxious input) to transmit to the brain, 
resulting in alleviation of pain.  A local inhibitory circuit is created in the substantia gelatinosa 
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of the dorsal horn, whereby the size and number of fibres activated influences the spinal 
gating mechanism [298, 299].   
 
Furthermore, non-pharmacological interventions play a significant role in dampening pain 
perception through attention and cognitive processes.  Modification of pain perception occurs 
in the limbic system where emotional shading is added to the perception of pain.  Following 
detection of injury from the nociceptors and pain signal transmission to the substantia 
gelatinosa, afferent pathways project to the brain stem for discrimination and to the limbic 
system for affective processing of pain [300, 301].  Non-pharmacological intervention has a 
significant influence by tapping into pain modulation through cognitive-behavioural techniques 
and procedural preparation and relaxation, which act to reduce fear, anxiety and distress and 
give a sense of control.  Diversions, such as virtual reality, hypnosis, distraction and imagery, 
shift perception and attention to focus on more pleasant stimuli, facilitating psychological 
dissociation from the pain experience [108, 289].  
 
In keeping with neuronal pathways of pain, Melzack and Wall’s Gate Control Theory of pain 
(Figure 2-10) [298] proposes that in addition to the substantia gelatinosa, the central control 
mechanism (brain) of higher order cognition and emotive processing also acts to modify pain 
perception.  Physiological factors which influence pain attitudes and coping abilities, together 
with the level of attention, determine the extent of descending inhibitory influence over the 
substantia gelatinosa, in closing or opening the “gate” to pain perception [101]. 
 
 
 
Figure 2-10  The Gate Control Theory of Pain  [298] 
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2.6.2.1 Evidence of Pain Affect Modulating Pain Perception 
Pain-evoked cerebral activity has been shown, through use of functional magnetic resonance 
imaging and position emission tomography [12, 302-306], to activate pain unpleasantness 
and pain intensity regions of the brain including the anterior cingulated cortex, primary and 
secondary somatosensory cortices, the insula, and the thalamus.  Collectively these regions 
are often described as the “pain matrix.”  
 
Neuroimaging studies give insight into the significant links between the anterior cingulated 
cortex and pain affect, suggesting that attention and cognitive processes play a significant 
role in modulating pain perception [299, 304, 307-309].   This highlights the potential for pain 
reduction through non-pharmacological intervention.  A functional magnetic resonance 
imaging study by Hoffman [12] where 8 patients were exposed to a thermal pain stimulus 
whilst experiencing a period of virtual reality (VR) and no VR, found that the primary regions 
involved in emotional processing of pain (caudal anterior cingulated cortex) and the sensory 
component of pain (primary somatosensory cortex) both showed a reduction in activation 
during VR, along with the other regions making up the pain matrix (Figure 2-11).  
Neuroimages together with self-reports of pain intensity and pain unpleasantness, provide 
objective and subjective evidence that VR, one type of non-pharmacological intervention, 
modulates the sensory and affective components of pain to attenuate the perception of pain. 
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Figure 2-11  Neuroimages of pain regions [12] 
 
 
Other studies using neuroimaging have shown attention-demanding cognitive distraction 
during heat pain [304, 310, 311] and cold-pressor-tests [312] reduced the extent of pain-
stimulated activity in the cerebellum.  Increased neural activity was evident in the 
perigenual/rostral anterior cingulated cortex and orbitofrontal cortex, which exert descending 
inhibitory control, gating pain perception through activation of the periaqueductal gray and 
posterior thalamus (ventral posterolateral nucleus).  Increased activation of the 
periaqueductal gray occurs during distraction but is not activated during pain stimulation alone 
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[310].  Furthermore, the rostral anterior cingulated cortex is one cortical region that houses a 
high concentration of opioid receptors [313], highlighting further potential analgesic effects 
from stimulation to this region.  
 
2.6.3   Virtual Reality and Burns 
Diversion, relaxation and cognitive-behavioural techniques are pain management strategies 
that can be effectively used alongside pharmacological analgesia in combating burn-related 
pain.  Diversion incorporates distraction, imagery, hypnotic analgesia and VR interventions, 
which delve into the psychology of perception and attention.  These intervention techniques 
work towards psychologically dissociating the patient from pain [108, 289].  Immersive VR 
involves specialised technology creating an interactive virtual environment.  It encompasses 
multisensory stimuli of sight, sound and touch, greatly drawing the subject’s attention into the 
virtual world and creating a sense of ‘presence’ [314, 315].  Higher cognitive and emotional 
regions in the brain are activated by VR, compared to non-activation with standard video 
games [6, 9, 316, 317] and the level of immersion or strength of the ‘illusion’ of being drawn 
into the virtual world determines the strength of the analgesic effect [314, 318-320].  Averting 
attention away from the pain of wound care procedures and focusing within the virtual world 
dampens transmission to the thalamus, limbic system and cortex, and the full extent and 
awareness of pain is reduced [101, 291, 296]. 
 
The use of VR with burn patients has created much interest since the first published case 
report [317] of reduced pain ratings in adolescents during burn wound care procedures, 
compared to off-the-shelf Nintendo video games.  This was closely followed by the first 
controlled study with VR in adults with burn injuries during physical therapy range of motion 
exercises.  Statistically significant reductions were reported in pain intensity, unpleasantness, 
anxiety and time spent thinking about pain [319].   
 
An accumulation of studies in the area of burns report a discernible reduction in pain ratings 
when children are immersed in VR or tailored multi-modal computerised devices alongside 
pharmacological intervention [6, 7, 9, 10, 14, 314, 315, 320-324].   
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When the saturation effect of repeated use of VR over at least 3 separate days during 
physical therapy sessions was examined, there was found to be no diminishing effect on the 
extent of pain reduction [314].  Similarly, a study testing a computerised multi-modal device 
during repeated burn wound care procedures also reported positive effects maintained over 
time, with repeated use of the tailored computerised non-pharmacological intervention [6].  
Repeated viewing of the computerised content was highly accepted by children; therefore it 
may be assumed that it is not novelty alone that reduced pain perception [314]. 
 
2.6.3.1 Procedural Preparation 
Appropriate management of the patient’s first dressing change is critical to determining their 
ongoing pain, anxiety and emotional distress.  Extreme responses evoked during the initial 
dressing change are likely to lead towards increased responses over time and can create 
long-term pain management problems [108].   Everett et al. [294] described the necessity of 
patients understanding wound care procedures as the first step to ensuring successful 
distraction.  This is particularly important in the case of wound debridement, where dead skin 
is pulled and scraped away and blisters are de-roofed.  Patients and families need to 
understand the processes of cleaning the wound to create an optimal healing environment, 
and that no further damage to the burned area occurs.  Lack of understanding leads to loss of 
control and hypervigilance towards every move the nurse makes.  Fixation on what is 
happening and what will happen next decreases the likelihood of the patient diverting their full 
attention to cognitive distraction techniques. 
 
Preparation for the anticipation of a painful event can not only assist with distraction but also 
has the potential to significantly reduce the perceived level of unpleasantness of noxious 
stimuli [294, 325].  Accurate descriptions of the sensation to be experienced lessen the 
intensity of emotional responses during painful experiences, by minimising the incongruence 
between the expected and experienced sensations [326].  The effectiveness of providing 
procedural and sensory information prior to medical procedures has been studied across 
several paediatric clinical settings including: orthopaedic cast removal [327]; angiocatheter 
insertion [328]; cancer patients undergoing bone-marrow aspirations or lumbar punctures 
[329]; and in adults for general surgery [330], cholecystectomy surgery [331] and endoscopic 
procedures [332].   When combined in a meta-analysis, procedural preparation involving 
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sensory and procedural instruction was associated with lower pain levels, negative affect and 
distress, yielding strong negative effect sizes in comparison to sensory preparation alone, or 
to control groups [333].  The first reported trial of procedural preparation in the area of 
paediatric burn injuries was by Miller et. al. [6].  The study contained both a preparatory group 
and a distraction group (using the Multi-Modal Distraction Ditto™ device) compared to two 
other groups of standard distraction (e.g. toys, television) and off-the-shelf video games.   
 
2.6.3.1.1 The Ditto™ Device 
The multi-modal distraction “Ditto™” is a medical device that has a preparatory and 
distraction phase (Figure 2-12).  The preparatory phase involves the child engaging in the 
story “Bobby Gets a Burn”©.  This interactive story takes the child on a journey through the 
clinical procedures and sensory phases of a burn dressing change through the eyes of 
“Bobby,” a character the child can relate to, who has a burn injury and goes to hospital for his 
first dressing change.  The story aims to reduce anxiety and distress and instil a sense of 
control through knowing the sequential steps of the dressing change, whilst also exposing 
and de-sensitising the child to medical equipment (such as scissors, antiseptic and dressings) 
and staff they will encounter.  Feelings of pain, fear and anxiety are acknowledged and the 
sensory aspects of the experience are discussed, thereby equipping the child with strategies 
(such as asking to stop and take a break), whilst reassuring them along the way that 
everything is all right and that there is an endpoint.  
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Figure 2-12  The Ditto™ Device.   
The Ditto™ on its power docking station with the three Dittems (red: procedural preparation 
stories; green: games; and blue: touch and find stories) which magnetically insert into the top 
hole and load the chosen program.  
 
 
Following the preparatory story conducted in the waiting room, the child then engages in a 
choice of interactive stories or games forming the distraction phase of the Ditto™.  As 
previously discussed, the successful mechanism of VR and distraction is the shift of attention. 
Furthermore, a large degree of the success of the Ditto™ device may be due to the 
developmentally appropriate content of the preparatory stories, interactive touch-and-find 
stories and various games that have been specifically developed and targeted for children 3-
12 years old.  Customisation of non-pharmacological computerised intervention has been 
shown to be paramount to determining the effectiveness of the intervention.  A study in 
adolescents undergoing burn wound care procedures found that off-the-shelf virtual reality 
(Sony Play Station Portable®) did not reduce pain levels, more than standard distraction (e.g. 
television, music, caregiver distraction) [334].  Whereas, use of the customised Ditto™ device 
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with children during burn wound care procedures yielded significant reductions in pain ratings 
in comparison to off-the-shelf video games [6].  
 
In addition to the content, the design of the Ditto™ has been specifically tailored to a child’s 
needs.  Unlike most VR systems which have head-mounted goggles or helmets, the Ditto™ is 
an open-faced multi-modal design.  There are several advantages of this design in the area of 
paediatric burns: firstly, the design allows for the child to continually check-in and receive 
reassurance and support from their care-giver; children with burns on any part of their body 
can use the device, unlike head-mounted designs which excluded burns to the face or head; it 
also allows for the caregiver to watch the preparatory story, educating not only the child, but 
also the caregiver, so both parties know what to expect during burn wound care procedures.    
Other features of the Ditto™ that make it a child-friendly device with high clinical utility include 
a touch screen and motion-sensor device with a circular back and centre nipple allowing 
diverse applications for use in any position, such as one-handed operation on the bed, or 
propped on the child’s legs.  The device has no cords and is highly portable, it is also 
waterproof allowing for use in the bath and for easy cleaning after use [335].  
  
Ditto™ procedural preparation intervention has been shown to significantly reduce pre-
procedural pain scores [6].  Additionally, the previous study concluded that both Ditto™ 
intervention groups, (the Ditto™ procedural preparation group and Ditto™ distraction group) 
in comparison to standard distraction (e.g. toys, television) and off-the-shelf video games, 
reported significantly reduced pain levels during burn wound procedures; reduced nursing 
staff time taken to complete wound care procedures; and sustained reduced pain levels with 
repeated use of the device.  The powerful effect of procedural preparation alone was evident 
[6], suggesting that the child has a sense of control over what will happen and reduced 
anxiety and apprehension may reduce pain levels.  With repeated use, the child is reassured 
that the procedure is still the same and the story reinforces what they already know and have 
experienced.  The child can relate the Ditto™ procedural preparation story to their own similar 
experience and continue to cognitively and psychologically prepare themselves for another 
dressing change.   
 
Miller et.al. [7] conducted another RCT, combining the two phases of the Ditto™ intervention 
(i.e. children received Ditto™ procedural preparation and Ditto™ distraction) to compare the 
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effects against a control group receiving standard distraction.  Results confirmed the 
effectiveness of the Ditto™ intervention and yielded a stronger effect in significantly reducing 
pain ratings and treatment length when Ditto™ procedural preparation and distraction 
intervention were combined.  Retrospective review of medical notes identified that wounds of 
participants in the Ditto™ intervention group re-epithelialised at an average of two days faster 
than those who did not receive Ditto™ intervention.  This exciting and clinically significant 
finding highlights the potential of the Ditto™ device, with pain reduction having a possible 
flow-on effect of improving wound healing.  In the trial conducted by Miller et.al. [7], several 
factors were not controlled for including: burn wound depth and accurate measures of re-
epithelialisation (days to re-epithelialise were obtained from retrospective review of medical 
charts).  This preliminary finding proposes a possible link between pain, stress, anxiety and 
burn wound healing, initiating the body of work contained in this thesis, measuring stress and 
wound healing in a scientific and controlled manner in addition to pain levels.   
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Review of the literature at the commencement of this project confirmed that no study had 
explored the use of salivary cortisol and salivary alpha-amylase as biological markers of 
stress in children during acute burn wound care procedures.  This chapter describes the 
methods and the results of a pilot study conducted to ascertain the optimal saliva collection 
time points to be used in the primary study of this thesis in measuring stress biomarkers.  This 
chapter is an adaption from the manuscript entitled “Biological Markers of Stress During a 
Burn Dressing Change: A Pilot Study”, to present as a chapter in this thesis, maintaining 
consistency of formatting.  
 
 
 
 
 
 
This chapter has been submitted to the journal Wounds and is currently under peer-
review. 
 
 
 
  
Chapter 3. Pilot Study 
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3.1 Introduction 
Burns are highly stressful traumatic injuries, due to the nature of the injury itself and the 
resultant burn wound management procedures [336].   A high prevalence of psychological 
disorders are experienced by children with minor burns [20].   Opioid based medication 
commonly used during acute burn wound care procedures does not diminish procedural 
anxiety [337].  In spite of this, anxiolytic medications are rarely used [338].  Anxiety and fear 
experienced in the anticipation of burn wound treatment often transpires to a generalized 
hospital anxiety, where children’s anxiety levels escalate on the thought or sight of entering 
the hospital [339]. Acute burn injuries are treated in outpatient settings and therefore receive 
less contact time with staff, and less psychological support, than inpatients [20]. 
 
Burn wound care procedures may be overwhelming for young children, eliciting severe stress 
which impairs a child’s coping mechanisms [340] and may induce acute stress symptoms 
[21].  Anxiety disorders have been reported as high as 47% in children and adolescents 
following burn injuries [121].  Six months following the burn injury, prevalence of psychological 
disorders has been reported as high as 27% in young children [20] and presence of a PTSD 
diagnosis several years after the burn has been reported as high as 19% [84].  In addition to 
the psychological reactions of heightened stress and anxiety, burn injuries elicit a 
physiological stress response, releasing stress hormones [341]. 
 
Cortisol and catecholamines (adrenaline/noradrenaline) are considered the two major 
biomarkers of stress [224].  Salivary cortisol has a long standing history in research as a 
substantiated physiological measure of stress and anxiety [342].  Cortisol is an end-product of 
the hypothalamic-pituitary-adrenal (HPA) axis with the degree of activation proportional to the 
level of perceived stress [232].  Cortisol exists in protein-bound (90-93%) and free forms (7-
10%), both found in serum, whilst the free form is only found in saliva [228].  Free cortisol is 
representative of the biologically active fraction of the hormone, thus salivary cortisol is often 
considered a better measure of adrenocortical function than serum cortisol [229-231].   
 
Catecholamines (adrenaline/noradrenaline) are other markers of stress, traditionally 
measured in plasma, which requires invasive blood sampling.  Salivary catecholamines are 
not a viable measure of acute stress due to oxidative decay [224, 255] and have a delayed 
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appearance in saliva 60 minutes post stress [257].  Salivary alpha-amylase (sAA) is an 
alternate non-invasive measure of SNS activity.  Activation of the sympathetic and 
parasympathetic nervous system has a strong influence over salivary glands and controls the 
secretion of sAA [261, 262].  Studies by Chatterton in 1996 [272] examined the plasma 
catecholamines and sAA of young adults under physiological stress (physical exertion of 
running, exercises and exposure to heat and cold) and found stressed subjects had a 3-fold 
increase in sAA concentrations and a 5-fold increase in noradrenaline and adrenaline 
compared to controls.  Many studies using a standardized psychological stress test (The Trier 
Social Stress Test) to induce stress showed increases in sAA [254, 263, 268, 269, 274].  
Additionally, a number of studies reporting on a variety of psychological stresses, 
(summarized in a review by Nater and Rohleder [261]) conclude that sAA is responsive to 
changes in the SNS, supporting sAA as a surrogate marker of stress.  To date, no study has 
explored the use of salivary cortisol and sAA as biological markers of stress in children during 
a burn dressing change.  The aim of this pilot study was to measure the variation and peak 
levels in salivary cortisol and sAA, in children undergoing a burn dressing change in order to 
identify the research utility of this procedure and optimal saliva collection time points. 
 
 
3.2 Methods 
3.2.1   Participants 
This cross-sectional study was conducted in Brisbane, Australia, in March 2011.  Data were 
collected from children who attended outpatient clinics in the Stuart Pegg Paediatric Burns 
Centre at the Royal Children’s Hospital (RCH).  Participants were children aged 3 – 12 years 
undergoing their first burn dressing change.  The burn could be of any depth and percentage 
total body surface area (TBSA) and both inpatients and outpatients were eligible.  Exclusion 
occurred on the basis of: non-English speaking; cognitive/visual/auditory impairment; 
diagnosed developmental impairment; or a diagnosed illness in addition to a burn injury. 
 
Clinical judgment by the consultant doctor was used to estimate burn depth and burn TBSA 
was calculated using the Lund and Browder chart.  Demographic characteristics and pertinent 
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clinical characteristics were obtained.  Food and fluid consumption two hours prior to saliva 
samples and waking time were also recorded.  
 
Ethics approval was obtained from the Queensland Children’s Hospital Ethics Committee and 
The University of Queensland Ethics Committee.  As participants were minors, informed 
consent was obtained from caregivers, with assent obtained from children when appropriate.  
If children did not accept the Salivette™, collection ceased.  
 
3.2.2   Sample Collection  
Salivettes™ (Sarstedt Australia Pty Ltd) were used to collect saliva, by placing an absorbent 
synthetic roll in the child’s mouth for a period of two minutes.  Participant code number, date 
and time of collection were recorded for all samples.  A pre-procedural saliva sample was 
taken in the waiting room prior to administration of pharmacological pain relief (Oxycodone™, 
an opioid derived pain medication, dosage determined by body weight, 0.1-0.2mg/kg). 
 
Following dressing removal five saliva samples were collected: immediately after dressing 
removal (0 minutes) and then at five minute intervals over the next twenty minutes.  
Additionally, participants were each given a Salivette™ with verbal and written instructions to 
collect a saliva sample the next morning upon waking for baseline values.  Participants were 
instructed to store the sample in the fridge until returning the sample to the burns unit at their 
next dressing change (typically three days later).  
 
3.2.3   Sample Analysis 
Samples were refrigerated before centrifuging batches from 2-3 participants at 3000rpm at 
room temperature (22⁰C) for 10 minutes in an Eppendorf 5810R centrifuge.  Saliva was then 
aliquoted into two tubes and frozen at -80⁰C ready for cortisol and sAA analysis.  Saliva 
samples were analyzed by Queensland Pathology, using ultra high performance liquid 
chromatography-tandem mass spectrometry [343] to analyses cortisol and Amylase EPS-G7 
Reagent (Thermo Scientific, Middletown, VA, USA) to measure sAA, according to 
manufacturer’s instructions.  
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3.2.4   Statistical Analysis 
The association between the outcome variables (salivary cortisol and sAA) and age, TBSA, 
Entonox™ (a gas made up of 50% oxygen and 50% nitrous oxide), Oxycodone™ and days 
since injury were investigated.  Variables are summarized as median (range) for continuous 
data and frequency (percentage) for categorical data.  Cortisol and sAA results were log 
transformed (due to a positively skewed distribution).  To account for repeated measurements 
on participants we fitted a generalized estimating equation with Gaussian family, identity link, 
and a first-order autoregressive correlation.  Time of day was included as a main effect in all 
models due to its potential confounding effect.  Each variable along with time since dressing 
were included in the model as main effects, along with an interaction term between the 
variable and time since injury.  Analyses were conducted using Stata statistical software 
version 11 (StataCorp, College Station, TX, USA). 
 
 
3.3 Results 
Thirteen participants were recruited, two dropped out due to non-acceptance of the initial 
Salivette™ prior to their dressing change.  One participant was excluded during data analysis 
as the participant had vomited shortly before sample collection, which invalidated these 
results (stomach acid affected salivary analysis). Characteristics of the 10 participants 
analyzed are displayed in Table 3-1.   
 
No consistent pattern between patients was observed in either sAA or salivary cortisol levels 
during burn wound care procedures in the 20 minutes immediately post-dressing removal. 
Levels largely remained relatively stable; individuals with high levels at dressing removal were 
also likely to have high levels 20 minutes later, and vice versa.  sAA showed more prominent 
peaks than salivary cortisol.  Figure 3-1 shows that for five out of the ten participants’ sAA 
levels peaked immediately after dressing removal (at zero minutes), three peaked prior to 
receiving medication, and one individual peaked at 5 min and another individual at 10 min 
post-dressing removal.  The highest median sAA value (97.7 U/ml) occurred at zero minutes 
(range = 14.1 – 306.9 U/ml).  Waking cortisol levels were elevated and did not provide useful 
information in identifying stress peaks when examining morning cortisol samples.   
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Table 3-1 Participant Demographics and Clinical Characteristics 
The demographic and clinical characteristics of participants saliva was collected from during 
March 2011 at the Stuart Pegg Paediatric Burns Centre, Royal Children’s Hospital, Brisbane. 
 
 
 
Salivary cortisol levels are displayed in (Figure 3-2).  Levels from nine of the ten participants 
changed less than 1.9 nmol/L (range = 0.4 – 3.6 nmol/L) between zero to twenty minutes post 
stress.  Median salivary cortisol levels at each time point were similar; the highest median 
value (1.8 nmol/L) occurred 10 minutes post dressing removal (range = 0.4 to 15.0 nmol/L).  
Additionally, the least variability in salivary cortisol levels was seen at 10 minutes post 
dressing removal. 
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 Figure 3-1 Salivary Alpha-Amylase Levels:  Anti-logged salivary alpha-amylase (sAA) levels of 
each participant.  sAA was found to peak immediately post-dressing removal (at 0 minutes, 
median 97.7 U/ml, 14.1 – 306.9). 
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 Figure 3-2 Salivary Cortisol Levels:  Anti-logged salivary cortisol levels of each participant.  
Cortisol was found to peak at 10 minutes post-dressing removal (median 1.8 nmol/L, 0.4-15)  
 
 
The association between participant demographics or clinical characteristics and sAA and 
cortisol levels at the pre-medication time interval through to 20 minutes post dressing 
removal, are displayed in Table 3-2.  Of particular interest is the statistically significant 
association between depth of the burn and peak sAA levels, and days since injury and sAA 
levels.  Children with deep partial thickness burns had significantly lower sAA levels 
compared to children with superficial partial thickness burns (p<0.001, Table 3-2). It was 
found that for every increase in one day from the burn injury, sAA significantly decreased by 
0.3 U/ml, (p<0.001, Table 3-2), while cortisol levels did not change significantly. 
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Table 3-2 Factor Associations with Salivary Alpha-Amylase and Cortisol Levels. 
 
Table 3-2:  Association between demographic and clinical characteristics and salivary alpha-
amylase and cortisol.  Analyses were adjusted for time of day the sample was collected.  Both 
burn depth and days since injury showed significant associations (p-value <0.001) with 
salivary alpha-amylase levels. 
 
 
All participants received a standard dose of Oxycodone™ (determined by body weight), 
except for one participant (participant seven) who did not receive any medication.  
Interestingly, this participant’s cortisol and sAA levels were higher than 60-70% of 
participants.  Two participants received Entonox™ (participant two and six) in addition to the 
standard Oxycodone™ dose.  Participant six had the highest cortisol and high sAA levels 
whereas sAA and cortisol levels of participant two were comparable to the sample norm.  
Participant six was the only participant to have a burn in the genital region (all other 
participant burns were on the limbs or torso), which may have increased anxiety and 
contributed to particularly elevated salivary cortisol levels.  Additionally, this patient may have 
had a pre-existing undiagnosed psychiatric issue which may have altered stress levels 
detected.  
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3.4 Discussion 
We successfully measured salivary cortisol and sAA during burn dressing change procedures 
in a standard clinical setting.  sAA levels vary widely between children and are associated 
with burn depth and days since injury.  sAA may be more sensitive to picking up slight 
changes [245] resulting from mild stressors, which were not detected or reflected in salivary 
cortisol levels at the pre-medication time point (upon entering the waiting room of the burns 
centre).  The highest sAA levels occurred at zero minutes post dressing removal.  With sAA 
levels showing immediate elevation post stress, it may be postulated that the high sAA levels 
at the pre-medication time interval are related to the anxiety and distress associated with 
entering the hospital.  Memories of pain and anxiety from when they were admitted through 
emergency after their burn occurred or memories drawn from previous hospital and pain 
experiences also may be triggered at this time.   
 
The two factors which were significantly related to sAA levels may be reflective of the 
sensitivity of sAA as a measure of stress.  Wounds which were closer to re-epithelialisation 
(i.e. more days since injury) had higher sAA levels.  Higher levels of sAA were also found for 
superficial partial thickness burns in comparison to deep partial thickness burns.    Superficial 
partial thickness burns are often extremely painful as nerve endings are still intact, as 
opposed to deeper burns. 
 
The diurnal profile of sAA shows lowest levels occurring in the morning which is distinctively 
different to that of salivary cortisol, where levels peak upon waking.  As burn clinics occur in 
the early morning from 7:30am – 11:30am, studies conducted in morning burns clinics are 
best suited to sAA measurement, despite the inter-subject variability seen with sAA.  
Reference ranges and the diurnal pattern of sAA in a study by Nater [284], of 76 healthy adult 
volunteers (not under stress), also reported significant variance in sAA levels across 
participants.  Additionally, median morning sAA levels reported in Nater’s study (median = 
89.14 U/ml of 9:00am samples) compare closely to this pilot study (median = 97.7U/ml).   
 
Salivary cortisol levels recorded in this pilot study showed lower levels (median = 1.8nmol/L, 
range = 0.4 – 15 nmol/L), during stress compared to salivary cortisol reference ranges from 
healthy children not under stress.  Tornhage [250], collected salivary cortisol from 386 school 
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children (7-15 years) between 8:00-9:00am and reported cortisol levels varying from 1.0 – 
53.9 nmol/L with a median of 8.7 nmol/L.    The lower levels seen in this study may be due to 
the method of cortisol analysis used, as UHPLC MS/MS may have measured a specific 
fraction of cortisol in comparison to the radioimmunoassay used by Tornhage.  Others have 
also reported considerably lower salivary cortisol levels analyzed by liquid chromatography-
tandem mass spectrometry (mean 1.8 nmol/L) compared to an automated immunoassay 
system (mean 4.4 nmol/L) [344].  Alternatively, lower levels of cortisol, indicative of a blunted 
response have been described in several studies in the presence of depression [345]; post-
traumatic stress disorder [346, 347]; children exposed to trauma [348] and children with 
internalizing symptoms [349].  The latter could explain the lower levels in this study sample 
given children’s experiences of the burn injury and emergency treatment. 
 
The cortisol awakening response presents a challenge in measuring stress peaks during early 
morning burn clinics when cortisol levels are already naturally high.  Cortisol level peaks were 
less pronounced and were often difficult to identify for participants compared to sAA peaks.  
Typically, the pre-medication sample time point occurred within two hours after waking, which 
explains the elevated sample levels at this time.  As the pre-medication point was 
predominately within two hours of waking, it was not considered when determining the peak 
time point.  The cortisol levels at 10 minutes post dressing removal showed the least 
variability when examining time points from zero minutes onwards.   
 
Higher levels of sAA at zero minutes post-dressing removal is consistent with the fast 
activation of the sympathetic nervous system it represents, however this would need to be 
confirmed in a larger study.  Larger numbers are required to: identify consistent patterns in 
sAA responses; establish whether cortisol is a viable reflection of stress during morning 
collection; and whether a pronounced peak in response to stress can be identified.  Despite 
the small numbers of this study, the time points identified to have the highest levels of sAA 
and cortisol, are consistent with findings from Gordis et. al [274] in adolescents who 
underwent the well-validated Trier Social Stress Test (sAA peaked at zero minutes and 
cortisol peaked at 10 minutes post stress).  The saliva collection time points at zero and ten 
minutes post stress identified in this pilot study will be used in a larger trial as an objective 
measure of stress [350].  Future research projects may also wish to consider the 
establishment of a true baseline for comparison of stress levels, perhaps by collecting salivary 
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samples from normal children or the same child at an additional time point after the burn 
wound has healed (e.g. three months), when the child is not likely to be stressed.  
 
The opposing diurnal variations of cortisol and sAA present as a challenge in this pilot study 
to measure both the SNS and HPA activity at the same time point.  Traditionally, cortisol has 
been the predominant biological measure of stress used in studies.  However, sAA appears to 
have more clinical advantages over salivary cortisol in some circumstances.  sAA levels can 
be measured immediately following stress, therefore no delay in sample collection occurs.  
sAA appears to be more sensitive, being able to detect change resulting from small stressors, 
enabling greater clinical utility for a more diverse magnitude of patient stressors.  Additionally, 
sAA’s diurnal variations are more advantageous for morning collections.  Further research is 
warranted in this area to confirm the superiority of sAA as a measure of stress in children 
undergoing burn wound care procedures. 
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This chapter consists of a published manuscript entitled “Efficacy of a children’s procedural 
preparation and distraction device on healing in acute burn wound care procedures: study 
protocol for a randomised controlled trial.”  It describes the methodology of the randomised 
controlled trial to which the data of this thesis is based upon.   
 
 
 
 
 
 
This chapter has been published as a research publication in the peer-reviewed journal 
Trials. 
 
Brown, N. J., Rodger, S., Ware, R. S., Kimble, R. M., & Cuttle, L. (2012). Efficacy of a 
children’s procedural preparation and distraction device on healing in acute burn wound 
care procedures: study protocol for a randomised controlled trial. Trials, 13(1), 238. 
 
 
 
Chapter 4. Study Protocol: A randomised controlled 
trial 
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http://www.trialsjournal.com/content/13/1/238STUDY PROTOCOL Open AccessEfficacy of a children’s procedural preparation
and distraction device on healing in acute burn
wound care procedures: study protocol for a
randomized controlled trial
Nadia J Brown1*, Sylvia Rodger2, Robert S Ware3,4, Roy M Kimble1 and Leila Cuttle1Abstract
Background: The intense pain and anxiety triggered by burns and their associated wound care procedures are
well established in the literature. Non-pharmacological intervention is a critical component of total pain
management protocols and is used as an adjunct to pharmacological analgesia. An example is virtual reality, which
has been used effectively to dampen pain intensity and unpleasantness. Possible links or causal relationships
between pain/anxiety/stress and burn wound healing have previously not been investigated. The purpose of this
study is to investigate these relationships, specifically by determining if a newly developed multi-modal procedural
preparation and distraction device (Ditto™) used during acute burn wound care procedures will reduce the pain
and anxiety of a child and increase the rate of re-epithelialization.
Methods/design: Children (4 to 12 years) with acute burn injuries presenting for their first dressing change will be
randomly assigned to either the (1) Control group (standard distraction) or (2) Ditto™ intervention group (receiving
Ditto™, procedural preparation and Ditto™ distraction). It is intended that a minimum of 29 participants will be
recruited for each treatment group. Repeated measures of pain intensity, anxiety, stress and healing will be taken at
every dressing change until complete wound re-epithelialization. Further data collection will aid in determining
patient satisfaction and cost effectiveness of the Ditto™ intervention, as well as its effect on speed of wound
re-epithelialization.
Discussion: Results of this study will provide data on whether the disease process can be altered by reducing
stress, pain and anxiety in the context of acute burn wounds.
Trial registration: ACTRN12611000913976
Keywords: Burns, Child, Pain, Stress, Anxiety, Salivary cortisol, Salivary alpha-amylase, Virtual reality, Randomized
clinical trialBackground
Burn pain
Pain is multidimensional and highly complex, and
involves the integration of sensation and perception.
Emotions, individual attributes, cognitive, environmental
and cultural factors, together with the child’s focus of* Correspondence: n.brown3@uq.edu.au
1Centre for Children’s Burns and Trauma Research, Queensland Children’s
Medical Research Institute, University of Queensland, Royal Children’s
Hospital, Brisbane, Queensland, Australia
Full list of author information is available at the end of the article
© 2012 Brown et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orattention and level of control, all play a significant role
in diminishing or magnifying the perception of pain
[1,2]. Despite considerable advances in burn wound
management, procedural pain is both the most intense
pain, and the most common type of burn pain to be
undertreated [3]. Lack of well-established evidence-
based protocols of burn pain management; inaccurate
fears of addiction; infrequent pain assessment; and poor
correlations between the nurse’s and the patient’s per-
ception of pain, attribute to the occurrence of under
medication in children [4]. It is not surprising that theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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stress and anxiety, particularly for children.
Procedural anxiety
Anxiety, which commonly co-exists with pain, impedes
our coping mechanisms and ability to tolerate pain.
Anxiety is a future-orientated emotion of apprehension,
nervousness, tension, fear and worry, accompanying
physical sensations and influencing subjective perception
[5]. Highly anxious burn patients are, therefore, more
susceptible to lower pain tolerance [6,7]. Several studies
refer to the reciprocal relationship between pain and
anxiety [8,9]. In addition to anxiety, burn injuries, which
are a type of trauma, may induce acute stress symptoms,
[10] and psychological disorders, including post-
traumatic stress disorder (PTSD) [11].
The effect of stress on the body
Pain and anxiety places the body under both physical
and physiological stress. Stress has been reported to
interrupt and delay the cascade of healing in several
studies, including skin barrier recovery after tape strip-
ping [12,13]; punch wound biopsies [14-16]; suction
induced blisters [17,18] and pre-surgical stress [19]. The
biological mechanisms behind this may be explained
through the stress induced elevation of glucocorticoids
and adrenaline and noradrenaline levels. Elevation of
these stress hormones produces an immunosuppressive
effect, reducing the infiltration and activation of neutro-
phils and macrophages [20], and also suppressing the
production of proinflammatory cytokines IL-1β and
TNF-α [21]. Proinflammatory cytokines are crucial to
the recruitment of phagocytic cells to clear away con-
taminating debris; in activating and recruiting cells
involved in wound healing, including lymphocytes and
other macrophages; and regulating fibroblast chemo-
taxis, proliferation, collagen synthesis and endothelial
cells involved in the repair process [22]. Attenuation of
the expression of these proinflammatory cytokines is
likely to impair healing through delaying the inflamma-
tory stage of wound healing [23].
Additionally, immune function plays a pivotal role,
particularly in the early processes of wound healing. Ele-
vated glucocorticoids, adrenaline and noradrenaline alter
cellular function and differentiation of T cells, causing a
shift from Th1 cellular to Th2 humoral immune func-
tion [24]. Stress-induced suppression of Th1 cellular im-
munity may inhibit the secretion of inducible nitric
oxide synthase (iNOS) in macrophages [22]. Angiogen-
esis, endothelial and epithelial cell proliferation and mi-
gration are central to wound healing and are highly
influenced by nitric oxide [25]. Additionally, an increase
in iNOS production has been shown to be just as detri-
mental as iNOS deficiency [26]. Stress-induced increasesof adrenaline in mice were shown to heighten iNOS to
cytotoxic levels, impairing wound healing [20]. A stress–
induced shift to Th2 humoral immunity activates mast
cells, which release histamine and result in inflamma-
tion. The Th2 profile up-regulates B lymphocytes, lead-
ing to the production of antibodies [27], rather than
contributing to wound healing processes. Stress may still
continue to disrupt healing after wound closure. Fibro-
blasts, together with their by-products collagen and
matrix metalloprotinases (MMPs), comprise the main
contributors to wound maturation [28]. Stressed mice
displayed reduced levels of matrix MMP-2 and MMP-9,
which are involved in cell migration and collagen turn-
over. Consequently, reduced levels may delay granula-
tion tissue re-modeling, resulting in a less organized
collagen structure (rather than being aligned parallel
with the lines of contraction) and immature collagen
scaffolds [20].
Reducing pain, anxiety and stress
Dampening pain intensity, unpleasantness, anxiety and
time spent thinking about pain through the use of vir-
tual reality (VR), has created much interest since the
first published case report in 1999 with adolescents dur-
ing burn wound care procedures [29]. An accumulation
of studies in the area of burns are reporting a discernible
reduction in pain ratings when VR is used alongside
pharmacological intervention [30-39]. VR encompasses
multisensory stimuli from sight, sound and touch,
greatly drawing the subject's attention into the virtual
world, creating a sense of “presence” [31]. VR acts to
psychologically dissociate the patient from pain by acti-
vating higher cognitive and emotional regions in the
brain. The full extent and awareness of pain is reduced,
as seen in functional magnetic resonance imaging which
showed a dampened transmission to primary regions
involved in emotional processing of pain (caudal anterior
cingulated cortex) and the sensory component of pain
(primary somatosensory cortex) [40]. Distraction has
also been shown to gate pain perception through activa-
tion of the periaqueductal gray, which was not activated
during pain stimulus alone [41].
The multi-modal distraction Ditto™ (Diversionary
Therapy Technologies, Queensland, Australia) is a med-
ical device that has a preparatory and distraction phase
[42]. The preparatory phase involves the child engaging
in the story “Bobby gets a Burn©”. This interactive story
has been specifically tailored for 3- to 12-year-olds to ex-
plain the clinical procedures and sensory phases of a
burn dressing change in a child-focused manner. The
story aims to reduce anxiety, fear and distress through
exposing and desensitizing the child to the procedure; ac-
knowledging feelings associated with the sensory aspects
of the procedure; and instilling a sense of control62
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what will transpire. Following the preparatory story,
conducted in the waiting room, the child engages in a
choice of interactive stories or games throughout
wound care procedures, forming the distraction phase
of the Ditto™. A large degree of the success of the
Ditto™ device is due to its novel design [42], and the
unique and child-friendly educational content concern-
ing the procedure [34]. Off-the-shelf virtual reality sys-
tems have not previously been able to significantly
decrease burn pain scores in adolescents [43]. However,
the novel and customized content and technology of the
Ditto™ has proven effective in reducing pain levels com-
pared to off-the-shelf video games [34].Figure 1 Study design flow chart. The sequential order and timing of daResults from Miller’s trials [33,34] confirmed the ef-
fectiveness of the Ditto™ in significantly reducing pain
ratings and treatment length. Retrospective review of
medical notes identified the Ditto™ treatment group
wounds re-epithelialized an average of two days faster
than the standard distraction group [33]. This exciting
and clinically significant finding highlights the potential
of this Ditto™ device with pain reduction and also pos-
sibly improving wound healing. In the Miller trial, burn
wound depth was not matched between control and
treatment arms and the measurement of wound re-
epithelialization was only obtained retrospectively from
the chart notes. The possible link between stress and
burn wound healing have stimulated the development ofta collection within the context of burn wound care procedures.
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pain in a scientific and controlled manner.
Objectives
The aim of this study is to determine whether use of the
Ditto™ device is associated with the rate of burn wound
healing (re-epithelialization).
Methods
Design
This study is a prospective, superiority, randomized con-
trolled trial, consisting of two parallel groups. Participants
will be randomized to receive either (1) standard prepar-
ation and standard distraction (control group), or (2) the
Ditto™ device, including preparation and distraction phases
(treatment group), to test the superiority of this new non-
pharmacological intervention on acute burn wounds. The
data collection design is displayed in Figure 1.
This trial protocol was ethically approved by both the
Queensland Children’s Health Services (Royal Children’s
Hospital) Human Research Ethics Committee and The
University of Queensland Ethics Committee, and was
registered with the Australian New Zealand Clinical
Trials Registry (ACTRN12611000913976).
Setting and participants
Participants are being recruited from the Stuart Pegg
Paediatric Burns Centre at the Royal Children’s Hospital,
Brisbane, Australia. Children presenting to this center
from August 2011 will be screened on admission for
eligibility to this trial.
Inclusion criteria
Participants who are aged between 4 and 13 years with
an acute burn injury of any depth and a burn total body
surface area of <15%, presenting on their first dressing
change, will be considered for inclusion in this study.
Exclusion criteria
Children will be excluded from the study if they are
non-English speaking; have a cognitive, visual or audi-
tory impairment, or a diagnosis under the Autism
Spectrum Disorders; have a diagnosed illness in addition
to a burn injury; have been reported to the Suspected
Child Abuse and Neglect (SCAN) system (as these chil-
dren may have additional emotional and psychological
issues affecting stress, anxiety and coping mechanisms);
receive sedative medication (Midazolam, Entonox™
(BOC Healthcare, Worsley, Manchester, UK)); and if
their burns require grafting. Several of these exclusions
will not become known until after patient recruitment
and randomization due to the nature of the clinic and
the inability to predict patient and wound management
needs prior to dressing removal.All eligible children will be invited to participate. Par-
ticipation in the study will not alter the standard medical
treatment received.
Interventions
Various outcome measures and saliva samples will be
collected at several time points during the burn wound
care procedures (Table 1), with the intervention (Ditto™)
used prior to treatment as preparation and during treat-
ment as a distraction at every change of dressing.
Waiting room
A baseline saliva sample 1 will be obtained in the waiting
room prior to nursing administration of pharmacological
pain relief in accordance with standard practice protocols
within the Burn Centre (primarily oxycodone, an opioid
derived pain medication, dosage determined by body
weight, 0.1 to 0.2 mg/kg). Saliva samples will be collected
with Salivettes™ (Sarstedt Australia Pty, Ltd. Mawson Lakes,
SA, Australia), by placing the synthetic roll in the child’s
mouth for a period of two minutes. Baseline measures will
be taken in the waiting room for: heart rate (HR); oxygen
saturation; pain ratings from the nurse and the child; a self-
report anxiety measure from children eight years and over;
height and weight. Demographic information and pertinent
clinical characteristics will be obtained from the caregiver
and patient chart: mode and site of injury; total body sur-
face area (TBSA) of burn; depth of burn; burn first aid
treatment received; skin color; medication administered;
hours per week spent engaging in computer games and
home video games. TBSA is calculated using the Lund and
Browder chart [44]. Food and fluid consumption two hours
prior to saliva samples will also be recorded as possible
confounding variables of salivary analysis in addition to the
time of sample collection and time of waking.
Participants will then be randomly allocated to one of
two groups:
(a) Treatment Group: Ditto™ device including
preparation and distraction phases.
While waiting for medication to take effect, children
will be given the Ditto™ device in the waiting area to en-
gage in the procedural preparation story of “Bobby gets
a Burn©.” Upon entering the treatment room, partici-
pants will engage in their choice of games or interactive
stories on the Ditto™ device. Engagement will occur
prior to the nurses commencing dressing removal proce-
dures and continue throughout the wound care proced-
ure. Figure 2 depicts a patient engaging in the Ditto™
device during the distraction phase of the treatment.
(b) Control Group: Standard preparation and
distraction64
Table 1 Schedule of measurements
Outcome measures Waiting room Pre-DR DR Post-DR Consult New DA Post new DA 3 months post healing
SalivetteW X X X
FLACC X X X X
FPS-R X X X X
VAS-A X X X X
Heart rate X X X X X
Oxygen saturation X X X
Parent demographic questionnaire X
CTSQ (1st COD only) X X
LDI (1st COD only) X
Photos X
Visitrak™ X
Time taken X X X
Dressing used X
Parent satisfaction questionnaire X
Ditto™ Enjoyment Scale X#
The outcome measures taken at each time point over the course of the study.
X = measure taken, # = Ditto™ intervention group only. COD, change of dressing; CTSQ, Children Trauma Screening Questionnaire; DA, dressing application; DR,
dressing removal; FLACC, Faces, Legs, Arms, Cry, Consolability; FPS-R, Faces Pain Scale-Revised; VAS-A, Visual Analog Scale–Anxiety; LDI, laser Doppler image.
Figure 2 Patient engaging in the Ditto™ distraction phase
during dressing removal. A burn patient engaging in Ditto™
distraction as nurses carry out the wound care procedures.
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tion, such as television, videos, books, toys and parental
soothing. Nursing staff may give information before or
during the process as per standard practice; however, no
Ditto™ device procedural preparation or distraction will
be available to the control group.
Dressing removal
Pain, anxiety and physiological measures will be repeated
prior to commencing dressing removal. All participants
will have their HR recorded at two-minute intervals via
an oximeter on their finger or toe. The choice of games/
stories by participants in the treatment group will be
recorded by the primary researcher.
Post dressing removal
Immediately following dressing removal and debride-
ment/wound cleaning, saliva sample 2 will be taken and,
at a further 10 minutes later, saliva sample 3 will be
obtained with date and time of collection documented.
A retrospective measure of pain/distress and anxiety
during the burn dressing removal and debridement will
be taken from the child and nurse. Time taken (in min-
utes) for dressing removal and debridement and the
number of nurses involved will also be recorded.
All participants will then have their burns scanned
using a laser Doppler imager (which measures burn
depth by displaying blood perfusion of tissue) on their
first dressing change only. A Visitrak™ (Smith & Nephew
Pty Limited, London, UK) trace of the wound area and
photos will be taken at every dressing change.65
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The type of new dressing applied will be documented
and HR, oxygen saturations and the number of nurses
and nursing time again recorded for the application of
the new dressing. The choice of Ditto™ distraction games
and stories that the treatment group engaged in will be
recorded.
Post new dressing application
Immediately following the new dressing application,
nursing retrospective pain/distress ratings and child
retrospective pain and anxiety ratings will be taken.
Measures will continue to be taken during every dres-
sing change (usually every three or seven days), using
the same protocol as above until complete re-epitheliali-
zation. Parents will be asked to rate their level of satis-
faction with pain management at the end of every
dressing change with the use of a visual analog scale
from “not satisfied” to “very satisfied.” Children in the
Ditto™ treatment group will be asked to rate their level
of enjoyment in using the Ditto™ on a 10 cm line visual
analog scale. Any relevant comments made by the par-
ticipant or parent/carer will be recorded.
Within the first week the Child Trauma Screening
Questionnaire (CTSQ) will be completed with children
six years and over through interview by the researcher.
The participants will then be reviewed by a consultant
as required.
Follow-up
At the three-month follow-up, the CTSQ will be re-
conducted via mail/phone, and a Salivette™ will be
mailed to participants to obtain sample 4, a true baseline
saliva sample (at a similar time of day to that of the pre-
medication saliva sample 1) and returned via post.
Outcomes
This study will assess the impact of the Ditto™ device on
wound healing of acute burn injuries. Healing will be
measured by the number of days until complete re-
epithelialization, with data collection commencing on
the first dressing change. Secondary outcomes will be
measuring the impact of the Ditto™ device on pain, anxiety
and stress.
Primary outcome measures
Wound healing
The amount of wound re-epithelialization and the num-
ber of days from the date of the burn injury until when
the complete wound re-epithelialization occurs will be
measured by (a) the consultant’s clinical judgment; (b)
blinded review of photographs; and (c) the Visitrak™
(Smith & Nephew) grids. Photos will be taken at every
dressing change with inclusion of a ruler and a grey scale(QPcard 101 v2, Kayell, VIC, Australia). Photograph
lighting levels will be standardized using AdobeW Photo-
shopW Elements 9 (San Jose, CA, USA)) to enable accur-
ate comparison of wound colors across photographs.
Blinded review of photos by a panel of burn wound spe-
cialists to assess re-epithelialization and general wound
appearance will occur upon cessation of data collection.
The Visitrak™ grids will be used to trace around the wet
(un-re-epithelialized) and dry (re-epithelialized) areas of
the wound.
A laser Doppler scan will be performed on the first
dressing change only, following debridement, to accur-
ately measure wound depth, allowing for comparison of
wounds across participants. Burns covering more than
one body part will be scanned separately. In addition,
more than one scan will be performed when burns are
circumferential or extend around curved surfaces in
order to capture accurate frontal, medial and/or lateral
views as appropriate. The MoorLDI2-BI2 laser Doppler
imager (LDI), Moor Instruments Limited, Devon, UK,
contains a visible red laser diode target beam of wave-
length 660 nm, and a near infra-red laser diode for mea-
surements by the laser Doppler with a wavelength of
780 nm. All scans will be performed in burn treatment
rooms maintained at a range of 22 to 24°C. A dark green
sterile surgical drape will be placed as a background
underneath the area to be scanned. The LDI scanner
head will be positioned approximately 35° off perpen-
dicular at a scanning distance range of between 40 and
70 cm from the wound and set on the fast scan reso-
lution setting. The onboard software package (moorBDA
v2.4, Moor Instruments, Axminster, Devon, UK) will be
used to calculate different wound depths (perfusion
units) as a percentage of total wound area.
Secondary outcome measures
Pain
Pain will be assessed before, during and after wound
care procedures by obtaining the participant’s self-report
of pain intensity using the Faces Pain Scale – Revised
(FPS-R); the nurse’s behavioral/observational rating
using the Face, Legs, Arms, Cry, Consolability (FLACC)
scale; and physiological indicators, including heart rate
and oxygen saturations. The Faces Pain Scale – Revised
(FPS-R) was chosen for this study over other pain scales
(for example, the Wong-Baker FACES Pain Scale) due
to its high clinical utility and psychometrically sound
properties [45].
Behavioral measures are an important tool to use as
an adjunct to self-report scales, particularly in children
who may be sedated by drugs; have a cognitive or com-
munication impairment; or are too young to compre-
hend a self-report scale. In addition, a child’s self-report
may be exaggerated, diminished or altered due to66
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factors [46]. The Face, Legs, Arms, Cry, Consolability
(FLACC) scale was chosen as it shows excellent respon-
siveness (detecting significant change in pain scores), re-
liability, content and construct validity [46].
Anxiety and fear
Emotional responses encompass negative affect and
emotional facets secondary to pain, including anxiety,
distress and fear. The fear thermometer [47] is an anx-
iety measure that may be used with younger children;
however, it was rejected as a measure as children under
eight years are reported to have difficulty cognitively dis-
tinguishing between the sensory experience of pain (pain
intensity) and the affective response (distress, anxiety,
fear) to pain [48]. An anxiety measure will only be taken
from children eight years and above, using the Visual
Analog Scale-Anxiety (VAS-A). The VAS-A has been
validated as an accurate self-report of anxiety for burn
injuries [49], as well as other patient populations [50-53],
and is more sensitive to change over time for pediatric
studies [54,55].
Stress
Salivary cortisol (reflecting the hypothalamic-pituitary-
adrenal axis activity) and salivary α-amylase (reflecting
sympathetic nervous system activity) will be used as bio-
logical markers of stress levels during burn wound care
procedures. SalivettesW without citric acid (Sarstedt Aus-
tralia Pty. Ltd.) will be used to collect saliva at three time
points: baseline in the waiting room prior to administra-
tion of pain medication; at 0 minutes following dressing
removal and debridement to capture the peak salivary α-
amylase levels; and at 10 minutes to capture the peak
cortisol HPA axis activity. These time points were identi-
fied in a pilot study of 10 patients. At these time points
the absorbent synthetic roll will be placed in the child’s
mouth for a period of two minutes. Date and time of
collection will be recorded and samples will be refri-
gerated at 2°C and processed within seven days. Sam-
ples will be spun in a centrifuge at 3,000 rpm at
room temperature (22°C) for 10 minutes and the saliva
frozen at -80°C until analysis by Queensland Pathology.
Ultra high performance liquid chromatography-tandem
mass spectrometry will be used to analyze salivary cor-
tisol [56] and Amylase EPS-G7 Reagent (Thermo Sci-
entific, Middletown, VA, USA) used to measure salivary
α-amylase, performed according to the manufacturer’s
instructions.
Detection of PTSD in children remains challenging as
the DSM-IV criteria for PTSD has been defined and
tested on adults [57] and shows lack of sensitivity in
diagnosing posttraumatic stress symptoms in young chil-
dren [10]. Screening tools were the only feasible measurefor this study due to clinical utility and the time con-
straints of the setting. The Child Trauma Screening
Questionnaire (CTSQ) [58] is a self-report tool for chil-
dren and adolescents 6 to 16 years, based on the 10-
item Trauma Screening Questionnaire for adults [59].
The CTSQ screens for hyper-arousal symptoms and for
re-experiencing symptoms following the traumatic event
[60]. The CTSQ is more accurate than the Children’s
Impact of Events Scale – version 8 in predicting PTSD
at one month and six months after injury and diagnosing
full and sub-syndromal PTSD [58].
Treatment satisfaction
Engagement, interaction and appropriate use of the
Ditto™ will be measured by participant satisfaction. If a
participant refuses to use the Ditto™ they will be
excluded from the study. If, however, a child accepts the
use of the Ditto™ and appears disinterested and does not
completely engage with the Ditto™, this will be reflected
in the child’s rating of how much they liked using the
Ditto™. Other measurements of engagement were con-
sidered such as video recording, motion monitors meas-
uring limb activation, and frequency measures of time
spent looking away from the device. These latter mea-
sures were unsuitable for the Burn Centre outpatient en-
vironment and contradicted the specific design of the
Ditto™ [42], which enables the child to interact with
their caregiver, receive reassurance or check on the
wound care procedures at any stage.
Indigenous children and children from other ethnici-
ties with darker complexions will be offered the Ditto™
procedural preparation stories with characters that have
darker skin tones. Furthermore, the exposure and fre-
quency of use of other types of video game technologies
will be recorded for each participant and correlated with
Ditto™ satisfaction.
The caregiver is asked to rate their level of satisfaction
with the pain management their child received (from
not satisfied to very satisfied) on a visual analogue scale.
The caregiver is also given the opportunity to comment
on the positive and negative aspects of treatment and
this feedback will remain confidential and will not be
shown to the clinical treating team. Satisfaction with the
Ditto™ during wound care procedures is evaluated by the
child rating how much they liked using the Ditto™ on a
10 cm line sliding scale from enjoyment to disinterest,
depicted by child-friendly images of a smiley face
thumbs up and an unimpressed thumbs down face
anchoring each end of the scale.
Recruitment and withdrawals
Sample size
The standard deviation used in sample size calculations
was based on a previous study by Miller [33], who found67
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was four days. Calculations were based on detecting a clin-
ically important difference in time to re-epithelialization
between the control and Ditto groups of three days. With
a power of 80% and significance level of 0.05, a sample size
of 29 participants per group is required.
We expect 10% of eligible participants to dropout be-
fore wound re-epithelialization. We anticipate approxi-
mately 33% of participants recruited would later be
found not to meet the eligibility criteria for the study
due to factors including: the need for grafting; use of
Entonox™; pre-existing anxiety conditions becoming
known; and child protection concerns being raised.
Therefore, it is anticipated that approximately 98 partici-
pants will need to be recruited in total, in order to
achieve final participant numbers of 29 in each group.
Randomization
Participants are randomized using a portable computer-
ized random number generator. Randomization is per-
formed by nursing or administration staff members in
the Burn Centre who are not associated with the study.
The primary researcher is then informed as to which
group the participant has been consigned.
Implementation
Recruitment will take place between 9 August 2011 and
31 August 2012. It is expected the required sample size
will be achieved within this time period. Enrolment of
participants is carried out by the primary researcher.
Children are screened on presentation to the Burn Cen-
ter for eligibility to this prospective randomized con-
trolled trial. Once it has been established that the child
meets all eligibility criteria, the primary researcher
approaches the parent/caregiver/s to explain the study
and provide them with a copy of the study information
sheet. Parent/caregiver/s are encouraged to ask ques-
tions. Parents are guided through the informed consent
form step-by-step to ensure they understand all aspects
of the research project and what participation will
involve.
Blinding
The non-pharmacological intervention received cannot
be masked. Assessment of the primary outcome, re-
epithelialization, is undertaken by burn wound specia-
lists who are masked to treatment received by the
participant.
Discontinuation/adverse events
Dizziness and nausea are potential adverse effects from
engagement in virtual reality. No such effects were
reported in previous studies that used the Ditto™ device
[33,34,61]. If such effects are experienced by participants,they are free to cease participation if desired. All adverse
events will be recorded in both treatment groups.
Statistical methods
Data analysis
All analysis will be conducted using Stata/SE 11 (Stata-
Corp LP, College Station, TX, USA). Analysis will be per-
formed based on the “intention-to-treat” principle,
where participants will be analyzed according to the
treatment they were allocated. Any dropouts will be
excluded from analysis. Participant’s baseline demo-
graphic, clinical and social characteristics will be sum-
marized using descriptive statistics. Between-group
differences at baseline will be investigated using Fisher’s
Exact test (categorical data) or Student’s t-test (continu-
ous data). The association between treatment received
and healing outcomes will be investigated using regres-
sion models. Continuous outcomes will be investigated
using linear regression and binary outcomes with logistic
regression. If assumptions for linear regression are not
met, outcomes will be analyzed using non-parametric
tests. Regression models will include treatment group as
the only main effect, unless groups are significantly
unbalanced at baseline, in which case the regression
models will include two main effects (treatment group
and time) as well as a treatment-by-time interaction
term. The efficacy of the Ditto™ may differ according to
age and the number of days to re-epithelialization will
be affected by the depth of the burn. Analysis will also
be conducted with data stratified for depth of burn
(superficial/superficial partial thickness/deep partial
thickness/full thickness) and age of participant (for ex-
ample, under 7 years 11 months/8 years and greater,
with age strata based on age group validity of the VAS-
A). Where appropriate, repeated-measures analysis will
be undertaken using Generalized Estimating Equations.
Treatment and time will be included as main effects,
and a treatment-by-time interaction will be performed.
For continuous outcomes we will assume a Gaussian
Family and for binary outcomes the Binomial Family,
each with their natural link. An exchangeable correlation
structure will be assumed. For all analyses a P-value of
0.05 will be considered significant. There will be no ad-
justment for multiple comparisons.
Data storage
Data are stored securely by the principal investigator in
locked filing cabinets within the secure area of the
Queensland Children’s Medical Research Institute, The
University of Queensland. Data are entered into an Excel
spread sheet. Incomplete data from medical records are
checked for and identified when entering data into Excel.
All other incomplete data are coded accordingly as miss-
ing, unknown or not applicable. The data set will be68
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On completion of the trial, data will be kept for a period
of 15 years in accordance with the ethical requirements
of the Queensland Children’s Health Services (RCH)
Human Research Ethics Committee.
Discussion
This trial utilizes a number of measures to investigate
the links between the novel Ditto™ procedural prepar-
ation and distraction intervention and the patient’s ex-
perience of pain, stress and anxiety, to ultimately
determine the impact this has on re-epithelialization of
acute burn wounds. This is the first RCT in the area of
acute burn injuries which examines the relationships
among pain, stress, anxiety and re-epithelialization.
The rate of re-epithelialization has discernible implica-
tions for the formation of hypertrophic scarring and the
long term physical and psychological issues resulting
from scarring. The significance of this study is that if the
Ditto™ intervention is associated with a reduction in
time taken for acute burn wounds to re-epithelialize,
patients may heal within the optimal 10 to 14 days, re-
ducing the likelihood of hypertrophic scarring [62].
This trial will also be the first to measure the utility of
salivary cortisol and salivary α-amylase as indicators of
stress during acute burn wound care procedures. Data
collected in the course of this study will seek to answer
many questions regarding the pain and stress experi-
enced by burned children, including: do children’s stress
and pain levels predict re-epithelialization rate?; are pain
and stress levels positively correlated?; and is there an
association with age or gender?
There are some limitations with this study, mostly
related to dealing with children in pain. There may be
challenges with obtaining laser Doppler image (LDI)
scans to determine burn wound depth. During scans
children are required to remain very still for up to sev-
eral minutes, ideally with their wounds free of dressings;
however, exposing wounds to air flow can cause
increased pain for the patient. The Visitrak™ measure
involves tracing wounds, which may also be challenging
for children not wanting their burns to be touched. The
individualized perception of pain poses an additional
limitation to measuring Ditto™ effectiveness. Exposure to
noxious stimuli as an infant has the potential to perman-
ently change the neuronal architecture of the developing
brain, thus resulting in greater pain sensitivity as adoles-
cents [63]. This study will include children with varying
experiences and memories of pain, which will shape
their experience of and rating of pain levels regardless of
Ditto™ engagement. To attempt to diminish this effect,
children known to have existing psychological issues, or
known to SCAN or child safety are excluded from this
study.The diurnal variation of cortisol may create challenges
in the analysis of salivary cortisol. The cortisol awaken-
ing peak occurs an hour after waking, and burn clinics
occur early in the morning, so when study samples are
taken it will be more difficult to identify any peaks in
stress levels. Ideally, a within-subjects design is best
when comparing highly variable biological markers;
however, as procedural preparation is a strong compo-
nent of this proposed study, a within-subjects design is
not feasible.
Significance of the study
The pain associated with burn injuries and the need for
additional treatment to standard pharmacological man-
agement is widely known and well established in the lit-
erature. Limited staff resources and busy burn clinics are
common place, highlighting the need for interventions
such as the Ditto™ device, which require very little set-up
time. The effectiveness of the Ditto™ device in reducing
pain and time taken for burn wound care procedures is
well established [33,34]. The potential of this device to
also improve wound healing is of great significance in the
burns field, possibly leading to decreased risk of scarring
and scar management requirements and perhaps the dif-
ference between grafting and not grafting more severe
burns. Establishing a link between reduced pain, stress
and anxiety and improving healing time in acute burn
wounds would be of major significance for patients and
health care providers, and has application for all health
care procedures which require pain/stress management,
not just acute burns.
Trial status
This trial is currently continuing to recruit participants
and collect data. The cessation of participant recruit-
ment is planned for 31 August 2012 and data collection
is likely to continue to January 2013 (with data collection
continuing until three months post re-epithelialization of
participant’s burns).
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Background: Burns and their associated wound care procedures evoke significant stress and
anxiety, particularly for children. Little is known about the body’s physiological stress
reactions throughout the stages of re-epithelialization following an acute burn injury.
Previously, serum and urinary cortisol have been used to measure stress in burn patients,
however these measures are not suitable for a pediatric burn outpatient setting.
Aim: To assess the sensitivity of salivary cortisol and sAA in detecting stress during acute
burn wound care procedures and to investigate the body’s physiological stress reactions
throughout burn re-epithelialization.
Methods: Seventy-seven participants aged four to thirteen years who presented with an
acute burn injury to the burn center at the Royal Children’s Hospital, Brisbane, Australia,
were recruited between August 2011 and August 2012.
Results: Both biomarkers were responsive to the stress of burn wound care procedures. sAA
levels were on average 50.2 U/ml higher ( p < 0.001) at 10 min post-dressing removal com-
pared to baseline levels. Salivary cortisol levels showed a blunted effect with average levels
at ten minutes post dressing removal decreasing by 0.54 nmol/L ( p < 0.001) compared to
baseline levels. sAA levels were associated with pain ( p = 0.021), no medication ( p = 0.047)
and Child Trauma Screening Questionnaire scores at three months post re-epithelialization
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( p = 0.008). Similarly, salivary cortisol was associated with no medication ( p < 0.001), pain
scores ( p = 0.045) and total body surface area of the burn ( p = 0.010).
Conclusion: Factors which support the use of sAA over salivary cortisol to assess stress
during morning acute burn wound care procedures include; sensitivity, morning clinic
times relative to cortisol’s diurnal peaks, and relative cost.
# 2013 Elsevier Ltd and ISBI. All rights reserved.
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Burns are a traumatic event and both the injury itself and the
associated wound care procedures evoke high levels of stress
and anxiety [1]. Despite this, there are very few studies which
measure biological markers of stress in patients with acute
burns. Catecholamines and cortisol are the two most
commonly used biomarkers of stress [2]. The hypothalamus
is alerted to both physical and emotional threats and controls
the stress response by activating the central hypothalamic–
pituitary–adrenal (HPA) axis which secretes glucocorticoids,
and the peripheral locus ceruleus–norepinephrine (LC–NE)
stress systems which secrete epinephrine/norepinephrine (E/
NE) [3]. The degree of activation is proportional to the stress
experienced.
The steroid hormone cortisol (also known as hydrocorti-
sone), is the primary glucocorticoid in humans. Cortisol is
historically used in research as a substantiated physiological
measure of stress and anxiety. Several studies in severe burns
of large total body surface area (TBSA) have measured serum
cortisol [4–7] and urinary cortisol [5,8,9]. Salivary cortisol is
often considered as a better measure of adrenocortical
function than serum cortisol, as it is not only a less invasive
measure, but also free cortisol (the predominant form in
saliva) is the biologically active fraction of the hormone rather
than bound cortisol [10–12]. To the best of our knowledge,
there is only one study that has measured salivary cortisol [13]
for acute burn injury patients, however, this study had high
attrition rates, highlighting the need for further studies.
Plasma blood analysis of catecholamines (E/NE), is not only
an invasive measure, but also requires immediate processing
following blood draw. These challenges make it almost
impossible to include as a measure in clinical trials [14].
Furthermore, difficulty in maintaining stability of salivary
catecholamines due to oxidative decay [2,15], together with
their delayed appearance rate (peaks occur 60 min post stress)
[16], highlight the need for alternate measures of sympathetic
nervous system (SNS) activity.
Growing literature supports salivary alpha-amylase (sAA)
as a surrogate marker of SNS activity, providing evidence that
sAA is responsive to stress and reflects the fast activation
pattern of the SNS [17–21]. sAA is one of the major proteins in
saliva and accounts for 40–50% of protein produced by the
salivary glands [18,22]. Activation of the autonomic nervous
system has a strong influence over the salivary glands and
controls the secretion of sAA [22]. Mastication activates
salivary production, however salivary flow is not the primary
determinant of stress-induced increases in sAA and therefore
unlikely to significantly confound results [23]. Additionally
age, medication, food, caffeine, alcohol, smoking, medicalPlease cite this article in press as: Brown NJ, et al. Biological markers of
10.1016/j.burns.2013.12.001drugs, exercise and somatic or psychiatric diseases can alter
sAA activity [18]. No studies of burn injury have been
published which measure sAA as a biomarker of SNS activity.
The aim of this study was to establish if salivary cortisol and
sAA were sensitive to detecting stress during acute burn
wound care procedures. Furthermore, this study compared
the utility of the biomarkers and identified wound manage-
ment factors or patient/wound demographics associated with
salivary cortisol and sAA levels.
1.1. Design
This is a prospective longitudinal study assessing salivary
cortisol and sAA as biological markers of stress, based on data
collected from a randomized controlled trial (RCT) on burn re-
epithelialization [24–26]. The Queensland Children’s Health
Services (Royal Children’s Hospital) Human Research Ethics
Committee and The University of Queensland Ethics Com-
mittee approved this RCT and it was registered with the
Australian New Zealand Clinical Trials Registry
(ACTRN12611000913976).
2. Methods
2.1. Setting & participants
Data were collected from August 2011 to August 2012 at the
Stuart Pegg Pediatric Burns Center (SPPBC) at the Royal
Children’s Hospital (RCH), Brisbane, Australia. The RCH is a
tertiary pediatric burn referral center servicing approximately
800 new burn patients per year. Inclusion criteria were; (1)
children aged 4–13 years, (2) acute burn injury, and (3) burn
total body surface area (TBSA) less than 15%. Exclusion criteria
were; (1) non-English speaking, (2) a diagnosed condition/
illness/developmental delay/psychological condition in addi-
tion to a burns injury, (3) prior history of suspected child abuse
and (4) grafting of burns. Data collection did not alter the
standard medical treatment received.
Participants were recruited and consented at the first
change of dressing (COD), with data repeatedly collected at
every dressing change until discharge from the outpatient
burns clinic. Demographic questionnaires were completed by
caregivers and charts were reviewed to obtain pertinent
clinical characteristics about the patient and their burn injury.
2.2. Sample & data collection
Prior to the administration of pharmacological pain relief pre-
procedurally, Saliva Sample 1 was obtained in the waiting stress in pediatric acute burn injury. Burns (2014), http://dx.doi.org/
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10 min
Plus 3 mths post
re-epitheli aliza on
Fig. 1 – Flow diagram of data collection. CTSQ: Child Trauma Screening Questionnaire; COD: change of dressing; HR: heart
rate; LDI: laser Doppler imaging.
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Faces Pain Scale-Revised (FPS-R) [27] and children 8 years and
over rated their anxiety on the Visual Analog Scale-Anxiety
(VAS-A) [28]. A behavioral/observational rating of pain/
distress was recorded by the nurse on the Face, Legs, Arms,
Cry, Consolability (FLACC) scale [29], and heart rate was also
recorded. Children then received pain relief in the form of
narcotic (OxycodoneTM opioid, 0.1–0.2 mg/kg); narcotic com-
bined (OxycodoneTM and either paracetamol or ibuprofen; or
codeine and paracetamol); or non-narcotic analgesia (para-
cetamol and/or ibuprofen).
Heart rate (HR) was monitored and recorded every two
minutes during wound care procedures. Immediately after
dressing removal and wound debridement/cleaning, Saliva
Sample 2 was obtained at zero minute post stress, then Saliva
Sample 3 was obtained at 10 min post stress (see Fig. 1). Saliva
was collected by placing a SalivetteTM (synthetic roll) without
citric acid (Sarstedt Australia Pty. Ltd.) in the child’s mouth for
a period of 2 min. The optimal saliva collection time points
were identified from a pilot study on 10 patients where saliva
was collected immediately after dressing removal (0 min) and
then at five minute intervals over the next 20 min. The pilot
identified sAA levels peaked immediately (0 min) following
dressing removal and cortisol levels peaked ten minutes post-
dressing removal. These peak time points for sAA and cortisol
have also been reported in previous studies by others [30,31].
As clinics occurred in the morning and the cortisol awakening
response occurs 30–45 min post-waking [32], the time of day
saliva sample collections occurred were recorded.
Pain/distress and anxiety ratings from the child and nurse
were repeated prior to dressing removal and post dressing
removal (retrospective review). Laser Doppler imager (LDI)
scans were performed on the first change of dressing only to
measure burn depth and TBSA was calculated using the Lund
and Browder chart [33]. The Child Trauma Screening Ques-
tionnaire (CTSQ) is a validated screening measure for the
identification of post-traumatic stress disorder (PTSD) [34],
and was completed with children 6 years and above, within
the first week post injury.Please cite this article in press as: Brown NJ, et al. Biological markers of
10.1016/j.burns.2013.12.001Three months following re-epithelialization of the burn
injury, participants were asked to collect a saliva sample at a
similar time of day to that of Saliva Sample 1 and return via
mail. This was called Saliva Sample 0 and was collected to
establish a baseline level for each participant. Additionally,
participants were asked to repeat the CTSQ and return via mail
along with the saliva sample.
2.3. Saliva sample analysis
Analysis of saliva samples was performed by Queensland
Pathology. Samples were refrigerated at 4 8C and within seven
days of collection, spun in a centrifuge (3000 rpm at 22 8C, for
10 min) and frozen at 80 8C. Salivary cortisol was analyzed
for $14AUD/sample using ultra high performance liquid
chromatography–tandem mass spectrometry [35], and sali-
vary alpha-amylase was analyzed for $3AUD/sample using
Amylase EPS-G7 Reagent (Thermo Scientific, Middletown, VA,
USA).
2.4. Statistical analysis
The amount of sAA and salivary cortisol at each time point
were examined using the Shapiro–Wilk Normality Test, and
then transformed to approximate normally distributed data. A
square root transformation was used for the sAA data, and a
one divided by square root transformation for the cortisol
data. Mixed-effects linear regression models were used to
examine associations between the dependent variables sAA or
salivary cortisol and the variables: age; gender; body mass
index; burn depth by laser Doppler Imager; burn total body
surface area (TBSA); maximum heart rate during dressing
removal; FPS-R (child’s self-report of pain); FLACC scale
(nursing report of pain/distress); VAS-A (child’s self-report
of anxiety); medication received; CTSQ at one week post-
injury and three months post-re-epithelialization. Back-
transformations were performed before presenting results.
Using raw data, a ratio of sAA over cortisol was calculated as
reported in previous studies [36,37] and a regression analysis stress in pediatric acute burn injury. Burns (2014), http://dx.doi.org/
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dysregulation. All regression models contained three hier-
archical levels: (1) participant identification, (2) burn site on
each participant, (3) the change of dressing number (e.g. 1st,
2nd etc.). Analyses were conducted using Stata statistical
software version 12 (StataCorp, College Station, TX, USA).
3. Results
Data were collected on a total of 77 participants aged from 4
years 1 month to 12 years 9 months (Table 1). Laser Doppler
Images were able to be performed on 59 out of the 77
participants. The average blood flow of each burn wound was
calculated, and the median value was 1138 perfusion units
(PU), with the deepest PU reading in wounds ranging from 97
PU to 977 PU (Table 1). This indicates burn wounds were
primarily superficial partial thickness, with many wounds
identified to also have deeper areas. Reasons for not
performing scans on every participant included: movement
by the child; pain and anxiety experienced by the child; and
the hectic flow of burn clinics. Complete data sets of saliva
samples (i.e. three sample time points collected at every
dressing change until discharge from the burn clinic) were
collected on 72 of the 77 participants. Baseline saliva samples
(sample 0: collected three months post re-epithelialization)
relied on participants returning samples via mail and were
received from 57 participants (74%).
3.1. Biomarker responses to wound care procedures
Salivary cortisol and sAA were sensitive to stress, reflecting
significant changes during burn wound care procedures. Table
2 displays the association between all dressing changes andTable 1 – Demographics and burn clinical characteristics.
Median (range)
Age (months) 97(50–153)
LDI average of wound area (PU) 1138(472–1699)
LDI deepest wound reading (PU) 624(97–997)
n (%)
Gender Male 46(60)
Ethnicity Caucasian 68(88)
Mechanism Scald 41(53)
Contact 25(33)
Flame 4(5)
Friction 6(8)
Chemical 1(1)
Site Axilla/upper limb 32(41)
Lower limb 23(30)
Chest/torso/back 16(21)
Genitals/buttocks 3(4)
Head/face 3(4)
Medication (COD 1 only) Narcotic 42(55)
Narcotic combined 20(26)
Non-narcotic 4(5)
Nil 11(14)
LDI, laser Doppler imaging; PU: perfusion units; and COD: change
of dressing.
Please cite this article in press as: Brown NJ, et al. Biological markers of
10.1016/j.burns.2013.12.001stress biomarkers. For sAA, all recordings taken at each
dressing change were significantly higher ( p < 0.001) than
readings taken at three months post re-epithelialization.
Similar results were observed for salivary cortisol and the ratio
of sAA over cortisol, except for the waiting room measure
(Table 2).
When examining stress over the first three dressing
changes, sAA levels continued to increase compared to
baseline levels ( p < 0.001) as wounds re-epithelialized
(Fig. 2). Salivary cortisol levels were significantly lower at
the first two dressing changes in comparison to baseline levels
at three months post-re-epithelialization (Fig. 2).
3.2. Associations with biomarkers of stress
The child’s self-report of pain (FPS-R) showed a significant
association with both sAA and salivary cortisol. In particular,
pain showed a strong negative correlation ( p = 0.021) with sAA
(Table 3). Pain levels significantly reduced ( p < 0.001 across the
period of re-epithelialization, with mean scores of 4.9(3.13) at
COD 1; 2.6(2.81) at COD 2 and; 1.9(2.65) at COD 3. The mean
pain score across all dressing changes was 3.3(3.19). Pain
levels reported by the child had no significant correlation with
either sAA or cortisol when examining COD one only ( p = 0.338
and 0.337 respectively).
Medication received was significantly associated with pain.
When examining the most painful initial dressing change, sAA
levels increased by 60 U/ml ( p = 0.015) when no medication
was received compared to when narcotic medication was
received. On average, across all dressing changes, sAA levels
increased by 10.2 U/ml ( p = 0.047) and cortisol increased by
0.65 nmol/L ( p < 0.001) when children received no medication
compared to receiving narcotic analgesia (Table 3).
Higher sAA levels during wound care procedures were
significantly associated with higher scores on the CTSQ. On
average, for every increase by 1 point on the CTSQ measured at
three months post re-epithelialization, sAA levels increasedFig. 2 – Changes in salivary biomarkers across dressing
changes: the changes in sAA (circles) and salivary cortisol
(squares) across dressing changes (1–3) in comparison to
baseline levels at three months post-re-epithelialization.
Legend: COD: change of dressing; WR: waiting room
sample; S1: stress sample one at zero minute post stress
(dressing removal); S2 = stress sample two at ten minutes
post stress.
 stress in pediatric acute burn injury. Burns (2014), http://dx.doi.org/
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Table 2 – Biological markers of stress salivary alpha-amylase and salivary cortisol during a burn dressing.
Time of
collection
Salivary alpha-amylase (U/ml) Salivary cortisol (nmol/L) Ratio of sAA/cortisol
M (SD) MD CI p-value M (SD) MD CI p-value M (SD) MD CI p-value
Saliva 0:
baseline
63.8 (54.5) Ref. Ref. Ref. 4.2 (3.2) Ref. Ref. Ref. 29.3 (42.4) Ref. Ref. Ref.
Saliva 1:
wait room
109.7 (95.3) 30.45 23.89, 37.00 <0.001 5.7 (17.0) 0.23 0.05, 0.51 0.111 50.2 (76.7) 8.1 1.03, 15.11 0.025
Saliva 2:
0 min
120.1 (104.1) 43.72 36.58, 50.86 <0.001 3.2 (5.6) 0.64 0.89, 0.40 <0.001 71.4 (92.6) 31.8 24.77, 38.88 <0.001
Saliva 3:
10 min
130.1 (124.1) 50.18 42.69, 57.68 <0.001 3.9 (7.8) 0.54 0.79, 0.30 <0.001 76.6 (110.9) 33.9 26.83, 41.06 <0.001
M: mean; SD, standard deviation; MD, mean difference; and CI: 95% confidence intervals.
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tions were found between CTSQ scores and cortisol levels.
TBSA was not correlated with sAA (0.79 (CI = 7.73, 6.15)
p = 0.824), however, on average, for every increase by 1% TBSA
burned, cortisol increased by 0.14 nmol/L (CI = 0.03, 0.25,
p = 0.014). No associations were found between either sAA
or salivary cortisol and: age; gender; LDI burn depth;
maximum heart rate during wound care procedures; pain
scores reported by the nurse (FLACC), anxiety scores reported
by the child (VAS-A); CTSQ within one week of injury; and body
mass index.
4. Discussion
Salivary cortisol and sAA were responsive to stress, showing
pronounced changes during wound care procedures com-
pared to baseline levels at three months post re-epithelializa-
tion. Results reflected a down-regulation of HPA axis activity
with a blunted cortisol pattern, and a heightened SNS
response to wound care procedures with elevated sAA levels.
Pain, medication and indicators of PTSD symptoms were
found to have strong associations with sAA levels. However, as
saliva samples were collected in the morning, and cortisol
levels are known to peak approximately 30–45 min post-
waking [32] this complicates the interpretation of the blunted
cortisol finding and the significant correlations found with
medication, pain and TBSA, favoring sAA as a better measure
of stress when assessing morning saliva samples.Table 3 – Factors associated with stress biomarkers.
All CODs Salivary alpha-amylase (U/ml)
M (SD) MD CI 
Medication:
Narcotic – Reference Reference 
Narcotic Combined – 7.97 7.07–23.00 
Non-narcotic – 7.97 7.20–23.15 
Nil – 10.20 0.14–20.25 
FPS-R 4.93(3.13) 1.39 2.58–0.21 
CTSQ 3 mth 3.47(2.45) 6.79 1.79–11.78 
TBSA 1.71(1.72) 0.79 7.73–6.15 
All CODs, data collected across all change of dressings; M, mean; SD, sta
FPS-R, faces Pain Scale-Revised; and CTSQ 3 mth, Child Trauma Screenin
* p<0.05.
Please cite this article in press as: Brown NJ, et al. Biological markers of
10.1016/j.burns.2013.12.001Our finding of a blunted cortisol response during pediatric
burn wound care procedures is in contrast to the response
seen for severe burns of large TBSA, where adrenal insuffi-
ciency occurs due to significantly higher levels of cortisol and
this results in a state of hyperinflammation and a prolonged
hypermetabolic response [38,39]. A blunted cortisol response
to stress was also found in a study by Busch et al. [13] on the
use of therapeutic touch for patients with small to medium
TBSA burns. This is the only other study in burns found to
measure salivary cortisol, however limited comparisons can
be drawn due to the small sample size of 19 analyzable
samples. Across other populations, a number of studies report
on blunted cortisol in response to stress for people with post-
traumatic stress disorder [40,41]; depression [42]; chronic
stress and anxiety [43–45]; and other stress related body
disorders including chronic fatigue syndrome, somatoform
disorders, rheumatoid arthritis and asthma [46]. Additionally,
our study also found a slightly larger burn TBSA was
significantly associated with higher cortisol levels, similar to
Vaughan et al. [47] who reported that serum cortisol and
urinary catecholamines were significantly elevated in propor-
tion to burn TBSA. It may therefore be hypothesized that
smaller burns result in little alteration in cortisol levels,
whereas larger burns may initiate a significantly heightened
cortisol response.
Blunted cortisol and heightened catecolamines have been
found in the presence of PTSD [41]. Burns are a traumatic event
and known to be the source of continued stress and anxiety
with over one third of children developing psychological Salivary cortisol (nmol/L)
p-value MD CI p-value
Reference Reference Reference Reference
0.299 0.02 0.26–0.31 0.868
0.303 0.21 0.11–0.53 0.202
0.047* 0.65 0.39–0.91 <0.001*
0.021* 0.05 0.10 to 0.0008 0.046*
0.008* 0.02 0.16–0.12 0.819
0.824 0.14 0.03–0.25 0.010*
ndard deviation; MD, mean difference; CI, 95% confidence intervals;
g Questionnaire completed three months post re-epithelialization.
 stress in pediatric acute burn injury. Burns (2014), http://dx.doi.org/
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ing an acute burn injury [1,48]. Heightened SNS activity
indicated by elevated sAA levels was significantly associated
with higher scores on the CTSQ at 3 months post burn re-
epithelialization. This finding of heightened SNS activity as a
risk factor for the development of acute stress symptoms and
PTSD, together with an asymmetry between sAA and cortisol
levels, is consistent with a number of studies [40,49–51].
Furthermore, our finding of a continued increase in sAA levels
over time across dressing changes (despite pain scores
decreasing over time), provides evidence for the occurrence
of longer-term stress responses.
Glucocorticoids may play an influential role in the regula-
tion of the SNS due to the reciprocal innervation between the
HPA axis and SNS and a negative feedback loop [3,41]. The SNS
may therefore remain hyperactive due to the failure of cortisol
to inhibit an increase in NE [41]. Prolonged elevation of the SNS
has been suggested to disrupt normal memory processing and
facilitate inappropriate memory consolidation, developing a
PTSD-like response [41]. Based on previous studies, and our
finding of an association between SNS activity and higher
CTSQ scores at 3 months post re-epithelialization, it may be
hypothesized that if stress (E/NE) can be reduced during burn
wound care procedures, this may reduce the likelihood of
PTSD developing. Alternatively, a lower responsive threshold
of the SNS compared to the HPA axis has been suggested as a
theoretical basis explaining the higher sensitivity of sAA over
cortisol.
Other possibilities may explain the decrease in salivary
cortisol levels post stress. Salivary cortisol may not be a
sensitive marker to detect changes during morning clinics,
when levels are naturally decreasing due to diurnal variations
[52]. A meta-analysis of 208 studies encompassing 6153
participants exposed to laboratory psychological stressors
illustrated the difference in average effect size between
studies carried out in the morning (0.14 (CI = 0.03, 0.25,
p < 0.05), compared to afternoon (0.46 (CI = 0.31, 0.61,
p < 0.01), when levels are more stable, and studies are able
to detect significantly greater changes. Time of day signifi-
cantly predicted effect size, accounting for 9% of variance
between morning and afternoon studies [53]. In this study
minimal variation occurred in the time of day samples were
collected (all but four participants had dressing changes occur
between 7:00 am and 10:00 am), resulting in no significant
changes to the results when time of sample collection was
adjusted for in analysis. Therefore salivary cortisol may not be
a sensitive marker to detect changes during morning wound
care procedures and sAA may be a more appropriate measure
of stress in morning acute burn injury clinics.
Additionally, salivary cortisol has a wide normal range.
Salivary cortisol concentrations in 386 healthy children 7–15
years old were measured between 8:00 am and 9:00 am after a
period of rest. Large variations of normal were found with girls
ranging from 1.5 to 53.9 nmol/L and boys ranging from 1.0 to
33.2 nmol/L [54]. Comparisons between study participants and
these wide ranges of morning cortisol from healthy children,
offer little clarity. Furthermore, no true salivary baseline can
be obtained prior to the traumatic burn injury which further
complicates the interpretation of the results. For future
studies in the area of acute burn injury it is recommendedPlease cite this article in press as: Brown NJ, et al. Biological markers of
10.1016/j.burns.2013.12.001to conduct dressing changes and measures of salivary cortisol
and sAA in the afternoon, to offer comparison and basis to
draw more substantive conclusions.
Salivary alpha-amylase is a sensitive biomarker of stress
reflecting consistently heightened patterns and positive
associations with pain, medication and indicators of PTSD
symptoms. An average increase of 50 U/ml reflected the stress
experienced by children with acute burns as a result of wound
care procedures. Children who did not receive pain medica-
tion compared to those who received narcotic analgesia
(OxycodoneTM) had significantly higher sAA levels and cortisol
levels. This finding corroborates other studies reporting lower
cortisol levels in response to narcotic analgesia [6,55,56].
When examining the first change of dressing only, sAA levels
were 52 U/ml higher in children who did not receive medica-
tion. Based on this finding, the burn center will be reviewing
the practice protocols around administration of medication.
The first change of dressing is known to be the most painful
dressing change due to the thorough debridement of devita-
lized tissue that occurs. Pain scores reported by the child on
the FPS-R were negatively correlated with cortisol which is
consistent with the negative correlation with cortisol levels
pre and post stress. Interestingly, sAA levels were also
negatively correlated with the child’s pain scores. We would
expect sAA to increase when pain scores worsened. At the first
change of dressing, sAA levels increased as pain also
increased, although the correlation was not significant
( p = 0.338). However, as correlations related sAA levels to
pain scores across all dressing changes, lower pain scores
were reported as burns approached complete re-epithelializa-
tion, whereas sAA levels continued to increase. This may
explain the significant negative correlation found between
pain levels and sAA when analysis was performed across all
dressing changes. Heightened anxiety is a known association
with children visiting a hospital environment [57] and acute
stress symptoms are typically observed within the first month
post-injury [1], therefore it is not surprising stress levels
continue to remain high across all burn dressing changes
irrespective of pain experiences (Table 3). Additionally, with
the significant correlation between no medication receipt and
higher sAA levels (compared to narcotic analgesia), it may be
hypothesized that sAA levels decreased as the wound
approached re-epithelization since medication receipt
declined after the first change of dressing. Higher doses of
medication on the first change of dressing, compared to
subsequent dressings may also contribute toward explaining
why pain and stress levels were not significantly correlated on
the first change of dressing when pain levels peak.
Strengths of this study include the prospective data
collection, consistent timing of specimen collection and use
of validated pain and wound assessment tools, such as LDI.
Limitations include incomplete receipt via mail of Saliva
Sample 0, and the consequently reduced power of our
analyses. However, the return rate of Saliva Sample 0 is
similar to rates recorded at one and six month follow-ups
reported in a study by De Young et al. [1] at the same burn
center. The follow-up CTSQ and baseline saliva sample was
required to be collected at a time point greater than one month
post re-epithelization, since it has been shown that distress
responses are normal and expected during this acute phase stress in pediatric acute burn injury. Burns (2014), http://dx.doi.org/
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epithelization, rather than six months (as in the previous
trial by De Young et al. [1]) was chosen with the aim of
reducing the risk of lost to follow-up.
This is the first study to be published which measures sAA
and salivary cortisol in acute burns. Growing literature
supports salivary alpha-amylase (sAA) as a surrogate marker
of SNS activity, providing evidence that sAA is responsive to
stress and reflects the fast activation pattern of the SNS [17–
21]. Ease of interpretation (with increasing sAA reflecting
increasing levels of stress); sensitivity; immediate respon-
siveness to stress; diurnal variations favorable to morning
sample collection; and cheaper cost for analysis all yield
support for the use of sAA over salivary cortisol to measure
stress for acute burns during morning clinics.
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The relationships between pain, stress and anxiety, and their effect on burn wound re-
epithelialisation have not been well explored to-date.  This chapter will report of a 
randomised controlled trial which investigated the effect of the non-pharmacological 
Ditto™ (a hand-held electronic medical device providing procedural preparation and 
distraction) intervention on re-epithelialisation rates in acute pediatric burn injuries.   This 
chapter consists of a published manuscript entitled “Play and Heal: Randomized controlled 
trial of Ditto™ intervention efficacy on improving re-epithelialisation in pediatric burn 
injuries.”  
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a b s t r a c t
Background: The relationships between pain, stress and anxiety, and their effect on burn
wound re-epithelialization have not been well explored to-date. The aim of this study was to
investigate the effect of the DittoTM (a hand-held electronic medical device providing
procedural preparation and distraction) intervention on re-epithelialization rates in acute
pediatric burns.
Methods/Design: From August 2011 to August 2012, children (4–12 years) with an acute burn
presenting to the Royal Children’s Hospital, Brisbane, Australia fulfilled the study require-
ments and were randomized to [1] DittoTM intervention or [2] standard practice. Burn re-
epithelialization, pain intensity, anxiety and stress measures were obtained at every
dressing change until complete wound re-epithelialization.
Results: One hundred and seventeen children were randomized and 75 children were
analyzed (n = 40 standard group; n = 35 DittoTM group). Inability to predict wound manage-
ment resulted in 42 participants no longer meeting the eligibility criteria. Wounds in the
DittoTM intervention group re-epithelialized faster than the standard practice group (2.14
days (CI: 4.38 to 0.10), p-value = 0.061), and significantly faster when analyses were
adjusted for mean burn depth (2.26 days (CI: 4.48 to 0.04), p-value = 0.046). Following
procedural preparation at the first change of dressing, the DittoTM group reported lower pain
intensity scores (0.64 (CI: 1.28, 0.01) p = 0.052) and lower anxiety ratings (1.79 (CI: 3.59,
0.01) p = 0.051). At the second and third dressing removals average pain (FPS-R and FLACC)
and anxiety scores (VAS-A) were at least one point lower when DittoTM intervention was
received.
§ Trial registration ACTRN12611000913976.
* Corresponding author at: Centre for Children’s Burns and Trauma Research, Queensland Children’s Medical Research Institute, Level 4,
Foundation Building, Royal Children’s Hospital, Brisbane 4029, QLD, Australia. Tel.: +61 7 3636 4249; fax: +61 7 3636 5578.
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Conclusions: The DittoTM procedural preparation and distraction device is a useful tool
alongside pharmacological intervention to improve the rate of burn re-epithelialization
and manage pain and anxiety during burn wound care procedures.
# 2013 Elsevier Ltd and ISBI. All rights reserved.
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Burn wound pain remains insufficiently treated, despite
considerable advances in burn wound management [1].
Procedural burn pain occurring from therapeutic wound care
procedures, i.e. cleaning and debriding the wound, is the most
intense and the most common type of burn pain to be
undertreated [2]. The entire wound healing period can evoke a
high level of pain, stress and anxiety, particularly in children
[3–5]. Acute stress symptoms [6] and psychological disorders,
including post-traumatic stress disorder [7,8] are not uncom-
mon amongst children with burns.
Opioids, although the leading treatment for burn pain,
frequently are unable to provide effective analgesia. Studies
have reported as high as 52–84% of burn patients experienced
moderate to severe pain during wound care procedures
despite implementation of evidence-based pharmacological
management [9–11]. The evolving nature of burns and
complexity of pediatric procedural pain continues to challenge
burn specialists in achieving procedural pain management
consensus [1]. Non-pharmacological interventions are called
upon as an adjunct to controlling burn pain [12,13] and play a
significant role in dampening pain perception [9,14–16].
Multiple studies report a discernible reduction in pain levels
reported by burn patients when customized virtual reality is
used in conjunction with pharmacological interventions [17–
24]. Averting attention away from the pain of wound care
procedures and focusing on more pleasantly engaging sensory
stimuli dampens transmission to the thalamus, limbic system
and cortex, and the full extent and awareness of pain may be
reduced [25–28]. Emotive processing acts to modify pain
transmission according to Melzack and Wall’s Gate Control
theory, meaning an individual’s level of distress or anxiety
may influence pain perception [27].
The multi-modal distraction ‘‘DittoTM’’ is a medical
device that includes procedural preparation and distraction
phases; the preparation phase provides procedural and
sensory information prior to the medical intervention, while
the distraction phase consists of interactive stories and
games utilized during the medical procedure [29]. The
success of the novel DittoTM device may be due to its unique
design, interactive engagement, and developmentally ap-
propriate content specifically tailored for children 3–12 years
old [30–33]. In addition to significant reductions in pain
intensity and distress scores with use of the DittoTM, Miller
et al. [31] found wounds re-epithelialized an average of two
days faster for children using the DittoTM compared with
standard care, from retrospective review of medical notes.
The possible link between pain, stress and burn wound re-
epithelialization led to the development of this trial. The aim
of this study is to investigate the association between
DittoTM use and speed of burn wound re-epithelializationThis is the first study to objectively investigate the effect of a
non-pharmacological intervention on pediatric acute burn
wound re-epithelialization.
2. Methods
2.1. Design and setting
This study was a prospective, parallel-group, superiority,
randomized controlled trial, conducted in the Stuart Pegg
Paediatric Burn Center at the Royal Children’s Hospital,
Brisbane, Australia [34]. The trial took place between August
2011 and August 2012. Participants were randomized using a
computerized random number generator to one of two parallel
groups (Fig. 1), receiving either (1) standard preparation and
standard distraction (standard group), or (2) DittoTM procedur-
al preparation and DittoTM distraction (intervention group).
The Queensland Children’s Health Services (Royal Children’s
Hospital) Human Research Ethics Committee and The Univer-
sity of Queensland Ethics Committee approved the study, and
the study was registered with the Australian New Zealand
Clinical Trials Registry (ACTRN12611000913976).
2.2. Participants
Eligible participants included children aged between 4 and 13
years who met the inclusion criteria of: (1) an acute burn of any
depth (excluding erythema only), (2) <15% total body surface
area (TBSA) burnt, and (3) presented on their first dressing
change. Exclusion of patients was determined by: (1) non-
English speaking, (2) cognitive, visual or auditory impairment,
or a diagnosis under the Autism Spectrum Disorders, (3)
diagnosed illness in addition to a burn injury, (4) prior
reporting to the Suspected Child Abuse and Neglect system
(due to the likelihood of pre-existing emotional and psycho-
logical issues which may influence stress, anxiety and pain
measures), (5) receipt of sedative medication (Midazolam,
EntonoxTM), and (6) burns which required grafting.
Demographic and social characteristics, including age,
gender, ethnicity, family income and socio-economic status
were collected for all participants. Socio-economic status was
measured at the postcode level using the Socio-Economic
Indexes For Area [35] and categorized into tertiles.
2.3. Interventions and data collection
Data collection commenced on the first dressing change and
was repeated at every dressing change until complete wound
re-epithelialization/discharge from the burn center (Fig. 2).
Pain intensity, anxiety, stress and physiological measures
were recorded in the waiting room to obtain a baseline prior to
nursing administration of narcotic analgesia (OxycodoneTM86
b u r n s 4 0 ( 2 0 1 4 ) 2 0 4 – 2 1 3206opioid); narcotic combined analgesia (OxycodoneTM and either
paracetamol or ibuprofen, or codeine and paracetamol); or
non-narcotic analgesia (paracetamol and/or ibuprofen).
Participants were randomized into either the:
(1) DittoTM intervention group – participants engaged in the
DittoTM procedural preparation story of ‘‘Bobby gets a
burn#’’ whilst waiting for medication to take effect.
During all wound care procedures they engaged in a
choice of interactive stories or games as the distraction
component of the DittoTM intervention. DittoTM set-up and
engagement was facilitated by the primary investigator.
The DittoTM is intuitive and children can immediately
engage with the device after minimal orientation and
instruction (approximately 1 min).
(2) Standard practice group – no DittoTM was accessible to this
group and nursing staff instructed all participants as per
standard practice. Distraction available to the standard
practice group included use of television, videos, books,
toys and parental soothing.
Pain intensity, anxiety, stress, and physiological measures
were obtained prior to and immediately after dressing
removal/wound cleaning and new dressing application
(Fig. 2). Duration of dressing removal/application was timed
and heart rate was recorded at 2 min intervals using an
oximeter.
Prior to the new dressing application at the first change of
dressing only, burn depth was calculated by measuring blood
perfusion at the burn site using a Laser Doppler Image (LDI,
using MoorLDI2-BI2 laser Doppler imager, Moor Instruments
Limited, Devon, UK). The burn was photographed and a
VisitrakTM (Smith + Nephew) tracing of the burn was performed
to calculate wound surface area and non-re-epithelialized (wet)
areas. The participant was then reviewed by the consultant.
Data was repeatedly collected at every dressing change until
complete re-epithelialization/discharge. The total number of
dressing changes was recorded for each wound. At three
months following re-epithelialization, final measures of stress
(CTSQ and a saliva sample) were obtained by mail.
2.4. Outcomes
2.4.1. Primary outcome measures
2.4.1.1. Wound healing. The rate of wound re-epithelializa-
tion and the number of days from the date of the burn until
95% re-epithelialization was measured by (a) VisitrakTM and
(b) blinded review of photographs.
2.4.2. Secondary outcome measures
The Faces Pain Scale–Revised (FPS-R) [36,37] was used to
measure the child’s self-report of pain. Additionally, nurses
recorded a behavioral/observational rating on the Face, Legs,
Arms, Cry, Consolability (FLACC) scale [38]. Heart rate and
oxygen saturations were recorded as physiological measures of
pain and distress. The Visual Analog Scale-Anxiety (VAS-A)
[36,39] self-report measure of anxiety was recorded for children
8 years and above. The Child Trauma Screening Questionnaire
(CTSQ) [40] was completed with participants six years and above
at the first dressing change and then repeated three monthspost-re-epithelialization. The CTSQ was selected as a readily
obtainable measure given the time constraints of the outpatient
setting and its’ ability to detect re-experiencing of stress
symptoms following the child’s traumatic burn [41].
Saliva samples were obtained to measure biological
markers of stress; salivary cortisol and salivary a-amylase.
SalivettesTM (Sarstedt Australia Pty Ltd.), were placed in the
child’s mouth for a period of 2 min to collect saliva at the
following time points: (1) baseline (in the waiting room) prior
to medication, (2) zero minutes post-dressing removal and
wound debridement/cleaning, and (3) a further 10 min later.
An additional saliva sample (4) was obtained via mail at three
months post-re-epithelialization to obtain a true baseline.
Ultra high performance liquid chromatography-tandem mass
spectrometry was used to analyze salivary cortisol [42] and
Amylase EPS-G7 Reagent (Thermo Scientific, Middletown, VA,
USA) to analyze salivary a-amylase.
2.4.2.1. Treatment satisfaction. At the conclusion of every
dressing change caregivers rated their level of satisfaction
with regard to pain management on a visual analog scale
(from not satisfied to very satisfied). Participants in the
treatment group rated their level of satisfaction with the
DittoTM on a 10 cm line sliding scale anchored by a smiley face
thumbs up image at one end and an unimpressed thumbs
down face at the other end of the scale.
2.5. Statistical analysis
Sample size was based on detecting a clinically important
difference of 3 days for burns to re-epithelialize between the
treatment and standard practice group. Assuming a standard
deviation of four days [31], power of 80% and significance level
of 0.05, a minimum sample size of 29 participants per group
was required.
Analysis was performed using Stata/SE 11 (StataCorp LP,
College Station, TX, USA) based on the intention-to-treat
principle. Wound-specific analyses (re-epithelialization, burn
depth and dressing change) were performed per wound and
measures of pain, anxiety and stress were analyzed per
participant. Log transformations were performed on stress
biomarkers prior to statistical analyses due to skewness.
Descriptive statistics were used to report baseline demo-
graphic, clinical and social characteristics of participants.
Fisher’s Exact test (categorical data) or Student’s t-test
(continuous data) were used to investigate between-group
differences at baseline. Intra-class correlation coefficient tests
were performed on the blinded photo review variables of:
percentage re-epithelialized at each change of dressing; and
total number of days to re-epithelialize. High correlations
between raters (r = 0.83–0.97) enabled mean scores to be used
for analyses. A Student t-test was used to determine the
difference in days to re-epithelialize (by VisitrakTM and by
blinded photo review) between the groups. Hierarchical mixed
linear regressions were used to investigate associations
between intervention groups and wound-specific outcomes,
with a random intercept for each participant. This method
accounts for the interdependence of multiple wounds on the
same participant. An adjustment for mean wound depth was
performed by running regressions with burn depth (mean87
b u r n s 4 0 ( 2 0 1 4 ) 2 0 4 – 2 1 3 207perfusion units) as a main effect. The sensitivity of the
analysis to missing re-epithelialization data was examined by
assuming each wound that had not reached 95% re-epitheli-
alization on discharge did so seven days after the last dressing
change. Hierarchical mixed linear regressions with a random
intercepts model for each participant were used to investigate
associations between intervention group and pain (FPS-R,
FLACC) and anxiety measures (VAS-A, salivary alpha amylase,
and salivary cortisol). Each regression model included inter-
vention group and change of dressing as main effects, and a
group-by-change of dressing interaction. Association betweenAssessed for a 
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3. Results
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Fig. 2 – Data collection flow diagram. HR: heart rate; FLACC: Faces Legs Arms Cry Consolability scale; FPS-R: Faces Pain Scale-
Revised; VAS-A: Visual Analog Scale-Anxiety; LDI: Laser Doppler Image; CTSQ: Child Trauma Screening Questionnaire.
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of child protection involvement. Consequently 52 children
entered the standard practice group and 47 entered the Ditto
group. The inability to predict patient and wound manage-
ment needs prior to dressing removal (e.g. use of EntonoxTM;
need for grafting) and inability to collect on multiple
participants returning to clinic for dressing changes at the
same time, resulted in several participant exclusions follow-
ing group allocation (Fig. 1). A total of 75 children with 101
wounds were analyzed: 40 randomized to the standard
practice group, and 35 received DittoTM intervention and all
children accepted and willingly engaged in the intervention.
Some patients, particularly those with burns to both hands,
were able to stabilize the DittoTM on their legs, bed or pillow
and on occasions caregivers assisted in supporting the device
for young children.
Baseline demographics, clinical and wound characteristics
did not differ between the standard practice (n = 52) and
DittoTM intervention (n = 47) groups with regard to age, gender,
ethnicity, family income, burn depth, burn size, mechanism of
injury, medication receipt and baseline pain and anxiety
scores (Table 1). Although there was no statistically significant
difference ( p = 0.068) in the mean burn depth between the two
groups, the difference may be clinically important, so
consequently the primary analyses were adjusted for this
possibility.
Children who received DittoTM procedural preparation
and distraction intervention re-epithelialized (measured byVisitrakTM) an average of 2.1 days faster (95%CI = 4.38, 0.10;
p-value = 0.061) than the standard practice group. Three
wounds did not reach 95% re-epithelialization before dis-
charge, and a sensitivity analysis of these wounds produced
almost identical estimates as the original results. The difference
in days to re-epithelialize between the groups was similar when
analyses were adjusted for burn depth based on average wound
perfusion units (mean difference = 2.26 (CI: 4.48 to 0.04),
p = 0.046) and for the deepest area of the wound (lowest
perfusion units recorded in the wound area) (mean
difference = 2.12 (CI: 4.26, 0.03) p = 0.053) (Table 2). There
were also significantly fewer total dressing changes overall in
the Ditto group (mean difference = 0.61 (CI: 1.19, 0.03)
p = 0.039).
Blinded photo review of re-epithelialization identified the
DittoTM intervention group re-epithelialized 1.5 days faster
than the standard practice group ( p = 0.288). Twenty-six
percent of participants in the DittoTM group re-epithelialized
beyond 14 days and were assessed for scar monitoring and
management, compared to 48% in the standard practice
group. Child-reported pain intensity scores (FPS-R) following
procedural preparation were considerably lower (mean
difference = 0.64 (95%CI:1.28, 0.01) p = 0.052) in the DittoTM
group prior to dressing removal at COD 1 (Table 3). Similarly,
anxiety measured before dressing removal (child-reported
VAS-A score) was significantly less (mean difference = 1.79
(CI: 3.59, 0.01) p = 0.051) on COD 1 when children received
DittoTM procedural preparation (Table 3).89
Table 1 – Participant demographic, clinical and wound characteristics.
Standard (n = 52) DittoTM (n = 47)
Mean (SD) Mean (SD) p-Value
Age (months) 98.92(32.09) 99.85(29.74) 0.882
TBSA 1.87(2.13) 1.89(2.24) 0.839
Baseline pain FPS-R 0.89(1.37) 1.18(1.57) 0.634
FLACC 0.15(0.55) 0.02(0.15) 0.525
Baseline anxiety VAS-Anxiety 2.76(3.00) 2.60(3.36) 0.414
n (%) n (%) p-Value
Gender Male 33(63.5) 27(57.5) 0.541
Ethnicity Lighter skin complexion 44(84.6) 41(87.2) 0.709
Darker skin complexion 8(15.4) 6(12.8)
Family income <$26,000 9(20) 5(13.6) 0.569
$26,000–$67,499 10(22.2) 15(34.1)
$67,500–$144,999 14(31.1) 14(31.8)
>$115,000 12(26.7) 9(20.5)
SES Low 8(15.4) 9(19.2) 0.882
Medium 17(32.7) 15(31.9)
High 27(51.9) 23(48.9)
Mechanism Scald 26(50.0) 22(46.8) 0.510
Contact 18(34.6) 13(27.7)
Flame 3(5.8) 6(12.8)
Friction 4(7.7) 6(12.8)
Chemical 1(1.9) 0(0)
Medication (COD1) Narcotic analgesia 23(45.1) 27(58.7) 0.072
Narcotic combined analgesia 11(21.6) 14(30.4)
Non-narcotic analgesia 4(7.8) 1(2.2)
Nil 13(25.5) 4(8.7)
Wound characteristics Standard (n = 81) DittoTM (n = 60)
n (%) n (%) p-Value
Site Head/Face 1(1.7) 6(7.41) 0.317
Chest/Torso/Back 13(21.7) 15(18.5)
Genitals/Buttocks 1(1.7) 8(9.9)
Upper leg 10(16.7) 12(14.8)
Lower Leg/Foot 12(20.0) 15(18.5)
Upper Arm/Axilla 7(11.7) 6(7.4)
Lower Arm/Hand 16(26.7) 19(23.5)
Mean (SD) Mean (SD) p-Value
LDI Mean PU Mean (SD) 1151.86(263.04) 1034.96(323.28) 0.068
LDI Min PU Mean (SD) 604.07(154.57) 567.36(186.96) 0.083
SD: standard deviation; TBSA: total body surface area; FPS-R: Faces Pain Scale-Revised; FLACC: Faces Legs Arms Cry Consolability scale; VAS-A:
Visual Analog Scale-Anxiety; SES: socio-economic status; COD1: change of dressing 1; LDI: Laser Doppler Image; PU: perfusion units; min:
minimum.
b u r n s 4 0 ( 2 0 1 4 ) 2 0 4 – 2 1 3 209The first dressing change was painful regardless of
intervention received, as there was no difference between
the groups in pain intensity scores reported by the child (FPS-
R) and pain/distress scores reported by the nurse. However,
at subsequent dressing changes two and three average painTable 2 – Number of days for burns to re-epithelialize.
Days to re-epithelialize 
Days to re-epithelialize Adjusted for mean depth (mean PU) 
Days to re-epithelialize Adjusted for deepest depth (minimum PU) 
M: mean; SD: standard deviation; MD: mean difference; CI: 95% confidenc(FPS-R and FLACC) and anxiety scores (VAS-A) were at least
one point lower when DittoTM intervention was received
(Table 3). Similar reductions of pain scores (FPS-R) in the
DittoTM intervention group were reported during the period of
new dressing application at COD2 and COD 3, with aIntervention M (SD) MD CI p-Value
Standard
DittoTM
13.51(6.56)
11.35(3.61)
Ref
2.14
Ref
4.38, 0.10
Ref
0.061
Standard
DittoTM
13.51(6.56)
11.35(3.61)
Ref
2.26
Ref
4.48 to 0.04
Ref
0.046
Standard
DittoTM
13.51(6.56)
11.35(3.61)
Ref
2.12
Ref
4.26, 0.03
Ref
0.053
e interval; PU: perfusion Units (laser Doppler imager); min: minimum.
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Table 3 – Pain and anxiety scores reported by the child on the Faces Pain Scale-Revised (FPS-R) and the Visual Analog
Scale-Anxiety (VAS-A).
FPS-R Group M (SD) MD (CI) CI p-Value
COD 1
Pre-dressing removal Standard
DittoTM
1.38(1.93)
0.74(1.09)
Ref
0.64
Ref
1.28, 0.01
0.052
Dressing removal Standard
DittoTM
4.63(3.26)
5.14(2.96)
Ref
0.51
Ref
0.80, 1.81
0.446
New dressing application Standard
DittoTM
2.59(2.98)
2.20(2.27)
Ref
0.37
Ref
1.54, 0.79
0.527
COD 2
Pre-dressing removal Standard
DittoTM
0.91(1.81)
0.31(0.74)
Ref
0.60
Ref
1.26, 0.05
0.069
Dressing removal Standard
DittoTM
3.14(3.08)
2.00(2.44)
Ref
1.11
Ref
2.46, 0.25
0.109
New dressing application Standard
DittoTM
2.00(3.05)
0.70(1.29)
Ref
1.51
Ref
2.89, 0.13
0.032
COD 3
Pre-dressing removal Standard
DittoTM
0.29(0.72)
0.36(0.81)
Ref
0.06
Ref
0.83, 0.95
0.894
Dressing removal Standard
DittoTM
2.43(3.07)
0.73(1.01)
Ref
1.79
Ref
3.74, 0.16
0.072
New dressing application Standard
DittoTM
2.20(3.33)
0(0)
Ref
1.90
Ref.
4.40, 0.61
0.137
VAS-A Group M (SD) MD (CI) CI p-Value
COD 1
Pre-Dressing Removal Standard
DittoTM
3.71(3.31)
2.01(2.49)
Ref
1.79
Ref
3.59, 0.01
0.051
M: mean; SD: standard deviation; MD: mean difference; CI: 95% confidence interval; MD: mean difference; COD: change of dressing; Ref:
reference variable in regression.
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difference = 1.51 (CI: 2.89, 0.13) p = 0.032).
Maximum heart rate, when adjusted for age was signifi-
cantly lower across all dressing changes (mean
difference = 4.89 (95%CI: 9.69, 0.09) p = 0.046) when chil-
dren received DittoTM intervention. Salivary cortisol levels
showed no significant differences between the groups at the
first, second and third dressing changes ( p = 0.918, 0.177, 0.676
respectively). Similar results were obtained for salivary alpha-
amylase ( p = 0.989, 0.234, 0.530). No difference in CTSQ scores
between the intervention groups were found in the first week
post-injury (CI = 1.49, 0.87; p = 0.602), or at three months
post-re-epithelialization (CI = 1.26, 2.00; p = 0.651). When
DittoTM intervention was received, the time taken to remove
the dressings on the first change of dressing was on average
1 min and 14 s faster (mean difference = 1.24 (CI: 2.95, 0.47)
p = 0.154) than the standard practice group. There was no
significant difference between the groups for parental satis-
faction ratings of pain management and treatment satisfac-
tion on a VAS scale (standard group mean = 9.52 1.07,
DittoTM intervention group mean = 9.56  1.06, p = 0.801),
where 10 was very satisfied.
4. Discussion
Burn wounds of children who received the DittoTM procedural
preparation and distraction intervention re-epithelialized on
average two days faster than the standard practice group.
DittoTM procedural preparation significantly reduced anxietylevels prior to the first dressing removal and the average heart
rate across all change of dressings. During the second and
third dressing changes, the DittoTM group’s pain and anxiety
levels were on average lower than the standard practice group.
This is the first RCT to report on the effects of non-
pharmacological intervention on burn re-epithelialization
and in the broader context, non-pharmacological intervention
hastening wound healing. The effects of pain and anxiety and
their connections with wound healing are yet to be fully
explained in the literature.
Patients in the DittoTM group showed a two day improve-
ment in rate of re-epithelialization which translated to a
sizable reduction in the need for scar monitoring and
management. Our burn center’s scar management practices
are generally implemented when burns take 14 days or longer
to re-epithelialize [43,44]. Based on the higher proportion of
participants in the control group requiring scar monitoring
and management in comparison to the DittoTM group, it may
be concluded that the two day difference between the groups
for superficial partial thickness burns becomes highly clini-
cally important, when the need for scar management
intervention may be eliminated.
Patient care protocols have been revised following this
study to include DittoTM intervention as standard practice. The
burn center’s nursing and allied health staff have been trained
by Diversionary Therapy Technologies, the producers of the
DittoTM in set-up, operating, maintaining and cleaning the
device. Additionally, specific competencies and training have
been developed and delivered to hospital volunteers at the
Royal Children’s Hospital who now come daily to burn clinics91
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the waiting room.
The first dressing change sets the scene and determines the
success of subsequent dressing changes [2]. Targeted and
appropriate DittoTM procedural preparation prior to the first
dressing removal significantly reduced child-reported anxiety
(VAS-A, p = 0.022). Appropriate preparation for the anticipa-
tion of a painful event has the potential to influence pain and
reduce the perceived level of unpleasantness of a noxious
stimulus [13,45]. Beyond the first change of dressing, repeated
DittoTM intervention at each change of dressing resulted in a
reduction by one point in anxiety and pain scores in
comparison to the standard practice group. The effectiveness
of providing specific and tailored procedural and sensory
information with the DittoTM device was reported by Miller
et al. [30] and the sustained positive effects on reducing pain
scores with use of the DittoTM were also found in this study.
Positive effects of providing targeted procedural preparation
prior to medical procedures have been studied across several
pediatric clinical settings including: orthopedic cast removal
[46], angiocatheter insertion [47], bone-marrow aspirations
and lumbar punctures [48]. Similarly in adult settings, studies
have examined this in surgical patients [49], cholecystectomy
surgery [50], and endoscopic procedures [51].
A positive effect was achieved in reducing pain intensity
with use of the DittoTM ( p = 0.051). Previous trials by Miller
et al. [30,31] identified a stronger effect of the DittoTM
intervention in reducing pain intensity compared to this
study. However, this study was designed following the
Pediatric Initiative on Methods, Measurement, and Pain
Assessment in Clinical Trials [36] and therefore used the
FPS-R, a more validated pain assessment tool than the Wong-
Baker FACES Pain Scale which was used in previous DittoTM
studies by Miller et al. The Wong-Baker FACES Pain Scale [52]
may have over-estimated differences in pain scores between
the groups in previous trials as no painful expression appears
below the score of six out of ten on this scale [53]. The Wong-
Baker scale has been criticized as a more accurate indicator of
pain affect (the emotive facets of pain), rather than pain
intensity [54]. Any intervention which achieves a reduction in
pain intensity is clinically important.
Pediatric pain assessment continues to challenge health
professionals with young children’s difficulty in understanding
and verbally expressing their pain experience, together with the
challenge of quantifying an individual’s subjective experience.
Interestingly, the high scores in parental satisfaction of their
child’s treatment, irrespective of pain ratings or intervention
received, suggests people expect burn dressing changes to be
painful.
There are several hypotheses which may explain the
mechanisms by which DittoTM enhances re-epithelialization.
Nurses may have been able to clean the wound more
thoroughly and create a wound environment more conducive
to healing when children were immersed in the DittoTM
distraction. Reduction of pain and anxiety achieved through
DittoTM intervention may also have enhanced re-epitheliali-
zation. The links between pain, stress and wound healing are
complex. Widgerow et al. [55] is one of the few to discuss the
multiple links between pain mediators such as substance P
and delayed healing. Substance P is known to stimulateangiogenesis, proliferation of fibroblasts and keratinocytes,
nerve growth and wound healing [56,57], and levels are altered
in abnormal healing conditions such as burn wound scarring
and diabetic wounds [58]. Additionally, the effect of stress
delaying wound healing has been widely reported across
several clinical settings [59–62] and stress or higher catechol-
amine and glucocorticoid levels have been shown to delay
inflammatory cell infiltration, suppress fibroblast migration
and reduce the production of granulation tissue [63]. Further
research is required to comprehend how the matrix of cellular
changes resulting from heightened pain, anxiety and stress
interact to impede wound healing.
The use of objective measures was a primary strength of
this study, particularly the use of LDI, allowing accurate
comparison of participant wound depths and VisitrakTM at
every COD enabling percentage of re-epithelialization to be
accurately calculated.
A limitation of this study was the variation in days
presenting to clinic for dressing changes due to the use of
both three and seven day dressings. There were a number of
different dressings used throughout the study; predominately
ActicoatTM or ActicoatTM 7 with or without Mepitel1; and on
occasions Betadine1, AllevynTM Ag, or Duoderm1. Through-
out the re-epithelialization phase, the dressing type was
determined by the consultant’s clinical judgement. Another
limitation is the nature of burn clinics where patients present
to the burn center at differing days post-injury. It is
recommended future trials stipulate dressing changes to
consistently occur every three days, to improve consistency in
the monitoring and assessing of re-epithelialization.
Exposure to repeatedly noxious stimuli as an infant can
have permanent changes on the neuronal architecture of the
developing brain, resulting in greater sensitivity to pain in
adolescence [27]. It may be beneficial for future studies
assessing pain to take a comprehensive history of past
injury/illness/hospital admissions/pain experiences.
5. Conclusion/recommendations
Future studies should investigate the effectiveness of the
DittoTM device in children with deeper burns and larger burn
TBSA, to further validate the positive effects of the DittoTM on re-
epithelialization. Furthermore, based on sustained positive
effects of the DittoTM with repeated use, it may be hypothesized
that the benefits of the DittoTM strengthen when repeated,
consistent procedural preparation and distraction are received,
creating a sense of structure, security and diversion for the child
to manage their feelings of anticipation and experiences during
dressing changes. The reduction in days to re-epithelialize with
use of the DittoTM and the resultant positive effects this may
have in reducing the need for scar management, highlight the
DittoTM device as a worthwhile tool to be used as an adjunct to
pharmacological analgesia for pediatric wounds.
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Introduction: An important treatment goal for burn wounds is to promote early wound
closure. This study identifies factors associated with delayed re-epithelialization following
pediatric burn.
Methods: Data were collected from August 2011 to August 2012, at a pediatric tertiary burn
center. A total of 106 burn wounds were analyzed from 77 participants aged 4–12 years.
Percentage of wound re-epithelialization at each dressing change was calculated using
VisitrakTM. Mixed effect regression analysis was performed to identify the demographic
factors, wound and clinical characteristics associated with delayed re-epithelialization.
Results: Burn depth determined by laser Doppler imaging, ethnicity, pain scores, total body
surface area (TBSA), mechanism of injury and days taken to present to the burn center were
significant predictors of delayed re-epithelialization, accounting for 69% of variance. Flame
burns delayed re-epithelialization by 39% compared to all other mechanisms ( p = 0.003).
When initial presentation to the burn center was on day 5, burns took an average of 42%
longer to re-epithelialize, compared to those who presented on day 2 post burn ( p < 0.000).
Re-epithelialization was delayed by 14% when pain scores were reported as 10 (on the FPS-
R), compared to 4 on the first dressing change ( p = 0.015) for children who did not receive
specialized preparation/distraction intervention. A larger TBSA was also a predictor of
delayed re-epithelialization ( p = 0.030). Darker skin complexion re-epithelialized 25% faster
than lighter skin complexion ( p = 0.001).
Conclusions: Burn depth, mechanism of injury and TBSA are always considered when
developing the treatment and surgical management plan for patients with burns. This
study identifies other factors influencing re-epithelialization, which can be controlled by the
treating team, such as effective pain management and rapid referral to a specialized burn
center, to achieve optimal outcomes.
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The past decade has seen much advancement in pediatric
burn treatments and outcomes. The focus in developed
countries has shifted from mortality to concerns around
morbidity; pain reduction and non-pharmacological interven-
tions; cosmetic outcomes; rehabilitation; quality of life and
psychosocial well-being. However, limited research has been
conducted on factors influencing rate of re-epithelialization
since Deitch et al. [1] first identified the importance of re-
epithelialization within 21 days post injury, to minimize the
likelihood of hypertrophic scarring.
Burn depth by laser Doppler imaging (LDI) remains the only
confirmed predictor of wound re-epithelialization to date [2,3].
Several studies have investigated risk factors for hypertrophic
scarring [1,4–7], reporting depth, days to re-epithelialization,
anatomical location of the burn, ethnicity and age as
predictors of hypertrophic scarring. Psychological factors
influencing burn re-epithelialization were investigated in a
retrospective study by Wilson et al. [8], who reported negative
burn perceptions held by the patient were a significant
predictor of re-epithelialization once burn and demographic
characteristics had been controlled for. Other than the depth
of a burn, risk factors for healing potential have not been
validated or investigated in a prospective study. Little is
known about whether risk factors for delayed re-epithelializa-
tion are the same as those identified and documented for
hypertrophic scarring.
This prospective study on burn re-epithelialization inves-
tigates multiple demographic and burn wound clinical
characteristics to identify factors influencing burn wound
re-epithelialization in children. Furthermore, links between
risk factors for delayed healing identified from this study will
be compared and contrasted to risk factors for hypertrophic
scar development reported in the literature. We hypothesize
there are multiple factors which can delay re-epithelialization;
including patient demographics and wound characteristics,
and the clinical management of patients and their wounds.
2. Methods
2.1. Design
Factors predicting delayed burn wound re-epithelialization
were investigated in this prospective longitudinal study by
analyzing data from a randomized controlled trial (RCT) on
burn re-epithelialization [9]. The RCT was registered with the
Australian New Zealand Clinical Trials Registry
(ACTRN12611000913976), and approved by the Queensland
Children’s Health Services (Royal Children’s Hospital) Human
Research Ethics Committee and The University of Queensland
Ethics Committee.
2.2. Setting and participants
Data were collected from the Stuart Pegg Pediatric Burn Center
(SPPBC) at the Royal Children’s Hospital, Brisbane, Australia
from August 2011 to August 2012. Inclusion criteria werechildren aged 4 years to 12 years 11 months who presented
with a burn of less than 15% total body surface area (TBSA).
Exclusion criteria were; (1) non-English speaking, (2) children
with a diagnosed condition/illness/developmental delay in
addition to a burns injury, (3) children with a prior history of
suspected child abuse and neglect, and (4) burns requiring
grafting. Data collection commenced at the first dressing
change, and did not alter medical treatment received. Partici-
pants were randomly assigned by administrative staff using a
portable computerized random number generator to one of two
groups: to receive a computerized procedural preparation and
distraction intervention; or to receive standard preparation and
distraction including television, videos, toys, and/or parental
soothing. Data were collected at every dressing change until
complete burn re-epithelialization [9].
2.3. Dressing change procedures
Participants received pain relief in the form of narcotic
analgesia (oxycodone opioid, 0.1–0.2 mg/kg); narcotic combined
(oxycodone and either paracetamol or ibuprofen; or codeine
and paracetamol), or non-narcotic analgesia (paracetamol and/
or ibuprofen). Administration of pain medication was deter-
mined by nursing pain assessments. Participants primarily
received narcotic pain relief on the first change of dressing.
All burns were debrided at the first change of dressing
(blisters were de-roofed and dead skin wiped away with gauze)
and Chlorhexidine solution was used to clean the burn at
every dressing change. Dressings were applied based on the
consultant’s assessment and consisted of Acticoat3TM (dress-
ing changes every three days) or ActicoatTM (dressing changes
every seven days) with or without MepitelTM.
2.4. Data measurements
A VisitrakTM grid (Smith + Nephew, London, UK) was used at
every dressing change to calculate the re-epithelized area of the
wound. The number of days post-injury before burns reached
95% re-epithelialization (based on VisitrakTM), was used to
calculate the dependent variable ‘‘days to re-epithelialize.’’
The MoorLDI2-BI2 laser Doppler imager (LDI, Moor Instru-
ments Limited, Devon, UK), was used at the first dressing
change to determine burn depth. Scanning distances ranged
between 40 and 70 cm, with the scanner head positioned
approximately 358 off perpendicular and set on fast scanning
resolution. The onboard software package (moorBDA v2.4) was
used to define regions of interest for each burn area, to calculate
the average perfusion units (PU) and minimum value PU of each
burn area, enabling comparison of average and minimum
values across burn wounds. TBSA of the burn injured area was
calculated using the Lund and Browder chart [10].
Pain, distress and anxiety scores were recorded before,
during and after wound care procedures by: (a) participant
self-report on the Faces Pain Scale-Revised (FPS-R); (b) the
nurse’s behavioral/observational rating on the Face, Legs,
Arms, Cry, Consolability (FLACC) scale; (c) and children 8 years
and above rated anxiety on the Visual Analog Scale-Anxiety
(VAS-A). Heart rate as a physiological indicator of distress and
anxiety was monitored and recorded every two minutes
during wound care procedures. Additionally, children six98
Table 1 – Participant demographics.
Mean (SD)
Age (months) 96.96 (29.67)
N (%)
Gender Male 46 (60)
Ethnicity Lighter skin complexion 68 (88)
SES Low (SEIFA  6) 24 (32)
High (SEIFA  7) 52 (68)
Medication (COD1) Narcotic analgesia 42 (55)
Narcotic combined analgesia 20 (26)
Non-narcotic analgesia 4 (5)
Nil 11 (14)
TBSA, total body surface area; SES, socio-economic status; COD,
change of dressing.
Table 2 – Wound clinical characteristics.
Mean (SD)
TBSA (%) 2.15 (1.95)
LDI Mean (PU) 1107.35 (282.44)
LDI Minimum (PU) 591.12 (164.04)
N (%)
Depth (clinical judgment) Superficial partial thickness 75 (70.8)
Deep partial thickness 30 (28.3)
Full thickness 1 (0.9)
Mechanism Scald 61 (57.6)
Contact 31 (29.3)
Flame 5 (4.72)
Friction 8 (7.6)
Chemical 1 (0.9)
Anatomical site Axilla/upper & lower arm 42 (39.6)
Upper & lower leg/foot 35 (33)
Chest/torso/back 22 (20.8)
Head/face 4 (3.8)
Genitals/buttocks 3 (2.8)
TBSA: total body surface area; LDI: laser Doppler imaging; PU:
perfusion units.
b u r n s 4 0 ( 2 0 1 4 ) 7 5 1 – 7 5 8 753years and above completed the 10-item Child Trauma
Screening Questionnaire (CTSQ) [11] within the first seven
days post injury and then repeated the CTSQ via mail at three
months post re-epithelialization, to identify symptoms of
Post-Traumatic Stress Disorder (PTSD).
2.5. Statistical methodology
The statistical analyses were conducted using the Stata
statistical software package [12]. The goal of the analysis
was to determine and understand the dependences between
number of days from injury to 95% re-epithelialization (the
dependent variable) and the following independent variables:
burn depth (LDI), TBSA, participant’s self-report of pain (FPS-
R), nurse’s rating of pain/distress (FLACC), participant’s self-
report anxiety scores (VAS-A), ethnicity, mechanism of injury,
days post-injury to present to the burn center, age, gender,
family income, mother’s highest education level, Socio-
Economic Indexes for Areas (SEIFA), site of injury, first aid,
maximum heart rate during the wound care procedures, and
nursing time taken to complete wound care procedures. Due
to a specialized preparation/distraction intervention being
randomly used for some of the patients during wound care
procedures, the categorical variable ‘‘group’’ (reflecting the
application of the distraction technique) was added to the
considered model. The Shapiro–Wilk test for normality
indicated ‘‘days to re-epithelialize’’ was not distributed
normally ( p < 0.001) and this dependent variable was loga-
rithmically transformed to achieve a normal distribution.
As there were multiple (4) burns per patient, we
considered clustering of burns with respect to each patient,
which gives rise to the two-level random-effects linear
regression with random intercepts to assess the effect of
each independent variable on burn re-epithelialization. The
two levels within the model are: (1) individual burn, and (2) the
patient on which this burn was located. The random effects
within the model are random intercepts for the respective
regression lines of days to re-epithelialize versus the consid-
ered independent variables for each patient.
It was shown that only independent variables burn depth,
TBSA, pain intensity, group, ethnicity, mechanism of injury,
and days taken to present to burns center had statistically
significant impacts on days to 95% re-epithelialization. For all
other considered independent variables: p > 0.1, which means
that these variables have insignificant impact on re-epitheli-
alization time. The test for the presence of non-linear higher
order terms in the dependence of days to re-epithelize on the
continuous and statistically significant variables revealed the
presence of statistically significant terms up to the power of
three for the LDI variable. All possible interactions between
the independent variables were considered, with only the
interaction term of the group and pain (FPS-R) variables found
to be significant.
Using the likelihood ratio test to compare the fit of the
random intercept model to that of the multiple regression
model without clustering, gives p = 0.018, which confirms the
need for using the random intercept model. At the same time,
comparing the random slope and random intercept models
did not show statistically significant difference ( p > 0.45).
Thus, we limit our model to only the consideration of randomintercepts. The assumption of normality for the random
intercepts was confirmed by the Shapiro–Wilk test (giving
p = 0.6) and the quantile–quantile plot.
3. Results
Data were collected on a total of 77 participants. The median
age was 8 years 1 month, with a range from 4 years 1 month to
12 years 9 months, (see Table 1 for demographic character-
istics). A total of 106 burns were analyzed, which were
primarily superficial partial thickness burns resulting from
scald injuries (see Table 2 for burn characteristics). According
to the Australian Bureau of Statistics Socioeconomic Indexes
for Areas (SEIFA) [13,14], participants were from primarily high
socio-economic status postcode areas (SEIFA  7), and from
parental report total annual family income was greater than
$67,500 for 59% of participants. Laser Doppler Imaging (LDI)
was not always possible to perform due to the hectic nature of99
Table 3 – Mixed effect model of factors delaying days to re-epithelialize.
ERC CI P-value Variance (%)
LDI 0.988 0.982; 0.994 <0.001 43.1
Days since injury 1.123 1.077; 1.171 <0.001 13.7
Pain (FPS-R) (PDI and SI) – – 0.95 –
Pain (FPS-R) (SI) 1.022 1.004; 1.041 0.015 5.96
Ethnicity 0.75 0.64; 0.89 0.001 5.56
Mechanism 1.39 1.12; 1.73 0.003 4.1
TBSA 1.036 1.003; 1.069 0.030 2.4
ERC, exponentiated regression coefficient; CI, 95% confidence interval; LDI, laser Doppler imaging; FPS-R, Faces Pain Scale-Revised; PDI,
computerized preparation/distraction intervention group; SI, standard intervention; TBSA, total body surface area.
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Fig. 1 – Prediction of days to re-epithelialize based on burn
depth. (a) The dependence of the number of days to I95%
re-epithelialization for a scald burn versus minimum
value blood flow (perfusion units) recorded for each burn
on laser Doppler imaging (LDI) for patients from ethnicities
of lighter skin complexion. (b) The dependences of the
number of days to I95% re-epithelialization for a burn
versus average LDI blood flow (perfusion units) for a scald
burn for patients from ethnicities of lighter skin
complexion (curve 1); flame burn for patients from
ethnicities of lighter skin complexion (curve 2); and scald
burn for patients from ethnicities of darker skin
complexion (curve 3). The total body surface area of the
burn for all the curves in this figure equals 1%. The gray
bands show the 95% prediction intervals for the respective
regression (solid) curves.
b u r n s 4 0 ( 2 0 1 4 ) 7 5 1 – 7 5 8754outpatient burns clinics, movement by the child, and pain and
anxiety experienced by the child. LDI was performed on a total
of 84 of the total 106 burns. One full thickness burn was
recorded. Due to the small size of this burn (approximately
1 cm2), it was not grafted and therefore eligible to include in this
study. No statistically significant differences were found in the
model when comparing the different types of Acticoat dressings
(three or seven day dressings) with or without MepitelTMapplied
to participants’ burns. No burn wound infection was reported by
the consultants during this study. Group randomization
resulted in 41 participants receiving computerized procedural
preparation and distraction and 36 participants receiving
standard procedural preparation and distraction.
Burn depth, ethnicity, pain scores, TBSA, mechanism of
injury and days taken to present to the burn center were
significant predictors of re-epithelialization, accounting for
69.3% of the total variability of days to re-epithelialize (Table
3). The non-linear LDI terms up to the power of three were
significant in the considered model. This was required to
account for the non-linear relationship whereby low LDI
readings (deep burns) took non-proportionally longer to re-
epithelialize than superficial burns (higher LDI readings),
which re-epithelialized relatively quickly. For simplification,
higher order terms are not shown in Table 3. The percentage of
variance each variable contributes to our model is detailed in
Table 3 in order of their relative importance. Burn depth (by
LDI) was the most important predictor accounting for the
largest fraction (43.1%) of variance of days to re-epithelialize
and TBSA appears as the least important factor responsible
only for 2.4% of this variance.
Burn depth determined by LDI was not surprisingly a strong
predictor of re-epithelialization (Fig. 1a and b). When
examining the lowest blood flow recorded for each burn area,
the median was 624PU, which indicates a superficial partial
thickness burn, but the range was 97PU to 977PU, as many
burns had deeper areas. When comparing participant’s lowest
PU readings, a value of 200PU (category green; prediction of
healing potential >21 days) took 44% longer to re-epithelialize
than a value of 400PU (category yellow; prediction of healing
potential 14–21 days). The average blood flow in the burn areas
on LDI scans ranged from 471.7PU to 1699PU, with a median of
1137.9PU (superficial partial thickness). An average PU of 800
compared to an average PU of 1000 took 25% longer to re-
epithelialize. The significant relationship between lower blood
perfusion (deeper burn) and more days to re-epithelialize
(Table 3 and Fig. 1a and b (curve 1)), form the basis of the
model, allowing comparison across participants and other
influential factors predicting re-epithelialization.Ethnicity was divided into two categories for analyses;
lighter and darker skin complexions. Participants in this study
who formed the darker skin complexion sub-group were from
Indian, North African, Middle Eastern, and Indigenous origins.
The majority of the lighter skin complexion sub-group were
Caucasian from Australia, with others from New Zealand,
American, Asian and European origins. Regression analyses
identified burns re-epithelialized an average of 25% faster
( p = 0.001) when participants were from ethnicities of darker100
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Fig. 2 – The dependency between days to present to the
burns center and days to re-epithelialize. The dependence
of the number of days to I95% re-epithelialization for
patients of ethnicities of lighter skin complexion with a
scald burn versus the number of days lapsing between the
injury and admission to the Stuart Peg Pediatric Burns
Center (SPPBC) for the first dressing change. The total body
surface area of the burn equals 1%. The error bars indicate
the 95% prediction interval for the presented dependence.
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Fig. 3 – The dependencies between pain, TBSA and re-
epithelialization. (a) The dependence of the number of
days to I95% re-epithelialization for a scald burn versus
pain score (Faces Pain Scale-Revised, FPS-R) for patients
from ethnicities of lighter skin complexion, with 1% total
body surface area, and average LDI = 1100 perfusion units
(PU); the gray band shows the 95% prediction interval for
the regression curve. (b) The dependences of the number
of days to I95% re-epithelialization for a scald burn versus
pain score (FPS-R) for patients of ethnicities of lighter skin
complexion, average LDI = 1100PU, and three different
values of the total body surface area of the burn: 1% (curve
1), 3% (curve 2), and 5% (curve 3).
b u r n s 4 0 ( 2 0 1 4 ) 7 5 1 – 7 5 8 755skin complexion, compared to lighter skin complexion (Table
3 and Fig. 1b, curve 3). Additionally, mechanism of injury was
found to be associated with re-epithelialization. Flame burns
took 39% longer to re-epithelialize ( p = 0.003), compared to all
other mechanisms, (Fig. 1b, curve 2).
Interestingly, the number of days before presenting to our
tertiary burn center was associated with time to re-epithelial-
ize (Table 3 and Fig. 2). If a child presented on day 5 as opposed
to day 2 post burn, burn re-epithelialization was delayed on
average by 42%, when adjusted for burn depth (Fig. 2).
The significant relationship between pain scores and re-
epithelialization is demonstrated by Fig. 3a. Pain scores of
children (FPS-R) who did not receive the specialized prepara-
tion/distraction intervention had re-epithelialization delayed
by 2.2% for every increase by one point on the pain scale (FPS-
R). At the same time, in the group who received the
preparation/distraction intervention, pain levels (according
to FPS-R) did not have any statistically significant impact on
number of days to re-epithelialize (Table 3). This loss of
statistical significance demonstrates that the intervention
alleviates the effect of pain on re-epithelialization of the burn.
It could thus be concluded that using the specialized
preparation/distraction intervention had a statistically signif-
icant impact on the healing process through mitigating the
negative impact of the associated pain.
Additionally, a comparable (although weak – see Table 3)
effect was found when examining re-epithelialization and
TBSA (Fig. 3b). Based on average depth (1116PU), a burn of 8%
TBSA re-epithelialized 30% slower than a burn of 1% TBSA. A
further examination of interactions between pain scores of
children who received standard intervention and size of burn
showed those with the largest TBSA (8%) and highest pain
score (10) took 63% longer to re-epithelialize compared to
children with the smallest TBSA (0.25%) and lowest pain
score (0).
Simple regression between anatomical sites of burns and
number of days to re-epithelialize suggested delayed re-
epithelialization for burns on the axilla/upper arm ( p = 0.05)and on the neck/head ( p = 0.03). However, adjustments for
other variables in the overall developed model made these
findings statistically insignificant ( p > 0.05). Optimal first aid
treatment of 20 min cold running water [15,16] was received by
51% of participants, 8% received no first aid and 5% of
participants used ice as first aid. Initially, simple regression for
the type of first aid treatment suggested a significant delay in
re-epithelialization when first aid of 10–15 min of cold running
water was used compared to 20 min of cold running water
( p = 0.02). However, after further adjustments for other
variables in the model, type of first aid received became not
significant.
SES, based on the Australian Bureau of Statistics Socio-
Economic Indexes for Areas was not found to be a significant
predictor of re-epithelialization. To evaluate the validity and
impact of the two pain scores and the anxiety score, (FPS-R,
FLACC and VAS-A), the developed statistical model was tested
with each of these scales separately. VAS-A resulted in an
insignificant impact on number of days to 95% re-epitheliali-
zation ( p > 0.4), whereas the other two scales resulted in
statistically significant effects ( p = 0.015 for FPS-R–see Table 3,
and p = 0.032 for FLACC) and approximately the same model fit
(69%). These outcomes were regarded as a confirmation that
the FPS-R and FLACC pain scales are similar in validity and
impact on the healing process of burns. We chose the FPS-R101
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patient reported measure of pain and had a higher statistical
significance. Analgesic medication was not found to be a
significant predictor of re-epithelialization. Only 11 partici-
pants (14%) did not receive medication.
4. Discussion
Ethnicity was the highly significant demographic risk factor
associated with delayed re-epithelialization. Burn depth, TBSA
and mechanism of injury were the wound characteristics
associated with delayed re-epithelialization. Pain levels
together with type of procedural preparation and distraction
intervention received and the time delay until the initial
presentation to the burns center, were found to be the clinical
management characteristics associated with delayed re-
epithelialization.
The distribution of SES across participants was an
unexpected finding and is interesting to note that two thirds
of the participants were considered high SES. This study
involved an outpatient sample with small TBSA burns. To
compare, an examination of inpatients with burns of 5%
TBSA who presented to the SPPBC in the last six months found
65% were of low SES (unpublished data). It may be hypothe-
sized that small burns do not discriminate across SES,
however more severe burns of larger TBSA requiring inpatient
stay may be associated with lower SES.
Ethnicity has been a long-standing risk factor known to
influence the likelihood of hypertrophic scarring. Deitch’s [1]
study reported the incidence of wound problems to be twice as
likely in patients with a darker complexion. Our study
identified that participants with darker complexion from
Indian, North African, Middle Eastern, Maori and Aboriginal
and Torres Strait Islander origins re-epithelialized an average
of 25% faster than participants of lighter skin complexion.
Participant numbers were small in the darker skin complexion
sub-group, thus comparison to other studies may assist in
interpretation of our results. Deitch’s re-epithelialization
(rather than incidence of hypertrophic scarring) data reported
that for adults (ethnicity was more evenly distributed across
adult wounds than pediatric), of the 69 wounds on participants
with a dark complexion, 51% re-epithelialized within 14 days,
whereas only 40% of the 52 wounds on participants with
lighter skin complexion re-epithelialized within 14 days.
When looking at incidence of hypertrophic scarring in these
re-epithelialized wounds, 11% of patients with darker com-
plexion developed hypertrophic scarring, compared to 0% of
patients with lighter skin complexion. One may hypothesize
that there may be a cellular difference in skin across
ethnicities which may explain a faster rate of re-epitheliali-
zation, but with a higher incidence of hypertrophic scarring in
darker compared to lighter skin complexions. Deitch’s study
was based on clinical judgment rather than LDI to determine
burn depth. Equal days to re-epithelialize (e.g. darker versus
lighter skin complexions re-epithelializing within 10–14 days)
were compared across participants with darker versus
lighter skin complexions. Considering our finding of faster
re-epithelialization occurring in children with darker
skin complexions, it may be hypothesized that the studyparticipants in Deitch’s study with the darker skin complex-
ion had deeper burns compared to the lighter complexion
group. Thus we can hypothesize there is a higher propensity
for hypertrophic scarring in people of darker skin complex-
ions, despite having faster rates of re-epithelialization.
Future studies are required to confirm the effect of differing
skin complexions on re-epithelialization and to confirm
Deitch’s findings on presence of hypertrophic scarring in a
prospective study of differing skin complexions with com-
parison of burn depth by LDI.
A larger TBSA was found to correlate with longer days to re-
epithelialize. This suggests that the larger the burn, the greater
the intensity of the local response. The degree of local
response may influence re-epithelialization and warrants
further investigation.
Anecdotally, burns heal differently depending on anatomi-
cal location, yet there is little supporting literature for this. The
study by Wilson et al. [8], was the one found which reported
burns on the face and hand re-epithelialized faster than other
sites. A similar relationship was identified in our data with
regard to burns of the axilla/upper arm and the neck/head
taking longer to re-epithelialize than other anatomical sites,
although this was not significant in our model. The neck is a
site of much movement, which may explain delayed re-
epithelialization and it is a challenging area to apply pressure
for scar management. Gangemi [4] reported significant
hypertrophic and contractured scars on the neck region,
additionally burns to the upper limb were also a site of
hypertrophic scarring compared to other sites.
Scalds are the primary leading cause for pediatric burn [17]
in developed countries and accounted for 57% of burns in this
study. Despite flame burns only accounting for 5% of burns in
this study, the significant delay in their time to re-epithelialize
( p = 0.003) is noteworthy. Gangemi et al. [4], analyzed 2234
burn sites in an adult population of which 1486 (67%) were
caused by flame. Interestingly, our finding of increased risk of
delayed healing time (with depth controlled for) when flame is
the mechanism of injury corresponds to Gangemi’s et al.’s
finding of a significantly higher risk for contracted scarring
with flame compared to all other mechanisms.
The number of days to present to the burn center was
significantly associated with re-epithelialization rates.
Delayed presentation may have occurred for several reasons
including: treatment in a non-burn specialized medical
facility; patients delaying or not seeking first aid and medical
intervention; or receiving inappropriate or alternate medical
intervention. One may hypothesize that early admission to a
specialized burn center enables thorough debridement to
occur at the early stages of inflammation, thus preparing the
wound bed for the proliferation stage of wound healing.
Anecdotally, burns arriving at the burn center secondary to
other medical settings have frequently presented with
incomplete debridement where blisters and devitalized tissue
remain at the wound site. Faster re-epithelialization was
reported in a porcine deep-dermal-partial thickness burn
model when burns were immediately debrided compared to
non-debrided burn wounds [18]. Additionally, early admission
to a burn center enables assessment from a specialized and
highly experienced multi-disciplinary burn team, with access
to improved or specialized dressings and equipment.102
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epithelialization when examining type of procedural prepara-
tion and distraction intervention received. Lack of access to a
novel computerized burn procedural preparation and distrac-
tion device during wound care procedures was associated with
delayed re-epithelialization. Previously, specifically tailored
computerized procedural preparation and distraction as a
non-pharmacological intervention during burn dressing
changes has been demonstrated to reduce pain and distress
compared to standard off the shelf computerized technologies
[19–21]. Procedural preparation alone has proven effective and
is a key component in reducing pain and distress in children
during burn wound care procedures [19]. Heightened feelings
of anxiety and anticipatory pain have also been reported as
predictors of pain intensity during dressing changes in older
subjects with chronic wounds [22]. Our findings identified an
association between a tailor-made computerized preparation/
distraction intervention and re-epithelialization, which fur-
ther supports the preliminary finding of an association
between use of this computerized intervention and a two
day reduction in burn re-epithelialization [19].
The effect pain has on initiating and mediating a myriad of
cellular events involved in re-epithelialization and wound
healing is still not well understood. Links between pain mediators
such as Substance P (SP) and 5-HT and their effects on nerves and
tissues during wound healing continues to be the focus of much
research [23]. Altered SP has been associated with impaired
healing in rats [24], and has been linked to impaired cutaneous
wound healing in association with diabetes mellitus or hyper-
trophic scar formation [25]. Further studies are required before
conclusions can be drawn on how reductions in pain transmis-
sion act on a cellular level to improve re-epithelialization.
A limitation of this study is the narrow patient sample with
regards to burn depth, as 591 PU was the average deepest area of
each burn and the majority of the burns in this study were
superficial partial thickness. It would be interesting to repeat
this study in a pediatric population of primarily deep partial
thickness burns. Furthermore, future studies should examine
demographic, wound and clinical management characteristics
in a population of burns which received surgical intervention, to
determine if the same predictors of wound healing are apparent.
In summary, clinical management characteristics influen-
tial in re-epithelialization and under the control of the burns
team include pain levels and time taken to present to a burn
center. Historically, pediatric pain has been under-treated [26–
29]. Higher pain levels experienced during burn wound care
procedures places patients at an increased risk of adverse
healing outcomes. Our findings highlight the necessity for
repeated pain assessments, use of specialized non-pharma-
cological intervention in addition to medication and improved
pain management in the area of pediatric burns to achieve
optimal outcomes. Additionally, it is vital that patients access
quality care in a tertiary burns center quickly in order to
optimize healing outcomes.
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Non-pharmacological interventions are considered an important component of total patient 
care.  The efficacy of using the computerised Ditto™ has been established in previous 
chapters, in particular reporting on its effect of hastening burn re-epithelialisation.  The 
objective of this chapter is to report on the cost-effectiveness of the Ditto™ intervention used 
during paediatric burn wound care, in comparison to standard practice.  No comprehensive 
economic evaluation has been carried out for paediatric burn outpatients to-date.  In today’s 
economic climate, there is a need to justify not only the positive clinical outcomes of 
interventions, but their cost-effectiveness to provide economic justification and improve 
clinical uptake of evidence-based practice.  This chapter is an adaption from the manuscript 
entitled “Cost Effectiveness of a Non-Pharmacological Intervention Used in Paediatric Burn 
Care” to present this manuscript as a chapter and maintain consistency in formatting 
throughout this thesis. 
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Chapter 8. Cost-Effectiveness of the Ditto™ 
Intervention 
 
Table 7-1 Participant Demographics 
Table 7-2 Wound Clinical Characteristics 
 
Figure 7-1 Prediction of days to re-epithelialize based on burn depth 
106
8.1 Introduction 
It is estimated over 500,000 children worldwide are hospitalised with a burn injury every year 
[25].  Burn care is undeniably expensive and arguably one of the highest financial costs in 
paediatric healthcare, yet limited health economic research has been conducted in the burns 
arena.   External financial pressures on healthcare budgets create much deliberation and 
contentious debates over balancing quality health care versus less costly service delivery 
[371].  There is much need for health research to extend beyond providing evidence of one 
practice being more effective than another.  Changes in practice need to be quantified in 
monetary terms with an economic evaluation to determine the feasibility of implementing new 
cutting edge treatments and interventions [372] and to justify set-up costs to hospital 
administrators.  Psychosocial costs to the patient include: the pain, anxiety and stress from 
the trauma of the burn injury itself and the associated wound care procedures; and may 
encompass additional psychosocial issues resulting from the physical disfigurement of 
hypertrophic scarring.  Severity of injury does not predict psychological costs to the patient.  
No quality of life measure has been specifically developed and validated for the paediatric 
burn population [372, 373].  Financial accountability that extends beyond acute wound care 
and scar management, and includes the complete long-term psychosocial costs to the 
patient, make the ‘true’ costs of burns unquantifiable.   
 
The most comprehensive cost-effectiveness analysis identified in the burn literature was a 
prospective study over a five year period conducted in the Burn Centre of Valencia, Spain 
[374].  This study incorporated incremental cost utility ratio analysis to determine the cost and 
quality of life of burn patients.  This cost analysis largely depended on Diagnostic-Related 
Groups (DRGs); used Silver Sulfadiazine (SSD) in the treatment of burn wounds; was 
primarily an adult inpatient population with mean age 40 years and mean total body surface 
area (TBSA) of burn 18.2%.  General DRGs and Healthcare Resource Group cost coding 
provide a generic snapshot of costs and are not sensitive measures for picking up differences 
across individuals [375]. 
 
Two studies were identified in the burn literature that performed a cost-effectiveness 
evaluation on minor burns encompassing smaller TBSA (mean ≤10%) and primarily partial 
thickness depth [376, 377].  Both studies compared differing burn dressings.  Carayanni et.al. 
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[377] compared the dressing Moist Exposed Burn Ointment to povidone iodine plus 
bepanthenol cream, however the primary outcome endpoint was only 50% re-epithelialisation.  
Furthermore, neither of these dressings are standard practice in burn centres in developed 
countries.  Advances in the technology of burn dressings in recent years has changed 
standard practice from twice daily applications of SSD and similar ointments/creams to 
improved silver impregnated dressings such as Acticoat™ [24].  This change of practice has 
seen a shift from inpatient to outpatient management of the small partial thickness burn injury, 
where dressings are changed every three to seven days.  Despite Silverstein et.al. [376] 
evaluating the effectiveness of a commonly used silver impregnated dressing (Mepilex® Ag) 
in a multi-centred trial, the comparator group received SSD dressings.  Additionally this study 
did not use a valid and reliable measure of burn re-epithelialisation or burn depth, did not 
include scar management costs, and used cost estimates established from only 40% of the 
sample population (four from each centre).  No economic evaluation has been performed for 
paediatric burn outpatients that uses advanced silver impregnated dressings only, or that 
uses validated measures of re-epithelialisation and wound depth.     
 
This study aims to establish the cost-effectiveness of a procedural preparation and distraction 
Ditto™ intervention which was compared to standard practice in a randomised controlled trial 
(RCT) measuring burn re-epithelialisation [350].  The Queensland Children’s Health Services 
(Royal Children’s Hospital) Human Research Ethics Committee and The University of 
Queensland Ethics Committee approved this RCT and it was registered with the Australian 
New Zealand Clinical Trials Registry (ACTRN12611000913976). 
 
 
8.2 Methods 
8.2.1   Setting & Participants 
Data were collected from the Stuart Pegg Paediatric Burns Centre at the Royal Children’s 
Hospital, Brisbane, which is a tertiary pediatric burn referral centre servicing approximately 
800 new patients per year.  Data collection occurred from August 2011 to August 2012.  
Children were included if they were aged 4 years to 13 years and had an acute burn injury of 
TBSA less than 15%.  Children were ineligible if they were non-English speaking, had a 
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diagnosed condition/illness in addition to a burns injury, had a prior history of suspected child 
abuse, or required a skin graft.  The standard medical treatment was not altered by data 
collection.   
 
8.2.2   Data Collection 
Recruitment and consent of participants occurred at the first change of dressing.  Prospective 
data were collected at every dressing change until burn re-epithelialisation [350].  Caregivers 
completed a general demographic questionnaire (including pertinent cost-related questions) 
and patient charts were reviewed to attain clinical characteristics about the patient and their 
burn.  The primary outcome measure of the RCT was burn re-epithelialisation.  A Visitrak™ 
grid (Smith & Nephew, London, UK) was used at every dressing change to trace around the 
burn area and record areas that had re-epithelialised.  On the first dressing change, burn 
wounds were scanned with the MoorLDI2-BI2 laser Doppler imager (LDI, Moor Instruments 
Limited, Devon, UK), to measure burn depth, enabling accurate wound comparison across 
participants.  Secondary outcome measures included: pain intensity, anxiety, stress and 
physiological measures.  These outcomes were recorded in the waiting room as a baseline 
measure, then before and after dressing removal and new dressing application [350].  
Dressings applied were decided by the consultant’s clinical judgement (primarily Acticoat™ or 
Acticoat™ 7, with or without Mepitel®).  Pain was rated by the child on the Faces Pain Scale-
Revised (FPS-R) [138] and rated by the nurses on the Face, Legs, Arms, Cry, Consolability 
(FLACC) scale [153].  Heart rate was monitored and recorded and a further anxiety measure 
was obtained from children eight years and over on the Visual Analog Scale-Anxiety (VAS-A) 
[75].  Pharmacological pain relief included narcotic (Oxycodone™ opioid, 0.1-0.2mg/kg); 
narcotic combined (Oxycodone™ and either paracetamol or ibuprofen; or codeine and 
paracetamol); or non-narcotic analgesia (paracetamol and/or ibuprofen) and administration 
were recorded.   
 
8.2.3   Interventions 
Administrative staff external to the study used a portable computerised random number 
generator to randomly assign participants to one of two groups: (1) to receive Ditto™ 
intervention [335], consisting of computerised multi-modal procedural preparation conducted 
in the waiting room, and then distraction intervention during wound care procedures, or; (2) to 
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receive standard preparation and standard distraction (such as videos, books, toys, television 
and/or parental soothing). 
 
8.2.4   Effect Estimation 
The number of days from injury until ≥95% re-epithelialisation was used as a measure of the 
intervention effect.  Accelerating re-epithelialisation is the prime objective of burn care.  
Minimising the number of days to re-epithelialise reduces the likelihood of hypertrophic 
scarring [16, 17, 60] and therefore reduces the cost to the health system and the patient.   
 
8.2.5   Burn Re-epithelialisation Costs 
All data during the re-epithelialisation phase of healing were collected prospectively at every 
dressing change from the healthcare provider and participant perspective.  All health care 
costs outlined are costs to the health system, as patients are not charged for health care in 
public hospitals in Australia such as The Royal Children’s Hospital, Brisbane.  Direct 
healthcare costs included: administered narcotic medication; size, type and quantity of 
dressings; nursing time to remove and apply dressings; and duration of consultant review.  
Nursing wages were based on 2012 Queensland Health Clinical Nurse Grade 6 with a 
standard (for Queensland Health employees) 25.85% on-costs added [378].  Consultant 
wages were based on 2012 Queensland Health Medical Officer Level 2 (Staff Specialist Level 
26) with 25.85% on-costs added [379].  Direct non-healthcare costs included travel and 
hospital parking costs.  Families were asked their mode of transport, time spent travelling, 
and distances travelled to and from appointments by each patient were calculated via 
postcodes.  Travel costs were calculated based on the Royal Automobile Club of Queensland 
estimates of running a medium sized car to be $0.76/km [380].  Postcodes were also used to 
determine public transport zones to establish travel costs.  Indirect non-healthcare costs of 
caregiver/s days off work were documented at every dressing change, and used together with 
their annual family income bracket (recorded on the participant demographic questionnaire) to 
establish time costs.  Quintiles from the Australian Bureau of Statistics household income 
distribution for Queensland in 2011-2012 [381] were used together with these income 
brackets to establish medians within income brackets.    
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8.2.6   Scar Management Costs 
A retrospective review of charts (whilst blinded to treatment group) was conducted to 
establish if scar management intervention was received after re-epithelialisation.  Three 
participants continued to receive scar management intervention beyond one year post re-
epithelialisation/date of chart review.  Future costs of scar management intervention for these 
three participants were based on estimations by the treating occupational therapist.  If patient 
charts reported the prescription of standard and/or customised pressure garments, patient 
order form records were obtained to establish exact costs.  Documented use of silicone 
moulds alongside pressure garments were included in direct healthcare costs based on the 
product cost and occupational therapist’s estimation of average moulds made per tub.  
Tubigrip product costs were used and amounts given were estimated based on the age of the 
child and the TBSA of burn.  Documentation of prescribed silicone products including 
Kelocote cream and Mepiform sheets, together with standard prescribing practices within the 
burn centre, were used to calculate amounts and costs of these products.  The individual 
patient’s hospital record number was used to track the exact cost for steroid injections 
received.  Occupational therapy scar management appointments are a standard 30 minutes.  
Scar management staff costs were calculated based on documented therapy appointments 
(using 2012 Queensland Health, Health Professional Level 4 wage rate and 25.85% on-costs 
added [382]).  Consultant reviews following scar management were based on an estimated 
average of 15 minute appointments (and wages were based on Queensland Health Medical 
Officer Level Two, MO2/L26, with 25.85% on-costs added [379]).  Direct non-healthcare costs 
included travel to and from documented scar management appointments and parking costs 
(extrapolated from RCT data of parent reported travel).  Indirect non-health costs of parental 
wages lost were estimated based on data collected from parental reports of time spent during 
the previous hospital visits for burn dressing changes. 
 
8.2.7   Statistical Analysis  
Analyses were carried out with a complete case dataset for the primary outcome of re-
epithelialisation.  Missing data from cost variables were inputted using mean imputation.  
Demographic and clinical characteristics across groups were compared with Chi-square tests, 
t-tests and Mann-Whitney U Tests when variables were not normally distributed.  Incremental 
cost-effectiveness ratios (ICER) were calculated from the ratio of mean cost differences 
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between the two groups (Ditto™ intervention and standard practice) divided by the difference 
in effect of days taken for burns to re-epithelialise.  Non-parametric bootstrapping was 
performed using 10,000 iterations which achieved convergence of the standard error and a 
stable estimate of the variance of the ICER.  This statistical method uses large numbers of 
simulated sample data to calculate the uncertainty around the sampling distribution of the cost 
and effect estimates [383].  A cost-effectiveness plane and cost-effectiveness acceptability 
curve were used to display the results.  Sensitivity analysis was performed to test the 
robustness of the results.  One-way sensitivity analysis was conducted on all probabilities and 
ratios by varying one variable at a time (these included: (i) removing the steroid injection 
variable; (ii) removing the Ditto™ variable and testing an alternate Ditto™ Lite variable, the 
newest version of the Ditto™).  A 3% rate of discount was applied to all costs that extended 
beyond a period of one year [374] to calculate costs in 2012 Australian Dollars.  Summary 
statistics of data non-normally distributed were reported in median and inter-quartile ranges 
(IQR), rather than as means and standard deviations.  Chi square and t-tests were used for 
normally distributed data and Mann-Whitney tests were used for non-normally distributed 
data.  The statistical analyses were conducted using the Stata statistical software package 
(StataCorp, College Station, Texas) [384] and Excel 2010 (Microsoft Pty Limited, North Ryde, 
NSW, Australia). 
 
 
8.3 Results 
Baseline demographic and clinical characteristics were comparable across groups (Table 
8-1).  The sample was typical of our outpatient burn population with majority of patients male 
(60% standard group, 57% Ditto™ group), presenting with a partial thickness burn, and a 
higher proportion of scalds as the mechanism of injury (55% standard group, 51% Ditto™ 
group).  On average, the typical paediatric burn outpatient presenting with a superficial partial 
thickness burn is approximately $1,000 (AUD$). 
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Table 8-1 Demographics and Clinical Characteristics 
 
 
 
8.3.1   Clinical Outcome 
Children who received Ditto™ procedural preparation and distraction intervention during burn 
wound care procedures re-epithelialised on average three days faster (p = 0.033) than 
children in the standard practice group (Table 8-2). This reduction in re-epithelialisation time 
translated to a smaller number of children requiring scar management in the Ditto™ group.  In 
the standard practice group, 19 (47.5%) children re-epithelialised in ≥14 days and were 
therefore assessed for scar management, of which 11 (27.5%) went on to receive scar 
management intervention.  Nine (25.7%) children in the Ditto™ group re-epithelialised in ≥14 
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days and were assessed for scar management.  Six (17.1%) of these children went on to 
receive scar management intervention. 
 
Table 8-2 Costs and Effects of Providing Ditto™ Intervention and Standard Care to 
Participants during Burn Re-epithelialisation and Scar management   
 
 
 
8.3.2   Cost Effectiveness Analysis 
Total direct healthcare costs, total direct non-healthcare costs and total overall costs were 
lower in the Ditto™ group (Table 8-3).  The standard group had lower total non-direct 
healthcare costs (Table 8-3).  Parents of children in the standard group reported fewer days 
off work taken to attend appointments, with the number of work days missed by Fathers was 
significantly less (Ditto™ group mean = 0.16 days, standard group mean = 1.2 days, p<0.001) 
in the Standard group compared to the Ditto™ group. 
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Table 8-3 Costs per category during Burn Re-epithelialisation and Scar management   
 
 
 
The mean total cost of direct healthcare per patient was $475 (SD = $1073) in the standard 
group, compared to $185 (SD = $200) in the Ditto™ group (Table 8-3).  Itemising the direct 
healthcare costs, the highest percentage of cost was in customised pressure garments for the 
standard group (32%) and burn dressings (59%) for the Ditto™ group (Table 8-3).  Cost 
differences are explained in the reduction in days for burns to re-epithelialise which translated 
to fewer patients in the Ditto™ group requiring the scar management of pressure garments, 
silicone products and steroid injections.    
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Table 8-4 Summary Statistics of the Incremental Cost-Effectiveness Ratio 
 
 
Comparing Ditto™ intervention against standard care on a cost-effectiveness plane, showed 
77.6% of the cost/effect pairs were within the north-east quadrant (Figure 8-1).  This is a 
strong indication that the Ditto™ intervention is more effective than standard care, however it 
is also more costly.  The percentage of incremental cost/effect pairs located in the south-east 
quadrant, indicating Ditto™ is more effective and less costly was 21.6%.  Only 0.1% of the 
cost/effect pairs were located in the north-west quadrant (less effective and more costly) and 
0.7% located in the south-west quadrant (less effective and less costly).   The point estimate 
gave us a base case incremental cost of $176.25 per child with a mean incremental effect of 
three days.  The median ICER was $64 (IQR = $10 - $106) for every one day reduction in 
days to re-epithelialise when children had access to Ditto™ intervention, over standard 
practice (Table 8-4).  The cost-effectiveness acceptability curve shows that the probability of 
Ditto™ intervention being cost-effective would be 95% if the willingness-to-pay threshold were 
$171 per one day reduction in re-epithelialisation (Figure 8-2). 
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Figure 8-1 Cost and Effect Differences of Ditto™ Intervention Versus Standard Care 
 
 
 
Figure 8-2 The Probability Ditto™ is Cost-Effective 
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Sensitivity analysis confirmed the results were robust.  The influence of the outlying high cost 
of steroid injections, received by only one patient in the standard care group as a scar 
management intervention, was tested by removing the cost from the analysis.  Comparable 
incremental cost-effectiveness ratios and similar cost-effectiveness acceptability curve were 
obtained in this sensitivity analysis.  Additionally, the cost of the newest version of the 
intervention device, the “Ditto™ Lite,” was also analysed and yielded very similar results to 
the original ICER’s and acceptability curve.  The cost-effectiveness plane showed 78% of the 
cost/effect pairs were within the north-east quadrant and 21% in the south-east quadrant.  
The probability of the Ditto™ Lite intervention being cost-effective would be 95% if the 
willingness-to-pay threshold were $172. 
 
 
8.4 Discussion 
This is the first comprehensive economic evaluation that examined the cost-effectiveness of a 
non-pharmacological intervention targeting a paediatric burn outpatient population.  Despite 
the initial outlay cost for the Ditto™ device, the intervention resulted in a significant gain, 
hastening burn wound re-epithelialisation [385], confirming a preliminary study [7]. Ditto™ 
intervention was more costly than standard care, however the benefits significantly outweigh 
the costs, with 99% of the cost/effect pairs falling in the more effective eastern quadrants. 
 
The speed of burn re-epithelialisation is paramount for the patient [386] and the health 
system.  A reduction of three days could mean a burn re-epithelialises within 10-14 days of 
injury, with decreased risk of hypertrophic scar development [16, 17].  This may reduce the 
burden of injury for the patient in terms of the psychological and psychosocial implications 
commonly accompanying burn scarring [23]; and for the health system, with regards to costs 
associated with scar management and rehabilitation.  
 
The mean direct healthcare cost per patient for the Ditto™ group was $185, compared to 
$475 in the standard practice group.  Limited comparisons can be made with other studies 
due to the minimal economic evaluations which have been conducted in the area of burn 
injuries.  Of the few studies investigating the cost of burns, the foci has been on inpatient 
stays and more severe burn injuries requiring grafting and often multiple surgeries [387-391].  
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These studies are either retrospective reviews or cost analyses that relied on codes of 
Diagnostic Related Group.  Analysis of costs based on hospital charges often grossly 
overestimate costs [387].   
 
Hospitalisations in Australia resulting from burn injuries, in comparison to the population were 
reported to equate to 47.9 cases per 100,000 population per year (based on data collected 
during 1999 to 2004) [28].  In 2000, the hospital costs of burns were estimated to be between 
$38.7 million to $40.2 million per year [28].  The shift in practice of treating superficial to deep 
partial thickness burn injuries predominately on an outpatient-basis, together with standard 
recording of burn data when patients are admitted for longer than 24 hours only [26], 
highlights that collected burn data only represents a fraction of all paediatric burn injuries 
treated at Australian and New Zealand burn centres.  The burden of burn injuries to the health 
system and patients are undeniably significant and this study is the first to report on burn 
outpatient costs.   
 
The strengths of this study include: the individualised cost data collected on each patient; the 
valid measures used in the assessment of re-epithelialisation and burn depth; and the 
statistical analyses conducted to account for the uncertainty of ICER of a non-
pharmacological intervention in paediatric burn outpatients.  A limitation of this study is the 
unequal increments of annual family income brackets used in the parental questionnaire to 
collect indirect non-health care cost data.  Accuracy of indirect healthcare costs may be 
improved in future studies with narrower ranges and equal distribution brackets of annual 
family income.  Secondly, the scar management data was retrospectively collected.  Order 
forms of specialised custom-made pressure garments were obtained, enabling exact costs to 
be established, and standard 30 minute scar management appointments enabled 
occupational therapy staff costs to be calculated.  However the accuracy of costing for 
silicone products relied on accurate documentation and product amounts were estimated 
based on the size of the burn and occupational therapy protocols.   
 
Burn care is resource intensive and requires specialist care [372].  With the challenge of 
healthcare budget constraints and the complexity of burn care, justifying the inclusion of 
cutting edge treatments and interventions within a specialist burn centre requires 
comprehensive economic evaluations to be undertaken.  The inclusion of wound care 
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management, scar management, psychosocial and quality of life measures in future 
economic evaluations are warranted to establish quality and cost-effective practices. 
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9.1 Summary of Main Findings 
Ultimately, burn care aims to foster an environment conducive to hastening burn wound re-
epithelialisation and reducing the likelihood of hypertrophic scarring, whilst abating secondary 
effects of wound care procedures including pain, anxiety and stress.  The work in this thesis 
describes a randomised controlled trial (RCT) conducted in a paediatric burn outpatient 
setting which confirmed the preliminary finding by Miller et.al. [7], that Ditto™ procedural 
preparation and distraction intervention reduces the number of days taken for burns to re-
epithelialise (Chapter 6).  The multitude of data collected during the RCT enabled the 
development of many other studies that form the body of work produced for this thesis.  
Several novel concepts were explored, including:  
 Non-pharmacological intervention improving burn re-epithelialisation rates (chapter 6). 
 Non-invasive biological measures of stress, and the identification of factors associated 
with a greater physiological stress response during burn outpatient wound care 
procedures (Chapter 3, 5). 
 The identification of factors delaying burn re-epithelialisation (Chapter 7).  
 A comprehensive economic evaluation of paediatric burn outpatients and the cost-
effectiveness of using a tailored non-pharmacological intervention (Chapter 8).   
These results will be discussed below, together with a description of how the original aims of 
the study were achieved. 
 
9.1.1   Non-pharmacological Intervention and Burn Re-
epithelialisation 
The primary aim of this thesis was achieved, confirming the hypothesis that faster burn wound 
re-epithelialisation occurred when children received Ditto™ procedural preparation and 
distraction intervention, compared to standard practice.  A difference in re-epithelialisation of 
two days (p=0.061) was identified.  When burn wound depth was adjusted for, the difference 
Chapter 9. Discussion and Conclusions 
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in re-epithelialisation rates just reached significance (p=0.046).  This is the first study to 
objectively investigate the effect of a non-pharmacological intervention on paediatric acute 
burn wound re-epithelialisation.   
 
Anxiety and fear experienced in the anticipation of burn wound treatment often progress to a 
generalised hospital anxiety, where children’s anxiety levels escalate on entering the hospital 
or even at the thought of it [339].  Children with acute burn injuries are treated in outpatient 
settings and therefore receive less contact time with staff and less psychological support [20].  
The Ditto™ delivers procedural preparation via a highly motivating electronic platform to 
reduce anxieties and misconceptions children may hold about what will transpire during burn 
wound treatment.  Results from our RCT showed that at the first dressing change after 
procedural preparation, the Ditto™ group reported lower pain intensity scores and lower 
anxiety ratings.  During wound care procedures children engaged in the Ditto™ distraction 
component, diverting attention and reducing the level of perceived pain.  At the second and 
third dressing removals average pain (FPS-R and FLACC) and anxiety scores (VAS-A) were 
at least one point lower when Ditto™ intervention was received.  The Ditto™ procedural 
preparation and distraction device is a useful tool for use alongside pharmacological 
analgesia to improve the rate of burn re-epithelialisation and manage pain and anxiety during 
burn wound care procedures. 
 
One other study has reported on the use of non-pharmacological intervention improving 
wound healing.  This was a study conducted with surgical patients who received relaxation 
and guided imagery pre- and post-surgery [195].  Previous research has identified the effects 
of stress on delaying wound healing in experimental studies, however further research in a 
clinical setting is required to investigate the positive effects that non-pharmacological 
interventions have on wound healing.  These findings highlight the need for health teams to 
adapt standard practice protocols to place greater emphasis on holistic patient management 
and to prioritise non-pharmacological interventions. 
  
9.1.1.1 Cost-effectiveness of Tailored Non-pharmacological Intervention 
Health research needs to extend beyond proving that one therapeutic practice is superior to 
another.  Changes in practice need to be quantified in monetary terms with an economic 
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evaluation to determine the feasibility of implementing new cutting edge treatments and 
interventions [372].  An economic evaluation encompasses not only acute wound care and 
scar management, but includes the complete long-term psychosocial costs to the patient.  
Currently, no burn-specific quality of life measure has been developed and validated in the 
paediatric burn population [372, 373] making the ‘true’ costs of burns unquantifiable [27].   
 
The cost-effectiveness study included in this thesis is the first economic evaluation performed 
with paediatric burn outpatients which utilised validated measures of re-epithelialisation and 
wound depth and included the use of advanced silver impregnated dressings.  Economic 
evaluations of outpatient burns in the literature are based on trials that include 
cream/ointment dressings (e.g. silver sulfadiazine) which are not standard practice in burn 
centres in developed countries [376, 377].  Alternatively, inpatient economic evaluations are 
largely based on hospital coding of diagnostic related groups [374] which do not provide 
accurate individual costs. 
 
When average hospital costs were investigated, our study found that treatment of a typical 
superficial partial thickness paediatric burn injury (mean TBSA of 2%), costs approximately 
$1,000 (AUD).  The economic evaluation calculated the difference in mean costs between the 
two groups (Ditto™ intervention and standard practice) divided by the difference in effect of 
days taken for burns to re-epithelialise to establish the incremental cost-effectiveness ratio 
(ICER).  The cost/effect pairs showed the Ditto™ intervention was more effective than 
standard care; however, it was also more costly.  The median ICER cost was $64 (IQR = $10 
- $106) for every one day reduction in days to re-epithelialise when children had access to 
Ditto™ intervention, over standard care.  
 
Injury prevention and safety education is under-resourced, and this contributes to the annual 
rise in incidence of preventable childhood injuries such as burns.  Health budgets will always 
be under pressure with political reforms; adverse environmental and lifestyle changes 
contributing to increased trends in childhood obesity and other preventable health conditions; 
and advancements in technology that continue to decrease mortality.  These factors further 
highlight the necessity for economic evaluations to justify allocation of funds from stretched 
healthcare budgets to interventions such as the Ditto™, which provide substantial 
improvements in patient outcomes.  Without economic evaluations, interventions like the 
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Ditto™ may otherwise be viewed by hospital administrators as unnecessary or luxury items.  
A reduction of days to re-epithelialise with use of the Ditto™ may translate to the prevention 
of hypertrophic scar development, with significant cost savings for the health system.  
Additionally, this would reduce the burden of injury for the patient, both acutely during burn 
wound treatment, and in the long-term regarding psychological and psychosocial outcomes, 
which are known to amplify with resultant burn scarring [23].    
 
9.1.2   The Physiological Stress of Burns 
Burns are a traumatic event known to evoke not only pain, but high levels of stress and 
anxiety [20].  There are many studies in the area of burn pain [32, 71, 101, 103, 108, 289, 
392-395], yet little is known about the body’s physiological stress reactions throughout the 
stages of re-epithelialisation following an acute burn injury.  Only one small study has 
objectively measured stress (using salivary cortisol as a biomarker) in acute burn patients, 
where a blunted effect was identified in response to the stress of burn wound care procedures 
[236].  An analysis of the longitudinal data from the prospective RCT conducted in this thesis 
investigated the body’s physiological stress reactions throughout burn re-epithelialisation 
(Chapters 3, 5).   
 
Saliva sampling using Salivettes™ was a non-invasive and effective way of measuring the 
stress biomarkers salivary cortisol and salivary alpha-amylase (sAA) in children undergoing 
burn wound care procedures.  Both biomarkers were responsive to stress with peaks 
occurring post dressing removal and wound debridement, which correlated with increases in 
child and nursing reported pain levels.  Results showed a blunted cortisol effect reflecting a 
down-regulation of the HPA axis and elevated sAA reflecting a heightened SNS response to 
wound care procedures.  The blunted cortisol response is similar to that seen by Busch et.al. 
[236].  However, in that study there were several limitations including: high attrition rates (20 
out of 39 participants dropped out); many missing cortisol data measurements (57% to 77% 
were missing); and lack of reporting of the time of day samples were collected.  All these 
issues limit the comparisons that can be drawn with this study.  The blunted effect seen in this 
study remains challenging to interpret as diurnal levels of salivary cortisol naturally decline 
during the morning, and clinics were held at this time.  Findings in the literature are divided, 
with some studies of salivary cortisol reporting an elevated response to stress, whereas 
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others more commonly related to PTSD [358, 359] and depression [360] report a blunted 
salivary cortisol response to stress.   
 
The baseline sample at three months post re-epithelialisation was taken at a similar time of 
day (i.e. within one hour) to the waiting room and wound care procedure samples, therefore, a 
statistical significance between baseline and waiting room levels was not expected and was 
not found (p = 0.111).  Despite salivary cortisol levels naturally declining during the morning 
clinics, the drop in levels in response to wound care procedures (over 10 minutes) were 
pronounced enough to identify a statistical significance (p<0.001) in comparison to baseline 
levels.  It may therefore be concluded that a stress response was identified reflected by 
blunted cortisol levels as a reaction to the stress of wound care procedures.    Burns are a 
traumatic event and the repetitive stress elicited over numerous dressing changes together 
with the anxiety provoked by hospital visits, explain why the salivary cortisol response pattern 
seen in this study of burn patients mimics the salivary cortisol pattern of patients with PTSD. 
 
Salivary alpha-amylase, a novel measure of stress in the area of burns, was found to be a 
better biomarker of stress from this burn outpatient population, compared to salivary cortisol.  
Not only were average sAA levels significantly higher than baseline levels (50.2U/ml higher, 
p<0.001) across all dressing changes, but interestingly, sAA levels continued to increase as 
the burn approached re-epithelialisation (p<0.001).  These results indicate that 
physiologically, the body is under prolonged stress during the healing phase. 
 
9.1.2.1 Factors Associated with Higher Stress Levels 
Higher pain levels, no medication receipt and indicators of PTSD symptoms (based on the 
results of the Child Trauma Screening Questionnaire) were found to have strong associations 
with sAA levels.  Similarly, levels of salivary cortisol were associated with no medication 
receipt, pain scores and TBSA of the burn.  These relationships are not surprising and 
corroborate reports in the literature of strong reciprocal relationships between pain and stress 
[79, 80, 396, 397].  Evidence-based paediatric pharmacotherapeutic standards of care 
mediating pain and anxiety experienced by burn patients are yet to be established and may 
act to prevent secondary pathological stress responses and traumatic stress symptoms [394].  
A multi-centre trial across four level one burn centres at the Shriners Hospitals For Children 
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reported consistent prescribing of opiates across centres.  However, a lack of standard of 
care was identified regarding the prescription of benzodiazepines, antidepressants, beta-
blockers, anesthetics, ketamine and propofol [394].  Following the results described in this 
thesis, opiates are now routinely prescribed within the Stuart Pegg Paediatric Burn Centre 
(SPPBC), Brisbane.  However, to date, no protocols exist for the prescription of other 
analgesic and anti-psychotic medication.  Future research delving into the biopsychosocial 
effects of differing pharmacological agents during paediatric burn wound management is 
critical for the establishment of universal, gold-standard pharmacological protocols to achieve 
optimal long-term psychological outcomes for burn patients. 
 
Other results in this thesis provide evidence to conclude that burn patients experience stress 
throughout the entire phase of healing.  Average heart rate across the dressing changes were 
significantly lower when Ditto™ intervention was received, suggesting non-pharmacological 
intervention plays a role in reducing emotional distress.  Further evidence supporting our 
finding of a relationship between acute stress and long-term stress symptoms (significant 
relationship between heightened sAA levels and CTSQ scores at three months post re-
epithelialisation), is the report by De Young et.al. [159] of a significant association between 
elevated heart rate in response to a burn injury and PTSD symptoms at six months post re-
epithelialisation.  
 
9.1.3   Factors Predicting Re-epithelialisation 
In this thesis, the first comprehensive study of the factors which delay re-epithelialisation has 
been conducted (Chapter 7).  There is considerable literature which explores factors 
associated with hypertrophic scar formation; however, until now, only the depth of a burn 
measured by laser Doppler imaging has been directly associated with burn wound re-
epithelialisation time.  The statistical model described in this thesis identified burn depth as 
the major factor contributing to delayed re-epithelialisation, followed by the number of days 
post-injury before presenting to our burn centre, pain levels (when Ditto™ intervention was 
not received), ethnicity, mechanism of injury, and burn size (TBSA).  Collectively, these 
factors accounted for 69% of variance in the model. 
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The relationship between increased number of days before presenting to our tertiary burn 
centre and longer re-epithelialisation rates was an unexpected finding.  It may be 
hypothesised that optimal pain management with the receipt of both pharmacological and 
non-pharmacological analgesia; thorough debridement of wounds at the early stages of 
inflammation by experienced staff; together with the involvement of the specialised multi-
disciplinary burn team, are key determinates in yielding these results.  Furthermore, burn size 
and depth do not predict the pain and anxiety children and families experience [2, 32, 82].  It 
is recommended that specialist burn centres advocate for all patients with burns (beyond 
erythema) be transferred from surrounding hospitals, in order to be managed by their highly 
experienced and specialised multi-disciplinary burn team at the earliest time possible. 
 
Children from darker skin ethnicities re-epithelialised faster in comparison to ethnicities of 
lighter skin complexion.  This was the other surprising finding, considering people with darker 
skin complexions have a higher incidence of hypertrophic scar formation and the longer a 
burn takes to re-epithelialise, the greater the likelihood of resultant hypertrophic scarring [16, 
57, 58].  It has always been assumed that the reason for the higher incidence of scarring 
occurring in dark skin was due to delayed re-epithelialisation in this sub population.  However, 
there is some evidence that the inverse is true.  A study by Deitch et.al. [16] included a higher 
number of (adult) participants from darker skin ethnicities, and a more equal ethnic 
distribution than our study.  Deitch et.al. found that 51% of participants in the darker skin 
complexion group re-epithelialised in less than 14 days, compared to only 40% in the group of 
lighter skin complexion.  An apparent faster healing rate may be due to the difficulty in 
clinically judging the depth of burns in pigmented skin which arguably, may result in under-
estimation of burn depth.  Unlike the study by Deitch et.al., our study used laser Doppler to 
assess burn depth.  Although it was not highlighted by Deitch’s et.al., the association between 
re-epithelialisation rates and pigmentation warrants further study. 
 
Several hypotheses may explain the biological basis for faster re-epithelialisation rates in 
patients of darker skin ethnicities.  Desquamation is the process of shedding from the outer 
surface of the epidermis or striatum corneum, and can be thought of as de-epithelialisation.  
Desquamation has been reported to occur at an increased rate of 2.5 times in darker skin 
ethnicities [398] and it may be linked with faster re-epithelialisation as the ability of the dead 
cells to be shed more quickly will prepare the wound bed for faster re-epithelialisation. 
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It has also been thought that darker skin may re-epithelialise faster due to the presence of a 
larger number of hair follicles.  Regardless of ethnicity, follicle density is known to be highest 
on the forehead and lowest on the calf [399].  However, several studies comparing 
Caucasian, African-American and Asian hair follicle density have confirmed Caucasian skin 
has the highest hair follicle density, followed by African-American and Asian skin [399, 400].  
A differing melanosome structure also exists across ethnicities.  Melanin acts to form a 
protective covering of the inner layers of the epidermis.  The higher propensity of melanin 
produced in the skin of people from darker skin ethnicities may contribute to explaining the 
ability of darker skin to form a protective layer more quickly than other skin types [401].  
Melanin is not only known to exist in larger amounts in African people, but also to exist in all 
epidermal layers, whereas melanin is found in smaller amounts and only in the superficial 
epidermis in Caucasian and Asian people [402].  Higher melanin offers stronger 
photoprotection, however it also increases the risk of hypo- and hyper-pigmentation [401].  
Indigenous people with dark complexions often occupied continents with hot climates and 
skin is known to change according to climate [401].  Evolutionary changes may thus have 
contributed to the genetic variation of skin composition and structure seen across differing 
ethnicities, so that differing skin composition and structure may explain the differences in re-
epithelialisation rates, rather than hair follicle density.   
 
The mismatch between faster re-epithelialisation and a higher incidence of hypertrophic 
scarring in darker skin ethnicities may be more related to collagen structure in dark skin rather 
than re-epithelialisation rate.  The difference in collagen structure appears to have strong 
genetic origins and may contribute to the tendency for darker skin ethnicities to form denser 
and more abundant collagen structures resulting in hypertrophic scarring.  Collagen genes 
(COL1A1, COL1A2, COL2A1 and COL3A1) were studied in 48 participants from four ethnic 
diverse population groups [403].  A total of 459 single-nucleotide polymorphisms were 
identified, of which 208 were population specific with 53% identified in the African American 
population, 19% in the Chinese American population, 17% in the Mexican American 
population, and only 11% in the European Americans [403].   
    
Interestingly, mechanism of injury was found to influence re-epithelialisation and hypertrophic 
scar formation.  When burn depth was adjusted for, our study found that a flame burn took 
39% longer than a scald burn of equal depth to re-epithelialise.  Further evidence of a 
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relationship between mechanism of injury and healing was reported in a study by Gangemi 
et.al. [60] which found flame burns to be associated with a significantly higher incidence of 
hypertrophic scarring, compared to other mechanisms.  Rapid and immediate cooling is 
associated with reduced oedema formation [31].  It may therefore be hypothesised that since 
flame is known to reach the highest temperature of all mechanisms, flame burns are likely to 
take longer to cool, affecting inflammation and wound re-epithelialisation.  Our finding 
warrants further study and may be a valued consideration when deciding to graft wounds, 
particularly in borderline cases when the decision to treat conservatively or with surgical 
intervention is unclear.   
 
The finding of a larger TBSA burn correlating with longer days to re-epithelialise is another 
consideration in the management of patients.  Gangemi et.al. [60] additionally reported an 
association between burn TBSA and hypertrophic scar formation, and drew links to a study 
reporting an association between larger burn TBSA and higher serum prolactin and 
interleukin cytokines (inflammatory mediators) within the first 12 hours post-burn.  Gangemi 
hypothesised there was an initiation of a systemic response following burn injury, which 
matches our finding of larger burn TBSA delaying re-epithelialisation.  
 
Future research is required to elucidate the emergent matrix of cellular events impeding 
wound healing.  It may be hypothesised that cellular changes during burn wound re-
epithelialisation are amplified by heightened pain, anxiety and stress.  The extent to which 
stress and pain mediators exert a biological effect on wound healing may be strongly 
influenced by the individual: how much time is spent thinking about pain; the individual’s level 
of anxiety, fear and emotive facets accompanying and intensifying pain perception; memories 
and cognitive processes influencing emotive processing; and environmental influences.  The 
links between pain and wound healing are complex and not well understood.  Widgerow et.al. 
[212] is one of the few in the literature to discuss the complexity and multitude of cellular links 
between pain mediators and their effects on delaying wound healing, (as reviewed in Chapter 
2, section 2.5).  The body of research linking stress to delayed wound healing has been 
outlined in Chapter 2 (section 4.2).  Furthermore, the existence of a neuroendocrine skin axis 
producing a local stress response [177, 180] in addition to the HPA axis and SNS central 
responses to stress, highlights the potential for extensive cellular changes resulting from 
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stress.  The protective responses of pain, stress and anxiety may exacerbate cellular changes 
occurring during burn re-epithelialisation, resulting in delayed wound healing. 
    
 
9.2 Strengths 
Conducting a randomised controlled trial, together with the inclusion of valid tools and 
measures are the primary strengths and the foundations on which this thesis is based.  No 
significant demographic differences or wound and clinical characteristic differences were 
found between the two intervention groups.  Burn depth was measured by a laser Doppler 
scan which is considered the gold standard [18], and allowed for accurate wound 
comparisons across participants.  The Visitrak™ was used at every dressing change to 
accurately calculate the percentage of re-epithelialisation [63] and determine when wounds 
reached ≥95% re-epithelialised.  Salivary biomarkers of stress were employed to obtain an 
objective measure of stress in response to burn care procedures.  
 
 
9.3 Limitations and Future Research 
9.3.1   Limitations in Study Design 
It was not possible to blind to the Ditto™ intervention as children engaged with the device 
throughout wound care procedures.  To overcome this potential bias, a blinded photo review 
was conducted to assess burn wound re-epithelialisation.  Different results were found for the 
number of days taken to re-epithelialise by blinded photo review compared to the Visitrak™.  
This is probably due to errors in clinical judgment, compared to the Visitrak™’s accurate 
mathematical calculations as Visitrak™ has been found to be a valid and reliable wound 
measurement technique [67, 69].  Similarly, inaccurate estimations based on clinical judgment 
have been reported in another study calculating burn size, where burn specialists over-
estimated burn TBSA by as much as 161%, in comparison to a computer-based method of 
calculation [39].  In addition to the challenge of determining percentage of re-epithelialisation 
from photos, reviewers reported difficulties determining wet versus dry areas from a 
photograph.  Despite the initial study design including a ruler and grey colour scale (QPcard 
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101 v2, Kayell Australia) in each photograph, (with the later enabling standardisation of photo 
lighting levels with Photoshop software (Adobe® Photoshop® Elements 9)), blinded photo 
reviewers reported challenges including: glare; less than ideal lighting levels; and difficulty 
determining re-epithelialisation with the inability to touch the wound in the photographic 
assessment of re-epithelialisation.  Advancements in technology with the introduction of 3D 
cameras may allow for improved measurement and comparison of burns across patients with 
the camera distance from the wound standardized, high quality images and the ability to 
rotate the three-dimensional image of the wound. 
 
Data collection commenced at the first change of dressing, which occurred on various days 
(range = 1 - 8 days) post-burn injury for different participants.  This was an unavoidable 
limitation of the study due to the nature of burn outpatient clinics.  Further variations occurred 
in days presenting to outpatient clinics for dressing changes due to the use of both three- and 
seven-day dressings within the burn centre.  Although there was no significant difference in 
dressing type received between the intervention groups, this may still have affected the 
accuracy of measuring exact days until complete re-epithelialisation.  This may be particularly 
integral for superficial-partial thickness to deep partial thickness burns, which are likely to re-
epithelialise around the 14 day window.  Assessing wounds daily would allow for a much 
more accurate measurement of days to re-epithelialise, but this would be unethical and 
counter-productive, subjecting children to additional experiences of pain, distress and anxiety.  
However, future studies should stipulate dressing changes every three days to improve 
consistency in the monitoring and assessing of re-epithelialisation. 
 
Pain is an individualised and subjective experience and presents even greater challenges in 
the area of paediatrics [404].  A myriad of factors can affect the pain experience and measure 
of pain intensity.  Firstly, the nociceptor neuronal pathways are complex.  Duel convergence 
of the sensory and affective nociceptive afferents, means that emotional shading is added to 
the pain experience [405].  Therefore emotions, past experiences, focus of attention, anxiety, 
fear, level of control over the situation and personality play a significant role in diminishing or 
magnifying the perception of pain [406].  Links between anxiety and pain have been 
established in the literature, with highly anxious burn patients reported to be more susceptible 
to lower pain tolerance [77, 78].  Additionally, exposure to repeatedly noxious stimuli during 
infancy has been reported to permanently change the neuronal architecture of the developing 
132
brain, resulting in greater sensitivity to pain in adolescence [101].  The VAS-Anxiety could 
only be used in children over eight years of age.  Future studies may benefit from exploring 
more in-depth measures of anxiety and personal traits and obtaining a comprehensive history 
of past injury, illness, hospital and pain experiences to aid in interpretation of pain and anxiety 
measures.   
  
The timing of clinics during the morning, close to the cortisol awakening response, was a 
limiting factor in the analysis of this stress biomarker.  Interpretation of declining salivary 
cortisol levels as a blunted effect in response to stress, is indiscernible without further studies.  
Investigating the salivary cortisol response during afternoon burn dressing changes is 
required to negate the possibility that the measurement of salivary cortisol may not have been 
sensitive enough to identify stress peaks during the declining diurnal levels.  Additionally, 
inclusion of a control group of normal children with sequential salivary measures, may have 
assisted in the interpretation of these biomarker results, and is recommended as a 
consideration for future research. 
 
Psychological conditions may impact on salivary measures of stress [59, 407].  Screening of 
psychiatric conditions in this study were based on prior history established from the medical 
notes and patients known to child safety (due to the increased likelihood that these children 
have experienced additional emotional and psychological issues affecting stress, anxiety and 
copying mechanisms), were excluded.  This screening process may not have been rigorous 
enough to identify all children with a pre-existing psychiatric condition, which is a limitation of 
this study.  
 
Furthermore, wound infection is also known to impact on stress [22], thus may be a limiting 
factor in our study.  However, silver dressings are routinely used in the SPPBC, thus greatly 
reducing the likelihood of wound infection occurring in patients participating in our study. 
 
9.3.2   Measures 
In this study 23% of participants were not scanned by laser Doppler imaging (LDI).  This was 
predominantly because the patient is required to remain very still for the period of the scan, 
usually 40 seconds to several minutes.  During this time the wound is uncovered which may 
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exacerbate pain (exposing the wound to air flow), creating an even greater challenge for 
children to remain still.  To minimise this issue, the scanning process was streamlined with 
prior set-up of equipment and wounds remaining covered, until the point of scanning.  To 
overcome missing data, all analysis of burn depth in the thesis used mixed linear regressions 
rather than analysis of variance, to deal with unequal cell size and loss of power. 
 
The non-pharmacological Ditto™ intervention received by the treatment group during burn 
wound care procedures could not be masked.  This limited the ability to collect blinded pain, 
distress and anxiety scores during wound care procedures.  However, self-report of pain is 
considered the gold-standard in the assessment of pain intensity, thus children rating their 
own pain experience on the FPS-R is likely to provide more powerful data than blinded 
observer assessment.” 
 
 
9.4 Clinical and Research Implications 
The collection of work contained in this thesis, combined with prior work conducted by others 
in this area [6, 7], have produced an overwhelming body of evidence on the positive effects of 
Ditto™ intervention in the area of paediatric burn injuries.  These definitive results have led to 
changes in clinical practice within the Stuart Pegg Paediatric Burn Centre, in regard to patient 
management.  The RCT conducted as part of this thesis (Chapter 6) is the last clinical trial to 
include a group of patients who did not receive Ditto™ intervention: Ditto™ procedural 
preparation and distraction intervention is now standard practice within the burn centre.  To 
minimise the clinical disruption of this change in practice, and achieve high clinical utility, 
hospital volunteers have been recruited to implement Ditto™ procedural preparation with 
children each morning in the waiting room of the burn centre.   
 
Achieving optimal pharmacological management in the area of paediatric burns plays an 
integral role in minimising the pain, anxiety and stress of children.  Outpatient management 
encompasses an additional challenge in prescribing medication in the monitoring of patients 
and possible side effects associated with drugs such as Oxycodone™ and Midazolam.  
Several significant associations with higher stress levels (salivary alpha-amylase) were 
identified including:  
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 Higher stress levels in children who received no medication, compared to the receipt of 
Oxycodone™. 
 Higher stress levels were associated with higher scores on the Child Trauma 
Screening Questionnaire at three months post re-epithelialisation. 
 
These findings have significant clinical implications for the burn centre and have instigated a 
review of pharmacological protocols.  A collaborative working party has been formed between 
members of the burn centre (SPPBC) and the Paediatric Pain team within the Royal 
Children’s Hospital Brisbane, and a liaison formed with the Anaesthetics Department, to 
investigate innovative pharmacological interventions (e.g. intra-nasal delivery of drugs) for our 
burn centre, targeting acute procedural pain and anxiety.  Until the burn outpatient procedural 
pain protocol has been developed, the burn team has agreed that all children will receive 
Oxycodone™ at the first change of dressing.  This change to clinical practice is likely to have 
a positive impact on reducing pain and stress levels of burn patients and may reduce the 
likelihood of long-term post-traumatic stress symptoms.  Additionally, the SPPBC will be re-
locating to a new facility within the Queensland Children’s Hospital.  This new facility will offer 
improved staffing, patient flow and patient monitoring, allowing for an overhaul of 
pharmacological administration and pain and anxiety protocols. 
 
Within the statistical model developed in Chapter 7, pain levels of children who did not receive 
the Ditto™ intervention, as well as delayed access to the tertiary burn centre (post-injury) 
were found to be significant indicators of delayed re-epithelialisation.  Together, these findings 
regarding patient management suggest that tertiary burn centres equipped with a specialised 
multi-disciplinary burns team and burn-specific resources can provide optimal care to burn 
patients which hasten re-epithelialisation.  Consequently, patients are now being transferred 
immediately to our burn centre rather than being treated initially at local hospitals.  Not only 
do the clinical findings justify this change in practice, but the economic evaluation (Chapter 8) 
further substantiates these changes in patient care.  The Ditto™ intervention yielded robust 
cost-effectiveness results in reducing days to re-epithelialise and achieving significant direct 
healthcare cost savings for the health system.  The cost-effectiveness analysis also yielded 
positive patient outcomes with the reduction in days for burns to re-epithelialise and possible 
reductions in the development of hypertrophic scarring.  This later finding may also translate 
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to reducing psychosocial implications, such as the effects on quality of life that accompanies 
permanent physical disfigurement [23]. 
 
 
9.5 Future Directions 
Drawing from the discernible findings in the area of burns, the future of Ditto™ research 
shows much potential for clinical trials in other areas of clinical practice.  In addition to burns, 
tailored Ditto™ procedural preparation stories have been developed and are available on the 
device for common procedures in the areas of oncology, radiology, general hospital 
procedures (e.g. IV cannula insertion, blood tests, injections), wound closure procedures, and 
preparation for going to theatre.  Collaborations with the oncology unit are already underway, 
with plans for Ditto™ clinical trials in this area in the near future. 
 
A number of future research projects have arisen from investigating factors delaying re-
epithelialisation (Chapter 7). The four findings identified each warrant an independent 
research study to investigate and corroborate these novel findings:  
1. The association between faster access to a tertiary burns centre and faster burn 
wound re-epithelialisation. 
The change in clinical practice for early transfer of all patients with burn injuries to the 
centre would enable a cohort study to be conducted, in order to compare the two 
different time periods: data collection of re-epithelialisation rates in patients accessing 
the burn centre on day one post-injury could be compared to the group who received 
Ditto™ intervention in this RCT at later days post-injury. 
  
2. Participants from ethnicities of darker skin complexions re-epithelialising faster 
than lighter complexions. 
It is recommended that a multi-centred prospective longitudinal trial across Australia 
and New Zealand, recruiting patients from a range of ethnic backgrounds be 
conducted.  Data collection would require a detailed demographic questionnaire 
exploring the ethnicity of patients and their families.  In addition to measures of burn 
aetiology and re-epithelialisation rate, it is recommended that constitutive skin colour 
be recorded, along with a measure such as the Fitzpatrick Skin Scale [408], a 
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commonly used skin pigmentation referencing scale.  This would provide a way of 
assessing and comparing skin types, whilst limiting patient or investigator ethnic/racial 
biases.   
 
3. The relationship between pain and re-epithelialisation. 
An association between the specialised non-pharmacological Ditto™ intervention and 
faster re-epithelisation rates was identified in comparison to children who did not 
receive Ditto™ intervention.  Further research delving into the interactions between 
nerves and skin cells is required to fully understand the biological effects of pain 
mediators on wound healing. 
 
4. The relationship between larger TBSA burns and delayed re-epithelialisation. 
Older children with larger TBSA partial thickness burns often received Entonox™ and 
therefore did not meet the RCT inclusion criteria (due to the sedative effect of 
Entonox™ and the requirement for its self-administration; holding the tube impeded 
Ditto™ engagement).  It is recommended that a study be conducted investigating both 
the relationship between pain and re-epithelialisation and the relationship between 
TBSA and re-epithelialisation.  A broader inclusion criteria than this RCT is 
recommended, including children who receive Entonox™ and those who require 
grafting.  Analgesia categories would be adjusted for in the analysis, and grafting 
accounted for as a sub-group in sample power calculations and analysis. 
 
Additionally, the identification of demographic, wound and clinical management 
characteristics that predict re-epithelisation in superficial to deep-partial thickness burns, 
endorses the need for future research in this area.  Currently other researchers in our centre 
are studying a population of burn patients who received surgical intervention, to ascertain 
whether the same wound healing predictors are associated with hypertrophic scarring. 
 
 
9.6 Conclusions 
This thesis explores multiple parameters around the re-epithelialisation of burn injuries in the 
paediatric outpatient population.  A specialised non-pharmacological Ditto™ intervention was 
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found to reduce the re-epithelialisation time of paediatric burn injuries by two days. At a 
structural level, longer re-epithelialisation times increase the likelihood of hypertrophic scar 
formation, equating to increased use of resources and significant cost implications to the 
health system and patient.  The Ditto™ was found to be highly cost-effective in an economic 
evaluation.  Furthermore, limited staff resources and ever-growing demands on clinical staff 
are common-place, highlighting the need for interventions with high clinical utility such as the 
Ditto™ device.  With more severe burns, a faster re-epithelialisation rate may also mean that 
grafting could be avoided in some cases.  Minimising the number of dressing changes, and 
reducing the pain, stress and anxiety experienced by patients, together with reducing the 
likelihood of hypertrophic scar formation may significantly improve the acute and long-term 
physiological and psychological outcome for patients and their families.  The benefits of 
hastening re-epithelialisation are multiple.   
 
The primary goal of burn care is to promote early wound closure.  Findings in this thesis have 
demonstrated the benefits of computerised non-pharmacological intervention and identified a 
novel association between receipt of Ditto™ intervention and hastened burn re-
epithelialisation.  Additionally, a number of fundamental and compelling relationships in 
factors delaying burn re-epithelialisation were revealed, which together provide a significant 
contribution to burn research and most importantly improving future burn patient care and 
outcomes. 
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